<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-HEADER AEXT-CLASS="Y">
<DOCUMENT-NAME ACODE="11011">사업보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20210122">4.2</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="01186671">(주)바이오시네틱스</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="LINK_FLAG" AFEATURE="BOTH">N</EXTRACTION>
<EXTRACTION ACODE="FIN_TYPE" AFEATURE="BOTH">A</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH">110111-2943010</EXTRACTION>
</SUMMARY>
</DOCUMENT-HEADER>

<BODY>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 정정문서 작성시 『정오표』 삽입</COMMENT>
<LIBRARYLIST>정정신고(보고)-대표이사등의확인.LCommon</LIBRARYLIST>
</INSERTION>

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">사 업 보 고 서</COVER-TITLE>
<P>&cr;&cr;&cr;</P>
<P USERMARK="F-16">                                    (제 17 기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20200101">2020년 01월 01일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31">금융위원회</TD>
<TD WIDTH="400" HEIGHT="31" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="31" ALIGN="RIGHT">2021년    03 월    19 일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31"></TD>
<TD WIDTH="400" HEIGHT="31"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="1">주권상장법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31"></TD>
<TD WIDTH="400" HEIGHT="31"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="31">(주)바이오시네틱스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31"></TD>
<TD WIDTH="400" HEIGHT="31"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="31">김  갑  식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31"></TD>
<TD WIDTH="400" HEIGHT="31"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="55">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="55">서울특별시 금천구 가산디지털2로 184, 708호&cr;(가산동, 벽산디지털밸리 2차)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31"></TD>
<TD WIDTH="400" HEIGHT="31">(전  화) 02-2113-1280</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31"></TD>
<TD WIDTH="400" HEIGHT="31">(홈페이지) http://www.bio-synectics.com</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31"></TD>
<TD WIDTH="400" HEIGHT="31"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="31">(직  책)  부 사 장               (성  명) 이  주  환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31"></TD>
<TD WIDTH="400" HEIGHT="31">(전  화) 02-2113-1280</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31"></TD>
<TD WIDTH="400" HEIGHT="31"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TOC>
<TITLE ATOC="N">목     차</TITLE>
<P>【대표이사 등의 확인】&cr;&cr;Ⅰ. 회사의 개요&cr;    1. 회사의 개요&cr;    2. 회사의 연혁&cr;    3. 자본금 변동사항&cr;    4. 주식의 총수 등&cr;    5. 의결권 현황&cr;    6. 배당에 관한 사항 등&cr;    7. 정관에 관한 사항&cr;&cr;Ⅱ. 사업의 내용&cr;&cr;Ⅲ. 재무에 관한 사항&cr;   1. 요약재무정보&cr;   2. 연결재무제표&cr;   3. 연결재무제표 주석&cr;   4. 재무제표&cr;   5. 재무제표 주석&cr;   6. 기타 재무에 관한 사항&cr;&cr;Ⅳ. 이사의 경영진단 및 분석의견&cr;&cr;Ⅴ. 감사인의 감사의견 등&cr;&cr;Ⅵ. 이사회 등 회사의 기관에 관한 사항&cr;   1. 이사회의 관한 사항&cr;   2. 감사제도에 관한 사항&cr;   3. 주주의 의결권 행사에 관한 사항&cr;&cr;Ⅶ. 주주에 관한 사항&cr;&cr;Ⅷ. 임원 및 직원 등에 관한 사항&cr;   1. 임원 및 직원의 현황&cr;   2. 임원의 보수 등&cr;&cr;Ⅸ. 계열회사 등에 관한 사항&cr;&cr;Ⅹ. 이해관계자와의 거래내용&cr;&cr;XI. 그밖에 투자자 보호를 위하여 필요한 사항&cr;&cr;【전문가의 확인】&cr;   1. 전문가의 확인&cr;   2. 전문가와의 이해관계&cr;</P>
<PGBRK></PGBRK>
</TOC>

<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>
<P></P>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">20210318170344.pdf_page_1_2.jpg</IMG>
<IMG-CAPTION ATOC="N">.</IMG-CAPTION>
</IMAGE>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">I. 회사의 개요</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0">1. 회사의 개요</TITLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『연결재무제표를작성하는주권상장법인』 삽입</COMMENT>
<LIBRARYLIST>11011#*연결재무제표를작성하는주권상장법인.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<P>
<SPAN USERMARK=" B">가. 회사의 법적, 상업적 명칭&cr;</SPAN>주식회사 바이오시네틱스라고 표기합니다. &cr;또한 영문으로는 Bio-Synectics, Inc. 라 표기합니다.&cr;&cr;
<SPAN USERMARK=" B">나. 설립일자 및 존속기간&cr;</SPAN>당사는 2004년 01월 29일에 설립되었습니다.&cr;&cr;
<SPAN USERMARK=" B">다. 본사의 주소, 전화번호 및 홈페이지주소&cr;</SPAN>주소 : 서울특별시 금천구 가산디지털2로 184, 708호(가산동, 벽산디지털밸리 2차) &cr;전화번호 : 02-2113-1285&cr;홈페이지 : http://www.bio-synectics.com&cr;&cr;
<SPAN USERMARK=" B">라. 중소기업 해당여부&cr;</SPAN>당사는 보고서 제출일 현재 중소기업기본법 제 2조에 의한 중소기업에 해당됩니다.&cr;&cr;
<SPAN USERMARK=" B">마. 벤처기업/이노비즈기업 해당여부</SPAN>
</P>

<TABLE BORDER="1" WIDTH="594" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="186"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>

<TD WIDTH="195" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">유효기간</P>
</TD>

<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">발행번호</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">비고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">벤처기업</P>
</TD>
<TD WIDTH="195" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2020,02.17~2022.02.16</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">제20200300123호</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">바. 주요 사업의 내용&cr;</SPAN>당사는 나노의약품 및 소재, 약물전달시스템 (DDS) 등을 주요사업으로 영위하고 있습니다. 기타의 자세한 사항은 동 보고서의 'Ⅱ. 사업의 내용’을 참조하시기 바랍니다. &cr;
</P>
<P USERMARK=" B">사. 회사의 주권상장(또는 등록ㆍ지정)여부 및 특례상장에 관한 사항</P>

<TABLE-GROUP ACLASS="SPC_CRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)여부</TH>
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)일자</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;여부</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;적용법규</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACODE="SPC_CHK" USERMARK="F-BT12">코넥스시장</TE>
<TU WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" AUNIT="SPC_DATE" AUNITVALUE="20171215">2017년 12월 15일</TU>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACODE="SPC_CHP" USERMARK="F-BT12">해당사항&cr;없습니다.</TE>
<TE WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACODE="SPC_LAW" USERMARK="F-BT12">해당사항&cr;없습니다.</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0">2. 회사의 연혁</TITLE>
<P USERMARK=" B">&cr;가. 회사의 연혁</P>

<TABLE BORDER="1" WIDTH="682" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="589"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">일 시</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">내                     용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2004.01</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="79">
<P USERMARK="F-BT12">주식회사 바이오시넥틱스 법인설립(설립 자본금 100,000,000원) / &cr;대표이사 김갑식 선임</P>
<P USERMARK="F-BT12">주소: 서울 마포구 신수동 1-1 서강창업보육센터</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2004.02</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">상호변경(주식회사 바이오시넥틱스 → 주식회사 바이오시네틱스)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2004.08</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">신기술보육(TBI)사업 신기술 사업자 선정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2005.05</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">벤처기업으로 지정 (신기술기업)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2005.07</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (유상증자, 누적자본금 200,000,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2006.07</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">NUFS™ 기술 국내 특허 취득</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2006.09</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (유상증자, 누적자본금 217,500,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2007.03</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">본점 소재지 변경 &cr;(서울시 금천구 가산동 470-5 에이스테크노타워 10차 209호)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2007.04</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">중외제약과 공동기술개발계약 체결 (BS-OXL 개량신약)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2008.08</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (무상증자, 누적자본금 252,500,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2008.08</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (유상증자, 누적자본금 307,500,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2008.10</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">대표이사 변경(김갑식 → 김갑식, 이주환(공동대표이사))</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2008.11</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (유상증자, 누적자본금 317,500,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2008.11</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">Korea BizBiz Day (프랑크푸르트/뉴저지/오사카) 기술발표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2009.03</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (무상증자, 누적자본금 407,500,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2009.08</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">파마킹과 연구개발계약 체결 (BS-MKT 개량신약)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2009.09</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">NUFS™ 기술 호주/중국 특허 취득</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2010.01</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">국제 부인암 학회 IGCS 2010에서 NUFS™ 기술 적용성과 발표&cr;(Taxane계 항암제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2010.04</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (유상증자, 누적자본금 423,500,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2010.12</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">본점 소재지 변경 (서울시 금천구 가산동 481-10 벽산디지털밸리2차 1517호)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2010.12</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (무상증자, 누적자본금 567,500,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2011.08</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">NUFS™ 기술 일본 특허 취득</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2011.08</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (유상증자, 누적자본금 587,500,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2011.11</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">㈜두산과 나노세라마이드 공동연구개발 및 사업화 계약 체결</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2011.12</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">BS-102 보건 복지부 선도형 암연구 사업단 과제로 선정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.02</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">Biopartnering North America에서 나노입자화 기술 발표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.03</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (유상증자, 누적자본금 787,500,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.07</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">Amway와 연구개발계약 체결 (Bioavailability 향상된 소재)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.07</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">NUFS™ 기술 미국 특허 취득</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.10</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (유상증자, 누적자본금 967,500,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2013.03</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">대표이사 변경(김갑식, 이주환(공동대표이사) → 김갑식)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2013.05</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (유상증자, 누적자본금 1,290,000,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2013.11</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">대웅제약과 공동연구개발 및 기술이전계약 체결 (BS-101)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2014.03</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">본점 소재지 변경 &cr;(서울시 금천구 가산디지털2로 184, 708호(가산동, 벽산디지털밸리2차))</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.03</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">NUFS™ 기술 유럽 주요국 특허 취득</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.09</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">SENS™ 기술 미국 및 중국 특허 취득</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.09</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">BS-102관련 논문 Int.J.of Nanomedicine에 게재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.12</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">자본금 증자 (유상증자(전환우선주), 누적자본금 1,548,625,000원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2016.09</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">표적항암제 프로젝트 ‘산업핵심기술개발사업’ 선정&cr;(산업통상자원부, 정부지원금: 40억/4년)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2016.10</P>
</TD>

<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">지점설치 (바이오시네틱스 제 1공장, 서울시 금천구 가마산로 96, 710호&cr;(가산동, 대륭테크노타운8차))</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2017.11</TD>
<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">자본금 증자 (유상증자(상환전환우선주), 누적자본금 1,759,892,500원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2017.12</TD>
<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">코넥스시장 상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2017.12</TD>
<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">삼양바이오팜과 기술이전계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.01</TD>
<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">한국팜비오와 NUFS™기술을 적용한 의약품의 생산 및 판매에 대한 업무제휴계약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.08</TD>
<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">미국 국립암연구소 산하 NCL(나노기술특성분석연구소), BS-102 관련 MTA 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.10</TD>
<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">BS-104 개량신약 임상시험 개시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2019.02</TD>
<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">한국팜비오와 나노항진균제 기술이전 계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2019.07</TD>
<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-BT12">나노코리아 2019 어워드 "생체이용률과 수분산성이 강화된 나노입자 기능성 소재"로 산업통상자원부 장관상 수상</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2019.09</TD>
<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">건강기능식품 GMP 획득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2019.12</TD>
<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">자본금 증자 (주식매수선택권 행사, 누적자본금 1,787,337,500원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2020.07</TD>
<TD WIDTH="598" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">KMF 할랄인증서 획득</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">나. 상호의 변경&cr;</SPAN>- 2004년 01월 29일 : 주식회사 바이오시넥틱스&cr;- 2004년 02월 16일 : 주식회사 바이오시네틱스
</P>

<P>&cr;
<SPAN USERMARK=" B">다. 본점소재지 및 그 변경</SPAN>
</P>
<P>- 2004년 01월 29일 : 서울시 마포구 신수동 1-1 서강창업보육센터</P>
<P>- 2007년 03월 19일 : 서울시 금천구 가산동 470-5 에이스테크노타워 10차 209호</P>
<P>- 2010년 12월 10일 : 서울시 금천구 가산동 481-10 벽산디지털밸리2차 1517호</P>
<P>- 2014년 03월 14일 : 서울시 금천구 가산디지털2로 184, 708호&cr;                               (가산동, 벽산디지털밸리2차)&cr;</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0">3. 자본금 변동사항</TITLE>
<P></P>
<P>증자(감자)현황</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="693" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="387"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="396" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="692" BORDER="1">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행&cr;(감소)일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)&cr;형태</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="442" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당&cr;액면가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행&cr;(감소)가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20040129">2004.01.29</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">보통주</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>20,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>5,000</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">설립자본</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20050722">2005.07.22</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>20,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>5,000</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">유상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20060919">2006.09.19</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>3,500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>15,000</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">유상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20080805">2008.08.05</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>7,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>-</P>
</TE>
<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER" USERMARK="F-BT12">무상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20080814">2008.08.14</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>11,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>5,000</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">유상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20081113">2008.11.13</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>2,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>50,000</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">유상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20090328">2009.03.28</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>18,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>-</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">무상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20100401">2010.04.01</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>3,200</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>50,000</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">유상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20101220">2010.12.20</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>28,800</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>-</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">무상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20110825">2011.08.25</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>4,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>50,000</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">유상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20120324">2012.03.24</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>40,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>5,000</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">유상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20121024">2012.10.24</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>36,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>-</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">무상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20130509">2013.05.09</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>보통주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>64,500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>31,000</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">유상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20151216">2015.12.16</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">
<P>우선주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>51,725</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">
<P>5,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">
<P>58,000</P>
</TE>

<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER">
<P USERMARK="F-BT12">유상증자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20170412">2017.04.12</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">보통주</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>2,580,000</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT" USERMARK="F-BT12">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT" USERMARK="F-BT12">-</TE>
<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER" USERMARK="F-BT12">액면분할</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="31" AUNIT="INC_DT" AUNITVALUE="20170412">2017.04.12</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="31" AUNIT="INC_DR_KND" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_CNT" USERMARK="F-BT12">517,250</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ACODE="INC_PAR_AMT" USERMARK="F-BT12">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="31" ACODE="INC_SL_AMT" USERMARK="F-BT12">-</TE>
<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ALIGN="CENTER" USERMARK="F-BT12">액면분할</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20171118">2017.11.18</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_STK_KND">우선주</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="35" ACODE="INC_CNT">
<P>422,535</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT" USERMARK="F-BT12">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT" USERMARK="F-BT12">7,100</TE>
<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ALIGN="CENTER" USERMARK="F-BT12">유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="31" AUNIT="INC_DT" AUNITVALUE="20180420">2018.04.20</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="31" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_CNT" USERMARK="F-BT12">25,190</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ACODE="INC_PAR_AMT" USERMARK="F-BT12">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="31" ACODE="INC_SL_AMT" USERMARK="F-BT12">1,500</TE>
<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ALIGN="CENTER" USERMARK="F-BT12">유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="31" AUNIT="INC_DT" AUNITVALUE="20180517">2018.05.17</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="31" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_CNT" USERMARK="F-BT12">2,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ACODE="INC_PAR_AMT" USERMARK="F-BT12">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="31" ACODE="INC_SL_AMT" USERMARK="F-BT12">1,500</TE>
<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ALIGN="CENTER" USERMARK="F-BT12">유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="31" AUNIT="INC_DT" AUNITVALUE="20180824">2018.08.24</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="31" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_CNT" USERMARK="F-BT12">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ACODE="INC_PAR_AMT" USERMARK="F-BT12">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="31" ACODE="INC_SL_AMT" USERMARK="F-BT12">1,500</TE>
<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ALIGN="CENTER" USERMARK="F-BT12">유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="31" AUNIT="INC_DT" AUNITVALUE="20190521">2019.05.21</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="31" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_CNT" USERMARK="F-BT12">7,700</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ACODE="INC_PAR_AMT" USERMARK="F-BT12">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="31" ACODE="INC_SL_AMT" USERMARK="F-BT12">1,500</TE>
<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ALIGN="CENTER" USERMARK="F-BT12">유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="31" AUNIT="INC_DT" AUNITVALUE="20191216">2019.12.16</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="31" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="98" HEIGHT="31" ACODE="INC_CNT" USERMARK="F-BT12">16,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ACODE="INC_PAR_AMT" USERMARK="F-BT12">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="31" ACODE="INC_SL_AMT" USERMARK="F-BT12">4,000</TE>
<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="31" ALIGN="CENTER" USERMARK="F-BT12">유상증자</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1. 당사는 2017년 4월 12일 기준 액면분할(500원) 및 &cr;2017년 11월 18일 기준 유상증자 제3자배정으로 422,535주(발행가액 7,100원)가 &cr;발행되었습니다. 2018년 4월 20일, 5월 17일, 8월 24일, 2019년 5월 21일, 12월 16일에 주식매수선택권 행사로 38,890주(발행가액 1,500원), 16,000주(발행가액 4,000원)가 발행되어 제출일 현재 총 발행주식수는 3,574,675주입니다.</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환사채 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환사채발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 신주인수권부사채 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환신주인수권부사채등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환형 조건부자본증권 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환형조건부자본증권등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0">4. 주식의 총수 등</TITLE>
<P>주식의 총수 현황</P>

<TABLE-GROUP ACLASS="TOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="663" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="325" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="665" BORDER="1">

<COLGROUP>
<COL WIDTH="25"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="61" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="314" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="61" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACOPYCOL="N" ACODE="STK_KND_TOT" ADELETECOL="N" AMOVECOL="N" USERMARK="F-BT12">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACOPYCOL="Y" ACODE="STK_KND_TOT" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT12">종류주식</TE>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="35" AUPDATECONT="N"> Ⅰ. 발행할 주식의 총수</TD>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="35" ACODE="ISU_STK1">
<P>16,000,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="35" ACODE="ISU_STK1">
<P>4,000,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="35" ACODE="SUM_ISU_STK1">
<P>20,000,000</P>
</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="35" ALIGN="CENTER" ACODE="NOTE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="35" AUPDATECONT="N"> Ⅱ. 현재까지 발행한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="35" ACODE="ISU_STK2" USERMARK="F-BT12">2,634,890</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="35" ACODE="ISU_STK2">
<P>939,785</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="35" ACODE="SUM_ISU_STK2" USERMARK="F-BT12">3,574,675</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="35" ALIGN="CENTER" ACODE="NOTE1" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="31" AUPDATECONT="N"> Ⅲ. 현재까지 감소한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="TOT_RST" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="TOT_RST" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ACODE="SUM_RST" USERMARK="F-BT12">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ALIGN="CENTER" ACODE="NOTE2" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="34" HEIGHT="124" AUPDATECONT="N"></TD>
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="31" AUPDATECONT="N"> 1. 감자</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="RDC_CNT" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="RDC_CNT" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ACODE="SUM_RDC_CNT" USERMARK="F-BT12">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ALIGN="CENTER" ACODE="NOTE3" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="31" AUPDATECONT="N"> 2. 이익소각</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="DST_CNT" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="DST_CNT" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ACODE="SUM_DST_CNT" USERMARK="F-BT12">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ALIGN="CENTER" ACODE="NOTE4" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="31" AUPDATECONT="N"> 3. 상환주식의 상환</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="RFD_CNT" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="RFD_CNT" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ACODE="SUM_RFD_CNT" USERMARK="F-BT12">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ALIGN="CENTER" ACODE="NOTE5" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="31" AUPDATECONT="N"> 4. 기타</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="ETC_CNT" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="ETC_CNT" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ACODE="SUM_ETC_CNT" USERMARK="F-BT12">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ALIGN="CENTER" ACODE="NOTE6" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="35" AUPDATECONT="N"> Ⅳ. 발행주식의 총수 (Ⅱ-Ⅲ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="35" ACODE="ISU_STK3" USERMARK="F-BT12">2,634,890</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="35" ACODE="ISU_STK3">
<P>939,785</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="35" ACODE="SUM_ISU_STK3" USERMARK="F-BT12">3,574,675</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="35" ALIGN="CENTER" ACODE="NOTE7" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="31" AUPDATECONT="N"> Ⅴ. 자기주식수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="TRS_STK" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" ACODE="TRS_STK" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ACODE="SUM_TRS_STK" USERMARK="F-BT12">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="31" ALIGN="CENTER" ACODE="NOTE8" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="35" AUPDATECONT="N"> Ⅵ. 유통주식수 (Ⅳ-Ⅴ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="35" ACODE="FLT_STK" USERMARK="F-BT12">2,634,890</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="35" ACODE="FLT_STK">
<P>939,785</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="35" ACODE="SUM_FLT_STK" USERMARK="F-BT12">3,574,675</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="35" ALIGN="CENTER" ACODE="NOTE9" USERMARK="F-BT12">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『자기주식 취득 및 처분 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*자기주식취득및처분현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆ 『종류주식(명칭) 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*종류주식발행현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">24_종류주식발행현황</FILENAME>

<P>
<SPAN USERMARK=" B">나. 종류주식 발행현황&cr;</SPAN>(1) 종류주식(전환우선주)발행 현황
</P>

<TABLE-GROUP ACLASS="ISS_CURR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="621" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="312"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="321" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="624" BORDER="1">

<COLGROUP>
<COL WIDTH="63"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="165"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="3" AUPDATECONT="N">발행일자</TD>
<TU WIDTH="324" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="ISS_DATE" AUNITVALUE="20151216" COLSPAN="2">2015년 12월 16일</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" COLSPAN="3" AUPDATECONT="N">주당 발행가액(액면가액)</TD>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="ISS_PRC" USERMARK="F-BT12">5,800</TE>
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="ISS_PRCK" USERMARK="F-BT12">500</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" COLSPAN="3" AUPDATECONT="N">발행총액(발행주식수)</TD>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="ISS_TOT" USERMARK="F-BT12">3,000,005,000</TE>
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="ISS_TOTK" USERMARK="F-BT12">517,250</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" COLSPAN="3" AUPDATECONT="N">현재 잔액(현재 주식수)</TD>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="ISS_PNT" USERMARK="F-BT12">3,000,005,000</TE>
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="ISS_PNTK" USERMARK="F-BT12">517,250</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="598" ROWSPAN="12" AUPDATECONT="N">주식의&cr;내용</TD>
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" COLSPAN="2" AUPDATECONT="N">이익배당에 관한 사항</TD>
<TE WIDTH="324" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="STK_BET" COLSPAN="2" USERMARK="F-BT12">보통주와 동일한 배당률 적용</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" COLSPAN="2" AUPDATECONT="N">잔여재산분배에 관한 사항</TD>
<TE WIDTH="324" HEIGHT="55" ACODE="STK_PRO" COLSPAN="2" USERMARK="F-BT12">잔여재산분배에 있어서 보통주에 대해 우선권 있음 </TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="177" ROWSPAN="5" AUPDATECONT="N">상환에&cr;관한 사항</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" AUPDATECONT="N">상환조건</TD>
<TE WIDTH="324" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="STK_REP" COLSPAN="2" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" AUPDATECONT="N">상환방법</TD>
<TE WIDTH="324" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="STK_WAY" COLSPAN="2" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" AUPDATECONT="N">상환기간</TD>
<TE WIDTH="324" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="STK_DAT" COLSPAN="2" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" AUPDATECONT="N">주당 상환가액</TD>
<TE WIDTH="324" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="STK_PRC" COLSPAN="2" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">1년 이내&cr;상환 예정인 경우</TD>
<TE WIDTH="324" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="STK_ONE" COLSPAN="2" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="304" ROWSPAN="4" AUPDATECONT="N">전환에&cr;관한 사항</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" AUPDATECONT="N">전환조건&cr;(전환비율 변동여부 포함)</TD>
<TE WIDTH="324" VALIGN="MIDDLE" HEIGHT="79" ACODE="STK_CHA" COLSPAN="2" USERMARK="F-BT12">전환청구서에 전환하고자 하는 주식의 종류,수, 청구일자를 기재하여 기명 또는서명날인하고 주권을 첨부하여 제출 </TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="119" AUPDATECONT="N">전환청구기간</TD>

<TE WIDTH="324" VALIGN="MIDDLE" HEIGHT="119" ACODE="STK_CDA" COLSPAN="2">
<P>납입기일 다음날로부터 10년 경과일 전일까지(또는 존속기간 말일 전일까지) 단, 만료일까지 전환권 미행사시 만료일에 보통주로 자동전환</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">전환으로 발행할&cr;주식의 종류</TD>
<TE WIDTH="324" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="STK_KID" COLSPAN="2" USERMARK="F-BT12">보통주 </TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">전환으로&cr;발행할 주식수</TD>
<TE WIDTH="324" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="STK_CHT" COLSPAN="2" USERMARK="F-BT12">517,250 </TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" COLSPAN="2" AUPDATECONT="N">의결권에 관한 사항</TD>
<TE WIDTH="324" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="STK_VOT" COLSPAN="2" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="623" COLSPAN="3" AUPDATECONT="N">기타 투자 판단에 참고할 사항&cr;(주주간 약정 및 재무약정 사항 등)</TD>

<TE WIDTH="324" VALIGN="MIDDLE" HEIGHT="623" ACODE="ISS_ETC" COLSPAN="2">
<P>① 전환비율 : 종류주식 1주당 보통주 1주</P>
<P>② 전환비율 조정에 관한 사항</P>
<P>-  IPO 공모단가의 70%에 해당하는 금액이 우선주식의 전환가격을 하회하는 경우 전환비율 조정</P>
<P>-  타사와 합병시 교환비율 산정시 평가가격의 70%에 해당하는 가격이 전환가액을 하회하는 경우 70%가 되도록 조정</P>
<P>-  전환가격을 하회하는 가격으로 유상증자, 주식연계사채 등을 발행하는 경우 전환가격을 그 하회하는 가격으로 조정</P>
<P>-  주식배당, 무상증자 등으로 발행주식수가 증가하는 경우</P>
<P>-  합병 및 주식교환 시 주당 평가가격의 70%가 전환가격을 하회하는 경우 주당 평가가격의 70%가 되도록 조정</P>
<P>-  주식분할 또는 병합 : 분할 또는 병합비율로 조정</P>
<P>-  무상감자 : 감자비율에 따라 조정 후행 투자자의 전환비율 조정이 본건 우선주식보다 유리한 경우 후행 투자자의 전환비율에 따라 전환비율 조정</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>
<P>(2) 종류주식 (상환전환우선주) 발행현황&cr;(기준일: 2020년 12월 31일)&cr;                                                                                                        (단위 : 원)</P>

<TABLE BORDER="1" WIDTH="622" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="63"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="163"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">발행일자</TD>
<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2017년 11월 18일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">주당 발행가액(액면가액)</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">7,100</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">발행총액(발행주식수)</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">2,999,998,500</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">422,535</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">현재 잔액(현재 주식수)</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">2,999,998,500</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">422,535</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="12" WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="708" USERMARK="F-BT12">주식의&cr;내용</TD>
<TD COLSPAN="2" WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">이익배당에 관한 사항</TD>
<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">보통주와 동일한 배당률 적용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">잔여재산분배에 관한 사항</TD>
<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-BT12">잔여재산분배에 있어서 보통주에 대해 우선권 있음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="299" USERMARK="F-BT12">상환에&cr;관한 사항</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">상환조건</TD>

<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">상환기간 내에 상환요청시 이익잉여금 한도내에서 상환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">상환방법</TD>

<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="79">
<P USERMARK="F-BT12">상환요구일로부터 30일 이내 현금 상환</P>
<P USERMARK="F-BT12">단, 주주 요청시 현금 이외에 유가증권 등으로 상환 가능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">상환기간</TD>

<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="79">
<P USERMARK="F-BT12">발행일로부터 3년이 경과한 날로부터 만기일 단, 특별상환권에 관한 사항에 따라 별개로 상환요청 가능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">주당 상환가액</TD>
<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">1년 이내&cr;상환 예정인 경우</TD>
<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-BT12">해당사항 없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="292" USERMARK="F-BT12">전환에&cr;관한 사항</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">전환조건</TD>
<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="79" USERMARK="F-BT12">전환청구서에 전환하고자 하는 주식의 종류, 수, 청구일자를 기재하여 기명 또는 서명날인하고 주권을 첨부하여 제출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103" USERMARK="F-BT12">전환청구기간</TD>

<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="103">
<P USERMARK="F-BT12">납입기일 다음날로부터 10년 경과일 전일까지(또는 존속기간 말일 전일까지) &cr;단, 만료일까지 전환권 미행사 시 만료일에 보통주로 자동전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">전환으로 발행할&cr;주식의 종류</TD>
<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-BT12">보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">전환으로&cr;발행할 주식수</TD>
<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-BT12">422,535</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">의결권에 관한 사항</TD>

<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="535" USERMARK="F-BT12">기타 투자 판단에 참고할 사항</TD>

<TD COLSPAN="2" WIDTH="322" VALIGN="MIDDLE" HEIGHT="535">
<P USERMARK="F-BT12">① 전환비율 : 종류주식 1주당 보통주 1주</P>
<P USERMARK="F-BT12">② 전환비율 조정에 관한 사항</P>
<P USERMARK="F-BT12">-  IPO 공모단가의 70%에 해당하는 금액이 우선주식의 전환가격을 하회하는 경우 전환비율 조정</P>
<P USERMARK="F-BT12">-  타사와 합병시 교환비율 산정시 평가가격의 70%에 해당하는 가격이 전환가액을 하회하는 경우 70%가 되도록 조정</P>
<P USERMARK="F-BT12">-  전환가격을 하회하는 가격으로 유상증자, 주식연계사채 등을 발행하는 경우 전환가격을 그 하회하는 가격으로 조정</P>
<P USERMARK="F-BT12">-  주식배당, 무상증자 등으로 발행주식수가 증가하는 경우 </P>
<P USERMARK="F-BT12">-  합병 및 주식교환 시 주당 평가가격의 70%가 전환가격을 하회하는 경우 주당 평가가격의 70%가 되도록 조정</P>
<P USERMARK="F-BT12">-  주식분할 또는 병합 : 분할 또는 병합비율로 조정</P>
<P USERMARK="F-BT12">-  무상감자 : 감자비율에 따라 조정&cr;후행 투자자의 전환비율 조정이 본건 우선주식보다 유리한 경우 후행 투자자의 전환비율에 따라 전환비율 조정</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0">5. 의결권 현황</TITLE>
<P></P>

<TABLE-GROUP ACLASS="VOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="62" AUPDATECONT="N">발행주식총수(A)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISU_STK_KND" USERMARK="F-BT12">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISU_STK" USERMARK="F-BT12">2,634,890</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISU_STK_KND" USERMARK="F-BT12">종류주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISU_STK" USERMARK="F-BT12">939,785</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="62" AUPDATECONT="N">의결권없는 주식수(B)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISN_STK_KND" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISN_STK" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISN_STK_KND" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISN_STK" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="62" AUPDATECONT="N">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISQ_STK_KND" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISQ_STK" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISQ_STK_KND" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISQ_STK" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="62" AUPDATECONT="N">기타 법률에 의하여&cr;의결권 행사가 제한된 주식수(D)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISJ_STK_KND" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISJ_STK" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISJ_STK_KND" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISJ_STK" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="62" AUPDATECONT="N">의결권이 부활된 주식수(E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISB_STK_KND" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISB_STK" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISB_STK_KND" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISB_STK" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="62" AUPDATECONT="N">의결권을 행사할 수 있는 주식수&cr;(F = A - B - C - D + E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISH_STK_KND" USERMARK="F-BT12">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISH_STK" USERMARK="F-BT12">2,634,890</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="31" ACODE="ISH_STK_KND" USERMARK="F-BT12">종류주식</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="31" ACODE="ISH_STK" USERMARK="F-BT12">939,785</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="31" ACODE="VOT_NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-6-0">6. 배당에 관한 사항 등</TITLE>
<P>주요배당지표&cr;(기준일: 2020년 12월 31일)</P>

<TABLE-GROUP ACLASS="DIVIDEND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="607" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="61" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="61" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전전기</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="31" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" USERMARK="F-BT12">제17기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="31" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" USERMARK="F-BT12">제16기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="31" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" USERMARK="F-BT12">제15기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="31" AUPDATECONT="N" ALIGN="CENTER">주당액면가액(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X23" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">500</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X23" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">500</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X23" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">500</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="31" AUPDATECONT="N" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X01" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X01" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X01" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="31" AUPDATECONT="N" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X35" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-1,838</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X35" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-1,115</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X35" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-1,046</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="31" AUPDATECONT="N" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X02" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-698</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X02" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-426</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X02" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-402</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="31" AUPDATECONT="N" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X24" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X24" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X24" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="31" AUPDATECONT="N" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X25" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X25" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X25" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="31" AUPDATECONT="N" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X05" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X05" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X05" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="62" AUPDATECONT="N" ALIGN="CENTER">현금배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="31" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X31" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X31" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X31" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="31" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X31" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X31" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X31" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="62" AUPDATECONT="N" ALIGN="CENTER">주식배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="31" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X32" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X32" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X32" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="31" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X32" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X32" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X32" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="62" AUPDATECONT="N" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="31" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X33" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X33" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X33" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="31" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X33" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X33" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X33" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="62" AUPDATECONT="N" ALIGN="CENTER">주당 주식배당(주)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="31" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X34" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X34" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X34" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="31" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X34" ADELIM="1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X34" ADELIM="2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="31" ACODE="X34" ADELIM="3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『과거배당이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*과거배당이력.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-7-0">7. 정관에 관한 사항</TITLE>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『정관변경이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*정관변경이력.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">49_정관변경이력</FILENAME>
<P>가. 사업보고서에 첨부된 정관의 최근 개정일은 2019년 3월 28일이며, 제17기 정기주주총회(2021.03.29) 안건 중 정관 변경 안건이 포함될 예정입니다.&cr;※제17기 정기주주총회에서 상정될 정관 일부 변경의 건 안건의 내용은 아래와 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="878" BORDER="1">

<COLGROUP>
<COL WIDTH="161"></COL>
<COL WIDTH="284"></COL>
<COL WIDTH="284"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="170" HEIGHT="33" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT12">의안</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="33" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT12">변경전 내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="33" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT12">변경후 내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="33" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-BT12">변경의 목적</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="11" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="170" HEIGHT="2910" USERMARK="F-BT12">제4호 의안 : &cr;정관 일부 변경의 건</TD>
<TD WIDTH="293" HEIGHT="199" USERMARK="F-BT12">(1) 제8조2 <주식 등의 전자등록> &cr;회사는 「주식ㆍ사채 등의 전자등록에 관한 법률」 제2조 제1호에 따른 주식 등을 발행하는 경우에는 전자등록기관의 전자등록계좌부에 주식 등을 전자등록하여야 한다.</TD>

<TD WIDTH="293" HEIGHT="199" USERMARK="F-BT12">
<SPAN>(1) 제8조2 <주식 등의 전자등록>&cr;회사는 「주식</SPAN>
<SPAN>ㆍ</SPAN>
<SPAN>사채 등의 전자등록에 관한 법률」 제2조 제1호에 따른 주식 등을 발행하는 경우에는 전자등록기관의 전자등록계좌부에 주식 등을 전자등록하여야 한다. </SPAN>
<SPAN USERMARK=" U">다만, 회사가 법령에 따른 등록 의무를 부담하지 않는 주식 등의 경우에는 그러하지 아니할 수 있다.</SPAN>
</TD>
<TD WIDTH="122" HEIGHT="199" USERMARK="F-BT12">비상장 사채 등 의무등록 대상이 아닌 주식 등에 대해서는 전자등록을 하지 않을 수 있도록 개정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="293" HEIGHT="199">
<P USERMARK="F-BT12">제12조 <신주의 동등배당></P>
<P USERMARK="F-BT12">당회사가 유무상증자 및 주식배당에 의하여 신주를 발행한 경우,신주에 대한 이익의 배당에 관하여는 그 신주를 발행한 때가 속하는 사업년도의 직전 사업년도말에 발행된 것으로 본다.</P>
</TD>

<TD WIDTH="293" HEIGHT="199">
<P USERMARK="F-BT12">제12조 <신주의 동등배당></P>
<P USERMARK="F-BT12 U">1. 회사가 정한 배당기준일 전에 유상증자, 무상증자 및 주식배당에 의하여 발행한 주식에 대하여는 동등배당한다.</P>
<P USERMARK="F-BT12 U">2. 제1항의 규정에도 불구하고 배당기준일을 정하는 이사회 결의일로부터 그 배당기준일까지 발행한 신주에 대하여는 배당을 하지 아니한다.</P>
</TD>

<TD WIDTH="122" HEIGHT="199">
<P USERMARK="F-BT12">동등배당 원칙 명시</P>
<P USERMARK="F-BT12">배당기준일 설정 후 신주발행에 의한 주주간 이해관계 상충 방지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="293" HEIGHT="559">
<P USERMARK="F-BT12">제16조 <주주명부의 폐쇄 및 기준일></P>
<P USERMARK="F-BT12">1. 당회사는 매년 1월 1일부터 1월 15일까지 주주의 권리에 관한 주주명부의 기재변경을 정지한다.</P>
<P USERMARK="F-BT12">2. 당회사는 매년 12월 31일 최종의 주주명부에 기재되어 있는 주주를 그 결산기에 관한 정기주주총회에서 권리를 행사할 주주로 한다.</P>
<P USERMARK="F-BT12">3. 당회사는 임시주주총회의 소집 기타 필요한 경우 이사회의 결의로 3월을 경과하지 아니하는 일정한 기간을 정하여 주주명부의 기재변경을 정지하거나, 이사회의 결의로 3월내로 정한 날에 주주명부에 기재되어 있는 주주를 그 권리를 행사할 수 있는 주주로 할 수 있으며, 이사회가 필요하다고 인정하는 경우에는 주주명부의 기재변경 정지와 기준일의 지정을 함께 할 수 있다. 이 경우 회사는 주주명부 폐쇄기간 또는 기준일의 2주간 전에 이를 공고하여야 한다.</P>
</TD>

<TD WIDTH="293" HEIGHT="559">
<P USERMARK="F-BT12">제16조 <주주명부의 폐쇄 및 기준일></P>
<P USERMARK="F-BT12 U">1. 회사는 매년 12월 31일 현재 주주명부에 기재되어 있는 주주를 그 결산기에 관한 정기주주총회에서 권리를 행사할 주주로 한다.</P>
<P USERMARK="F-BT12 U">2. 회사는 의결권을 행사하거나 배당을 받을 자 기타주주 또는 질권자로서 권리를 행사할 자를 정하기 위하여 이사회 결의로 일정한 기간을 정하여 주주명부의 기재변경을 정지하거나 일정한 날에 주주명부에 기재된 주주 또는 질권자를 그 권리를 행사할 주주 또는 질권자로 볼 수 있다.</P>
<P USERMARK="F-BT12 U">3. 회사가 제2항의 기간 또는 날을 정하는 경우 3개월을 경과하지 아니하는 일정한 기간을 정하여 권리에 관한 주주명부의 기재변경을 정지하거나, 3개월 내로 정한 날에 주주명부에 기재되어 있는 주주를 그 권리를 행사할 주주로 할 수 있다.</P>
<P USERMARK="F-BT12 U">4. 회사가 제2항의 기간 또는 날을 정한 때에는 그 기간 또는 날의2주 전에 이를 공고하여야 한다.</P>
</TD>
<TD WIDTH="122" HEIGHT="559" USERMARK="F-BT12">정기주주총회 개최시기의 유연성을 확보하기 위하여 조문 정비</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="293" HEIGHT="176" USERMARK="F-BT12">
<P>제20조 <소집시기></P>
<P>1. 당회사의 주주총회는 정기주주총회와 임시주주총회로 한다.</P>
<P>2. 정기주주총회는 매사업년도 종료 후 3월 이내에, 임시주주총회는 필요에 따라 이사회의 결의나 기타 법령이 정하는 바에 따라 소집한다.</P>
</TD>

<TD WIDTH="293" HEIGHT="176" USERMARK="F-BT12">
<P>제20조 <소집시기></P>
<P USERMARK=" U">회사는 매 결산기마다 정기주주총회를 소집하여야 하고, 필요에 따라 임시주주총회를 소집한다.</P>
</TD>

<TD WIDTH="122" HEIGHT="176" USERMARK="F-BT12">
<P>정기주주총회 개최시기의 유연성을 확보하기 위하여 수정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="293" HEIGHT="631" USERMARK="F-BT12">제45조 <감사의 수 및 선임
<SPAN>ㆍ</SPAN>해임>&cr;1. 당 회사의 감사는 1명 이상 2인 이내로 하며 주주총회에서 선임한다.&cr;2. 감사의 선임을 위한 의안은 이사의 선임을 위한 의안과는 별도로 상정하여 의결한다.&cr;3. 감사의 선임은 출석한 주주의 의결권의 과반수로 하되 발행주식총수의 4분의 1이상의 수로 하여야 한다. 그러나 의결권있는 발행주식총수의 100분의 3을 초과하는 수의 주식을 가진 주주는 그 초과하는 주식에 관하여 제1항의 감사의 선임에 있어서는 의결권을 행사하지 못한다. 다만, 소유주식수의 산정에 있어 최대주주와 그 특수관계인, 최대주주 또는 그 특수관계인의 계산으로 주식을 보유하는 자, 최대주주 또는 그 특수관계인에게 의결권을 위임한 자가 소유하는 의결권 있는 주식의 수는 합산한다.&cr;
</TD>

<TD WIDTH="293" HEIGHT="631" USERMARK="F-BT12">제45조 <감사의 수 및 선임ㆍ해임>&cr;1. 당 회사의 감사는 1명 이상 2인 이내로 하며 주주총회에서 선임·
<SPAN USERMARK=" U">해임</SPAN> 한다.&cr;2. 감사의 선임 
<SPAN USERMARK=" U">또는 해임</SPAN>을 위한 의안은 이사의 선임 
<SPAN USERMARK=" U">또는 해임</SPAN>을 위한 의안과는 별도로 상정하여 의결한다.&cr;3. 감사의 선임은 출석한 주주의 의결권의 과반수로 하되 발행주식총수의 4분의 1이상의 수로 하여야 한다. 
<SPAN USERMARK=" U">다만, 상법 제368조의4제1항에 따라 전자적 방법으로 의결권을 행사할 수 있도록 한 경우에는 출석한 주주의 의결권의 과반수로써 감사의 선임을 의결할 수 있다.&cr;4. 감사의 해임은 출석한 주주의 의결권의 3분의2이상의 수로 하되, 발행주식 총수의 3분의1이상의 수로 하여야 한다.&cr;5. 제3항·제4항의 감사의 선임 또는 해임에는 의결권 있는 발행주식총수의 100분의 3을 초과하는 수의 주식을 가진 주주(최대주주인 경우에는 그의 특수관계인, 최대주주 또는 그 특수관계인의 계산으로 주식을 보유하는 자, 최대주주 또는 그 특수관계인에게 의결권을 위임한 자가 소유하는 의결권 있는 주식의 수를 합산한다)는 그 초과하는 주식에 관하여 의결권을 행사하지 못한다.</SPAN>
</TD>
<TD WIDTH="122" HEIGHT="631" USERMARK="F-BT12">표준정관에 의거 감사선임에 관한 조문 정비 및 개정상법 제409조 제3항/ 제542조의12제7항 반영</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="293" HEIGHT="247" USERMARK="F-BT12">
<P>제52조 <재무제표 등의 작성 등></P>
<P>1. 당회사의 대표이사(사장)은 상법 제447조 및 제447조의2의 각 서류를 작성하여 이사회의 승인을 얻어야 하며 정기주주총회 회의일 6주간전에 감사에게 제출하여야 한다.</P>
<P>2. 감사는 정기주주총회 회의일의 1주전까지 감사보고서를 대표이사에게 제출하여야 한다.</P>
</TD>

<TD WIDTH="293" HEIGHT="247">
<P USERMARK="F-BT12">제52조 <재무제표 등의 작성 등></P>

<P USERMARK="F-BT12">1. 당회사의 대표이사(사장)은 상법 제447조 및 제447조의2의 각 서류를 작성하여 이사회의 승인을 얻어야 하며 정기주주총회 회의일 
<SPAN USERMARK=" U">또는 사업보고서 제출기한의</SPAN> 6주간전에 감사에게 제출하여야 한다.
</P>

<P USERMARK="F-BT12">2. 감사는 정기주주총회 회의일 
<SPAN USERMARK=" U">또는 사업보고서 제출기한의</SPAN> 1주전까지 감사보고서를 대표이사에게 제출하여야 한다.
</P>
</TD>

<TD WIDTH="122" HEIGHT="247">
<P USERMARK="F-BT12">표준정관에 의거 정기주주총회 개최시기의 유연성을 확보하기 위해 조문 정비</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="247" USERMARK="F-BT12">제55조<이익배당>&cr;1. 이익의 배당은 금전 또는 금전 이외의 재산으로 할 수 있다.&cr;2. 전항의 배당은 매결산기말 현재의 주주명부에 기재된 주주 또는 등록된 질권자에게 지급한다.&cr;3. 이익의 배당을 주식으로 하는 경우 회사가 수종의 주식을 발행한 때에는 주주총회의 결의로 그와 같은 종류의 주식으로 할 수 있다.</TD>

<TD WIDTH="293" HEIGHT="247" USERMARK="F-BT12">제55조<이익배당>&cr;1. 현행과 동일&cr;2. 전항의 배당은 매결산기말 
<SPAN USERMARK=" U">또는 이사회 결의로 정하는 배당기준일</SPAN> 현재의 주주명부에 기재된 주주 또는 등록된 질권자에게 지급한다.&cr;3. 현행과 동일&cr;
</TD>
<TD WIDTH="122" HEIGHT="247" USERMARK="F-BT12">표준정관에 의거 배당기준일을 이사회 결의로 정하는 날로 설정할 수 있도록 조문 수정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="293" HEIGHT="271" USERMARK="F-BT12">
<P>제56조 <분기배당></P>
<P>4. 사업연도개시일 이후 분기배당 기준일 이전에 신주를 발행한 경우(준비금의 자본전입, 주식배당, 전환사채의 전환청구, 신주인수권부사채의 신주인수권 행사에 의한 경우를 포함한다)에는 분기배당에 관해서는 당해 신주는 직전사업연도말에 발행된 것으로 본다. 다만, 분기배당 기준일 후에 발행된 신주에 대하여는 최근 분기배당 기준일 직후에 발행된 것으로 본다.</P>
</TD>

<TD WIDTH="293" HEIGHT="271">
<P USERMARK="F-BT12">제56조 <분기배당></P>
<P USERMARK="F-BT12 U">4. 제1항의 분기배당은 분기배당 기준일 전에 발행한 주식에 대하여 동등배당한다.</P>
</TD>

<TD WIDTH="122" HEIGHT="271">
<P USERMARK="F-BT12">표준정관에 의거 분기배당에 대한 동등배당 원칙 명시</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="293" HEIGHT="103"><신 설></TD>

<TD WIDTH="293" HEIGHT="103">
<P USERMARK="F-BT12 U">부 칙</P>
<P USERMARK="F-BT12">제1조<시행일></P>
<P USERMARK="F-BT12 U">이 정관의 개정사항은 주주총회의 승인을 받은 날로부터 그 효력을 발생한다.</P>
</TD>
<TD WIDTH="122" HEIGHT="103"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="293" HEIGHT="127"><신 설></TD>

<TD WIDTH="293" HEIGHT="127" USERMARK="F-BT12">
<SPAN USERMARK=" U">부 칙&cr;</SPAN>
<SPAN USERMARK=" U">제2조(감사 선임에 관한 적용례) 제45조제3항·제5항의 개정규정(선임에 관한 부분에 한한다)은 이 정관 시행 이후 선임하는 감사부터 적용한다.</SPAN>
</TD>
<TD WIDTH="122" HEIGHT="127"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="293" HEIGHT="151"><신 설></TD>
<TD WIDTH="293" HEIGHT="151" USERMARK="F-BT12 U">부 칙&cr;제3조(감사 해임에 관한 적용례) 제45조제4항·제5항의 개정규정(해임에 관한 부분에 한한다)은 이 정관 시행 당시 종전 규정에 따라 선임된 감사를 해임하는 경우에도 적용한다.</TD>
<TD WIDTH="122" HEIGHT="151"></TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 정관 변경 이력</P>

<TABLE-GROUP ACLASS="ART_BCK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="982" BORDER="1">

<COLGROUP>
<COL WIDTH="125"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="546"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">정관변경일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="165" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당주총명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="555" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요변경사항</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변경이유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="134" HEIGHT="319" AUNIT="ART_DATE" AUNITVALUE="20190328" VALIGN="MIDDLE">2019년 03월 28일</TU>
<TE ALIGN="CENTER" WIDTH="165" HEIGHT="319" ACODE="ART_NAME" VALIGN="MIDDLE" USERMARK="F-BT12">제 16기 정기주주총회</TE>
<TE WIDTH="555" HEIGHT="319" ACODE="ART_CHN" USERMARK="F-BT12">(1) 제2조(목적) : 신규사업 진행을 위한 사업목적 추가&cr;(2) 제8조(주권의 종류) : 주권 전자등록의무화에 따라 삭제&cr;(3) 제8조2(주식 등의 전자등록) : 주식 전자등록 의무화에 따른 근거 신설&cr;(4) 제14조(명의개서대리인) : 주식 전자등록에 따른 주식사무처리 변경내용       반영&cr;(5) 제15조(주주 등의 주소, 성명 및 인감 또는 서명 등 신고) : 주식 전자등록      에 따른 불필요 조항 삭제&cr;(6) 제19조(사채발행에 관한 준용규정) : 주식 전자등록에 따른 불필요 조항        삭제&cr;(7) 제44조(위원회) : 위원회 설치규정 신설&cr;(8) 제52조(외부감사인의 선임) : 법률 명칭변경에 따른 자구수정 및 주식회사     등의 외부감사에 관한 법률 제10조에 따라 개정 내용 반영&cr;(9) 부칙 신설 : 시행일 명시</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="319" ACODE="ART_RSN" VALIGN="MIDDLE" USERMARK="F-BT12">전자증권법&cr;시행에 따른&cr;주식의 전자등록&cr;사항 개정,&cr;주식회사 등의 외부감사에 관한 법률제10조에 따른 개정 내용 반영</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0">II. 사업의 내용</TITLE>
<P></P>
<P USERMARK=" B">[주요 용어 설명]</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="767">

<COLGROUP>
<COL WIDTH="211"></COL>
<COL WIDTH="538"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">용   어</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">설   명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">나노(Nano)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">10억 분의 1을 나타내는 접두사 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">약물전달시스템 (DDS)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">체내에 약물을 효과적으로 전달시키는 기술 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">난용성</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">물에 잘 녹지 않는 성질 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">목표화합물&cr;(Target compound)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">신약 개발 단계에서 원하는 목표(효능)를 이루기 위해 제조하는 화합물 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">개량신약</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">안전성, 유효성, 유용성에 있어 시판제제 대비 개선된 의약품 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">복제약(제너릭)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">이미 시판제제 되고 있는 약물과 차이가 없는 동등한 의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">SENS™</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">당류를 사용하여 활성물질을 나노화하는 당사의 나노기술</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">나노약물</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">유효성분의 입자가 나노 크기인 약물</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">고형지질</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">상온에서 고체상태인 지질</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">염(Salt)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">산의 음이온과 염기의 양이온이 정전기적 인력으로 결합하고 있는 이온성 물질인 화합물</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">부형제</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">의약품의 안정성, 편의성 등의 목적으로 첨가되는 물질로, 주성분(약물)이 아닌 불활성 물질 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">NUFS™</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">고형지질과 액상 이산화탄소를 이용하여 활성물질을 나노화하는 당사의 나노기술</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">커큐민(Curcumin)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">강황에 주로 포함되어 있는 폴리페놀 성분의 노란색 향신료로 항암, 항산화 등의 효과를 지니는 물질 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">세라마이드(Ceramide)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">피부 보호막이라고 불리는 각질층을 구성하는 지질 성분 중 하나로 보습에 매우 중요한 역할을 하는 물질 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">코큐텐(CoQ10)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">체내에서 에너지를 생성하는 것을 돕는 조효소의 하나로, 항산화, 혈압 조절 등의 효능을 지닌 물질 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">습식분쇄(Wet-milling)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">수(水)환경에서 약물을 분쇄하는 방법 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">엘로티닙(Erlotinib)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">폐암치료제로 알려진 표적항암제에 쓰이는 항암물질</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">서브마이크론(submicron)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">1 마이크론 크기보다 작은 크기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">나노결정(NanoCrystal) 입자</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">보통 지름이 수백 나노 미터 크기인 결정립으로 이루어진 물질</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생체이용률(Bioavailability)</P>
</TD>

<TD WIDTH="547" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">경구로 투여된 약물이 전신순환계에 들어가 생체에 이용되는 비율 (흡수율)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">1. 사업의 개요&cr;</SPAN>
</P>
<P USERMARK=" B">가. 업계 현황 및 전망&cr;</P>

<P>
<SPAN USERMARK=" B">(1) 나노 의약기술 개요&cr;</SPAN>
</P>
<P>나노기술(Nanotechnology)은 물질을 나노미터 크기의 범주에서 조작, 분석하고 이를 제어함으로써 새롭거나 개선된 물리적, 화학적, 생물학적 특성을 나타내는 소재, 소자 또는 시스템을 창출하는 과학기술을 말합니다. 물질을 제조 또는 합성하는데 있어서 기존의 방법은 구성 성분인 조성을 변화시키거나 결정구조 등 물질의 구조를 변형시키는 것이었고 그 외의 방법으로는 크기를 변화시켜 새로운 물성을 지닌 물질을 제조 또는 합성하는 방법이 있습니다. 나노기술의 경우는 크기를 변화시킴에 따라 새로운 특성의 새로운 물질을 탄생시킬 수 있다는 것이 주요 핵심이라고 할 수 있습니다.</P>
<P>나노(Nano)란 10억분의 1배의 뜻을 가진 접두어로서 인간은 미터 크기(m)의 세계에서 살고 있다고 할 수 있는데, 1미터의 백분의 1인 1센티미터(㎝)는 대략 개미의 크기이고, 바늘 직경이 1밀리미터(㎜) 정도입니다. 우리 몸에서는 머리카락 굵기는 100마이크로미터(㎛)보다 작고, 적혈구 직경은 약 7~8 마이크로미터 정도입니다. 나노미터(㎚)의 크기는 1 마이크로미터의 천분의 1로서, DNA의 폭 정도 크기이며 일반적으로 원자 3~4 개를 이어 놓은 크기라고 할 수 있습니다. 일반적으로 나노 기술에서 다루고 있는 크기는 대략 100나노(0.1㎛)이하를 의미하지만 의약품의 나노입자는 서브마이크론(submicron) 영역을 말하기도 합니다.</P>
<P>나노기술은 기존의 기술분야(물리, 화학, 재료, 전자 등)들을 횡적으로 연결하는 등 학문간 경계가 없는 학제간 연구 분야이며, 재료, 전자, 에너지, 우주공학, 의학 등 거의 모든 산업분야에 응용이 가능함에 따라 높은 경제적 파급성을 지니고 있습니다.</P>
<P></P>
<P USERMARK=" B">[나노기술과 타기술의 상호관계]&cr;</P>

<IMAGE>
<IMG WIDTH="537" HEIGHT="309" ALIGN="CENTER" HSPACE="0">포맷변환_나노코리아.net.jpg</IMG>
<IMG-CAPTION ATOC="N">(자료: nanokorea.net)</IMG-CAPTION>
</IMAGE>
<P USERMARK=" B"></P>
<P>당사가 속해 있는 나노 의약(Nanomedicine)기술은 일반적으로 100~500㎚ 크기의 기능성 나노 입자의 물적 특성을 기존의 의학기술에 접목하는 첨단 융합 기술로 정의할 수 있으며, 현대의학의 난제를 극복할 기술로서 전 세계적인 이슈를 모으고 있는 기술분야입니다.&cr;</P>

<P>
<SPAN USERMARK=" B">[나노의약 기술 개념 및 적용사례]&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="328" ALIGN="CENTER" HSPACE="0">화학세계 2014.05.jpg</IMG>
<IMG-CAPTION ATOC="N">(자료: 화학세계 2014.05)</IMG-CAPTION>
</IMAGE>
<P></P>
<P>의약품 약물의 입자크기를 나노미터 수준에서 제어하는 나노기술을 이용하여 개발된나노 의약품은 기존 시판되는 의약품 및 신약물질의 난용성을 해결하여 제형을 소형화 할 수 있으며, 특정 질병부위에 대한 선택적 표적화 치료요법이 가능하기 때문에 질병치료의 새로운 수단으로서 각광 받고 있습니다.</P>
<P>시중에 판매되고 있는 의약품의 40%, 신약 후보물질의 90% 이상이 물에서 잘 녹지 않는 난용성 약물로 알려져 있으며, 이러한 약물을 그대로 복용하였을 경우 우리의 신체 내에서 흡수가 제대로 일어나지 않아 약효를 발휘하지 못하게 됩니다. 그렇기 때문에 이러한 난용성 문제를 해결하여 물에 잘 분산이 되는 약물을 제조하는 기술이필요합니다. 이러한 난용성 문제를 해결하기 위해, 전통적으로는 약물에 염(salt)을 붙여 약물 자체의 구조를 변형시켜 물에서 잘 녹게 변화를 주거나, 약물 자체의 구조는 변화시키지 않되 배열을 바꿔 물에 조금 더 잘 녹게 하는 방법 등이 사용되었으며, 2000년대 초부터는 Elan사의 NanoCrystal? 기술을 선두로 하여 나노입자화(Nanoparticulation)라는 나노 기술을 적용하여 난용성 문제를 극복하고자 하는 움직임이 활발히 진행되고 있습니다.&cr;</P>

<P>
<SPAN USERMARK=" B">(2) 나노 약물전달시스템 적용 분야&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">① 신약(New drug) 제조&cr;</SPAN>&cr;현재 전세계적으로 개발 파이프라인에 있는 신약 후보 물질의 약 90%는 난용성 문제가 있는 것으로 알려져 있습니다. 기존에는 신약개발 과정에서 효능 및 독성 연구를 완료한 후 제형 연구를 수행하였으며, 이 경우 난용성의 문제를 극복하지 못하여 신약개발이 중단되는 경우가 종종 발생하였습니다. 그러나 최근에는 목표화합물(target compound)이 발굴되면 먼저 나노입자화 기술을 비롯한 다양한 가용화 기술을 이용한 제형화 연구를 동시에 수행하고 있는 추세입니다. 그리하여 신약 개발 초기부터 제제화 기술(나노입자 기술)을 적용하여 난용성 문제를 해결한 신약을 제조하고자 하는 움직임이 활발합니다.
</P>
<P>나노 약물전달시스템 기술을 신약에 적용함으로써, 난용성 약물을 물에서 분산이 잘 되는 약물로 변화시켜 신약 개발 성공률을 높일 수 있으며, 타 회사들의 진입 장벽을 높게 만들어서 제조한 신약의 개량신약 또는 복제약이 쉽게 만들어지지 않도록 방어할 수 있습니다.</P>

<P>&cr;
<SPAN USERMARK=" B">② 개량신약(IMD: Incrementally Modified Drug) 제조&cr;</SPAN>
</P>
<P> 최근 1개의 신약개발에는 5조원 이상의 비용과 10~15년의 시간이 소요되고 있지만, 새로운 신약으로 승인되는 약품의 수는 매년 줄어 드는 추세입니다. 이러한 상황을 타개하기 위해 많은 다국적 제약사들은 기존에 자신들이 보유하고 있는 블록버스터 제품(blockbuster drug)의 수명연장을 위해 많은 노력을 경주할 뿐만 아니라, 타 회사의 약물에 대해서도 개량을 통한 시장 선점을 위해 많은 노력을 하고 있습니다.</P>
<P>이렇듯 많은 다국적 제약사들이 비교적 짧은 개발기간(3~6년)과 적은 투자비용(약 100억원)으로 성공 가능한 개량 신약 연구에 몰두하면서 개량 신약 시장은 계속적으로 증가해 가고 있습니다. 다만, 단순 염변경을 한 개량신약의 경우, 시장에 1년 이상 먼저 진입한다고 해도 오리지널 제품 대비 강점 부재로 시장 확보를 실패하는 경우가 속출하기 때문에, 기존제제 대비 효능 증대, 부작용 감소, 투여 방법 개선 등의 유효성 및 편의성이 증대된 개량 신약의 개발이 절실히 요구되고 있습니다.</P>
<P>또한 전세계에서 시판되는 의약품의 40%는 난용성으로 인한 낮은 생체이용률, 식전 식후 생체이용률(BA) 편차, 개인간의 BA 편차 등의 문제를 갖고 있습니다. 이러한 약물의 경우, 효능을 발휘하게 하기 위해 활성물질의 투여 용량을 높이고 부형제(Excipient)를 과다 사용함으로써 약물 또는 부형제에 의한 많은 부작용이 나타나고 있습니다. 경구 제형의 경우, 의약품의 사이즈가 커져 환자들의 약물 복용에 많은 불편함이 있어 복약 순응도가 떨어지고, 이로 인해 치료 효능까지도 감소하는 경향이 있습니다 (2015년 미국 FDA 가이드 라인에 따르면 경구 제형의 사이즈가 8 mm가 넘으면 환자들의 약물 복용에 불편함이 있음으로, 의약품의 사이즈를 줄일 것을 권고하고 있습니다).</P>
<P>나노 약물전달시스템 기술을 적용하여 기존제제의 문제점을 극복한 개량신약을 제조하여 성공한 사례(예: 나노의약품Tricor?, Megace?ES 등)를 바탕으로 나노 약물전달시스템을 통해 생체이용률의 증가, 식전식후BA 편차 및 개개인간의BA 편차문제 등을 해결할 수 있다고 알려지면서 시판되고 있는 의약품 중 난용성의 문제가 있는 의약품들에 나노 기술을 적용하고자 노력하는 제약사들의 노력이 계속되고 있습니다.</P>

<P>
<SPAN USERMARK=" B">③ 복제약(generic) 제조&cr;</SPAN>&cr;당사의 나노기술의 경쟁사인 Alkermes사(Elan사)의 NanoCrystal? (wet-milling technology) 기술을 사용한 나노 의약품 중, 2000년 8월 처음으로 FDA의 승인을 받은 Rapamune?의 특허가 2018년에 만료된 것을 선두로, 나노입자화 기술을 적용한 초창기 의약품들의 특허 만료가 임박한 시점입니다. 이러한 나노 의약품의 경우, 나노 기술이 아닌 다른 전통적인 기술로는 시판되고 있는 의약품과 동등한 효능을 맞추기가 어려워서 제네릭 개발이 난항에 부딪히는 경우가 많습니다. 이러한 문제를 해결하기 위해서는 NanoCrystal?처럼 나노기술을 적용할 수밖에 없으며, 당사의 NUFS™ 기술은 NanoCrystal? 기술을 대체할 훌륭한 도구가 될 수 있습니다.
</P>
<P>이 밖에도 나노기술은 의약분야 이외에도 기능성 식품 및 화장품 등 다양한 분야에까지 적용이 가능합니다. 식품의 경우 기존 기능성 식품원료 중 난용성으로 인하여 제형의 한계 및 낮은 효능을 가진 물질에 나노기술을 적용하여 관련 문제점을 극복할 수 있습니다. 화장품 산업에 있어서는 기존 화장품 원료 중에서 기능성은 뛰어나지만 난용성 등의 문제로 인하여 그 적용에 제한이 있는 원료들에 나노기술 적용을 적용하여 기능 개선 및 완제품의 품질 향상을 이룰 수 있습니다.</P>
<P></P>

<P>
<SPAN USERMARK=" B">(3) 시장규모 및 전망&cr;</SPAN>
</P>

<P>Statista 자료(2021년)에 따르면 2019년도 세계 의약품 시장 규모는 1조 2,504억 달러였으며, 더욱이 고령화 뿐만 아니라 최근 전세계를 위협하는 코로나19 신종 코로나바이러스로 인해 그 성장세는 더욱 가속화될 것으로 예상됩니다. 또한 글로벌 제약산업 분석업체인 이벨류에이트파마(EvaluatePharma)사에 따르면 처방약의약품의 매출은 2019년 8,440억 달러(약 978조원)에서 연평균 6.9%로 성장하여 2024년 1조 1,810억 달러(약 1,369조원)에 이를 것으로 전망하였습니다. 특히 다양한 혁신 신약이 상업화되면서 의약품 시장 성장을 이끌어가고 있으며, 글로벌 제약 및 바이오텍 기업들 모두 혁신 신약 파이프라인들을 보유하고 임상을 진행하고 있기 때문에 혁신 신약 중심의 시장 성장이 지속될 것으로 예상되고 있습니다.&cr;&cr;
<SPAN USERMARK=" B">[세계 의약품 시장 규모]&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="371" ALIGN="CENTER" HSPACE="0">사업.jpg</IMG>
<IMG-CAPTION ATOC="N">(Statista의 'Revenue of the worldwide pharmaceutical market from 2001 to 2019', 2021년 자료)</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK=" B">&cr;[세계 처방의약품 시장 규모 및 전망]&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="307" ALIGN="CENTER" HSPACE="0">그림.jpg</IMG>
<IMG-CAPTION ATOC="N">(EvaluatePharma의 World Preview 2020, Outlook to 2026, 2020년7월 자료)</IMG-CAPTION>
</IMAGE>

<P>&cr;세계 나노 약물전달기술 시장은 2014년 410억 달러에서 연평균 12.5% 성장하여 2023년에는1,190억 달러에 이를 것으로 전망되고 있습니다. (자료: Transparency Market Research, 2016.3) 또한 Research and Markets의 nanotechnology in Drug Delivery - Global Market Trajectory & Analytics 레포트(2020년 6월)에 따르면 나노기술관련 약물전달시장은 2020년 475억 달러에 이를 것으로 예상되며, 19.4%의 연평균 성장률을 바탕으로 2027년에 1,641억 달러에 이를 것으로 전망되고 있습니다.&cr;&cr;식품의약품안전처 보도자료(2020년 8월)에 따르면2019년도 국내 의약품 시장 규모는 전년대비 5.2% 증가된 24조 3,100억원으로 국내 의약품시장 역시 세계 의약품 시장 성장에 발맞추어 지속적으로 성장하고 있는 상황입니다.&cr;&cr;
<SPAN USERMARK=" B">[국내 의약품 시장 규모]</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="640">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="112" ALIGN="CENTER" HEIGHT="31">
<P>년도</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>2013</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>2014</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>2015</P>
</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>2016</P>
</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>2017</P>
</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>2018</P>
</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>2019</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="112" ALIGN="RIGHT" HEIGHT="32">
<P>시장규모(억원)</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32">
<P>193,244</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32">
<P>193,705</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32">
<P>192,365</P>
</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32">
<P>217,256</P>
</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32">
<P>220,632</P>
</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32">
<P>231,175</P>
</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32">
<P>243,100</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;더욱이 인구 노령화은 국내 및 세계 의약품 시장의 지속적인 성장에 크게 기여할 것입니다. 통계청 자료에 따르면 한국은 2000년 노인 비중이 7.3%에 이르며 고령화 사회에 진입한 뒤 17년 만인 2017년에 전체 인구에서 노인이 차지하는 비중이 14.2%로 증가되며 세계에서 가장 빠른 속도로 고령 사회에 진입하게 되었습니다. 그리고 이러한 속도로 계속 증가될 경우 2026년도에 초고령화 사회 (노인비중이 20%이상)에 진입할 것으로 예상된다고 합니다. 이러한 노인 인구 증가는 코로나19 팬데믹과 같은 전염병과 더불어 의약품 수요 증가에 크게 기여할 것으로 예상됩니다. &cr;&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">나. 회사의 현황&cr;</SPAN>
</P>
<P USERMARK=" B">(1) 사업 개황&cr;</P>
<P>당사는 물에서 거의 녹지 않는 난용성 물질을 물에서 잘 풀리는(분산되는) 물질로 변형시키는 특허화된 원천 나노기술을 보유하고 있으며, 이를 바탕으로 한 의약품의 개발·라이센싱 및 나노화된 소재의 제조·판매가 당사의 주된 사업 모델입니다.&cr;</P>

<IMAGE>
<IMG WIDTH="550" HEIGHT="172" ALIGN="CENTER" HSPACE="0">원천나노기술.jpg</IMG>
<IMG-CAPTION ATOC="N">.</IMG-CAPTION>
</IMAGE>
<P>현재 당사의 주 사업은 난용성 약물을 나노입자화하여 나노의약품 신약, 개량신약, 복제약을 개발하고 이를 국내외 대형 제약사에 기술 이전하는 것이며, 그 외에 화장품 및 식품 분야의 난용성 물질을 나노입자화한 나노 분말을 제조·판매하여 수익을 창출하고 있습니다.</P>

<P>&cr;
<SPAN USERMARK=" B">[회사의 성장 과정]</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="872">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="521"></COL>
<COL WIDTH="212"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>

<TD WIDTH="530" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">주요 성과</P>
</TD>

<TD WIDTH="221" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">영업상 주요전략</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12 B">설립시</P>
<P USERMARK="F-BT12 B">(2004년</P>
<P USERMARK="F-BT12 B">~2006년)</P>
</TD>

<TD WIDTH="530" VALIGN="MIDDLE" HEIGHT="79">
<P USERMARK="F-BT12">- 신기술보육(TBI)사업 신기술 사업자 선정</P>
<P USERMARK="F-BT12">- 벤처기업으로 지정 (신기술 기업)</P>
<P USERMARK="F-BT12">- NUFS™ 기술 국내 특허 취득</P>
</TD>

<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="79">
<P USERMARK="F-BT12">- 신기술 특허 획득</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="295">
<P USERMARK="F-BT12 B">1차</P>
<P USERMARK="F-BT12 B">성장기</P>
<P USERMARK="F-BT12 B">(2007년</P>
<P USERMARK="F-BT12 B">~2012년)</P>
</TD>

<TD WIDTH="530" VALIGN="MIDDLE" HEIGHT="295">
<P USERMARK="F-BT12">- 중외제약과 공동기술개발계약 체결 (BS-OXL 개량신약)</P>
<P USERMARK="F-BT12">- Korea BizBiz Day (프랑크푸르트/뉴저지/오사카) </P>
<P USERMARK="F-BT12">  기술발표 및 Partnering 참가</P>
<P USERMARK="F-BT12">- 파마킹과 연구개발계약 체결 (BS-108 개량신약)</P>
<P USERMARK="F-BT12">- NUFS™기술 미국/유럽 주요국/호주/중국/일본 특허 취득</P>
<P USERMARK="F-BT12">- 국제 부인암 학회 IGCS 2010에서&cr;   NUFS™기술 적용성과 발표 (BS-102)</P>
<P USERMARK="F-BT12">- ㈜두산과 나노세라마이드 공동연구개발 및 사업화 계약 체결</P>
<P USERMARK="F-BT12">- 보건복지부 선도형 암연구 사업단 과제로 선정 </P>
<P USERMARK="F-BT12">   (서울아산병원 주관, BS-102)</P>
<P USERMARK="F-BT12">- Biopartnering North America에서 나노입자화 기술 발표</P>
<P USERMARK="F-BT12">- Amway와 연구개발계약 체결 (Bioavailability 향상된 소재개발)</P>
</TD>

<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="295">
<P USERMARK="F-BT12">- 원천 나노기술 홍보</P>
<P USERMARK="F-BT12">- 국내외 주요 제약사에 </P>
<P USERMARK="F-BT12">   나노화 서비스 제공 </P>
<P USERMARK="F-BT12">   및 공동 연구 추진</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="367">
<P USERMARK="F-BT12 B">2차</P>
<P USERMARK="F-BT12 B">성장기</P>
<P USERMARK="F-BT12 B">(2013년</P>
<P USERMARK="F-BT12 B">~2018년)</P>
</TD>

<TD WIDTH="530" VALIGN="MIDDLE" HEIGHT="367">
<P USERMARK="F-BT12">- 대웅제약과 공동연구개발 및 기술이전계약 체결 (BS-101 제네릭 개발)</P>
<P USERMARK="F-BT12">- cGMP 공정 적합성 확인 </P>
<P USERMARK="F-BT12">- ㈜대웅제약의 전략적 투자 유치 </P>
<P USERMARK="F-BT12">- SENS™기술 미국 및 중국 특허 취득&cr;- BS-102관련 논문 International Journal of Nanomedicine에 게재됨</P>
<P USERMARK="F-BT12">- 한국투자파트너스, 프리미어파트너스 투자 유치</P>
<P USERMARK="F-BT12">- 산기평 산업핵심기술개발사업 과제로 선정 &cr;   (BS-103 & BS-104, 약 40억/4년)</P>
<P USERMARK="F-BT12">- 소재사업을 위한 공장 설립&cr;- 코넥스 상장</P>
<P USERMARK="F-BT12">- GMP 설비 구축 (의약사업)</P>
<P USERMARK="F-BT12">- 삼양바이오팜 기술이전 계약 체결 (BS-104)</P>
<P USERMARK="F-BT12">- 美.국립암연구소 산하 NCL (나노기술특성분석연구소)의 연구과제로 &cr;  선정되어 공동연구 진행 중 (BS-102)</P>
<P USERMARK="F-BT12">- 아리조나대학교와 나노소재관련 공동연구 진행 </P>
</TD>

<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="367">
<P USERMARK="F-BT12">- 기술의 상업화 가능성 확증</P>
<P USERMARK="F-BT12">- 자체 Pipeline 약물</P>
<P USERMARK="F-BT12">   구축 및 기술이전&cr; - 기술 사업화</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="151">
<P USERMARK="F-BT12 B">3차</P>
<P USERMARK="F-BT12 B">성장기</P>
<P USERMARK="F-BT12 B">(2019년~)</P>
</TD>

<TD WIDTH="530" VALIGN="MIDDLE" HEIGHT="151">
<P USERMARK="F-BT12">- 나노코리아 2019 산업통상자원부 장관상 수상 </P>
<P USERMARK="F-BT12">- 건강기능식품 GMP 획득</P>
<P USERMARK="F-BT12">- 가톨릭대학교와 개량신약 후보물질 관련 물질이전 계약(MTA) 체결 </P>
<P USERMARK="F-BT12">- 유럽 Z사와 개량신약 후보물질 관련 MTA체결 </P>
<P USERMARK="F-BT12">- 국내 S사과 신약후보물질관련 MTA 체결 </P>
<P USERMARK="F-BT12">- 국내 A사와 신약후보물질관련 MTA 체결</P>
</TD>

<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="151">
<P USERMARK="F-BT12">- 자체 Pipeline 약물</P>
<P USERMARK="F-BT12">    구축 및 기술이전 </P>
<P USERMARK="F-BT12">-  해외 사업화 추진</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">(2) 주요 사업분야&cr;</SPAN>
</P>

<P USERMARK=" B">(가) 의약품 사업&cr;&cr;
<SPAN USERMARK=" !B">당사의 주사업은 난용성 약물을 물에 잘 풀리는 나노약물로 변형시켜 나노의약품을 제조하는것으로, 나노 의약품 제조에 쓰이는 나노 원천기술을 약물별로 국내외 대형 제약사에 기술이전하여 계약금 (upfront), 단계별 기술료(milestone), 로열티 (royalty) 수익을 창출하는 것입니다. </SPAN>
</P>
<P>2015년 이전까지는 원천 나노기술의 상업화 가능성을 확인하는데 주력하며, 국내외 제약사에서 나노화를 의뢰하는 난용성 약물을 나노화하는 용역 위주로 사업을 진행하였습니다. 하지만 2015년 투자 유치 이후, 타 제약회사의 난용성 약물을 나노분말로 제조하는 것에서 그치는 것이 아니라 자체 역량을 키우고자 시장성, 특허성 등을 바탕으로 후보 약물을 선정하고 이를 독자적으로 연구하며, 약물 파이프라인을 구축해 나가고 있습니다.</P>

<P>2017년 초부터는 (1)Bio, Interbiz, CPhI 등의 사업 파트너링 행사에 참여, (2) 특허 출원 및 논문 게재, (3) 전문 기술이전 컨설팅 업체 고용 등을 바탕으로 나노원천기술 및 파이프라인 약물들을 홍보하는 것에 주력하며, 독자적으로 연구를 진행한 나노의약품을 국내외 대형 제약사에 기술이전하기 위해 노력하고 있습니다. 뿐만아니라, 기존 파이프라인 약물의 성공사례를 바탕으로 국내외 대형 제약사에서 자체 진행 중인 약물에 당사의 나노 원천기술을 적용하여 나노의약품을 개발하고자 나노화 의뢰를 요청하는 건수가 지속적으로 증가하고 있습니다.&cr;&cr;
<SPAN USERMARK=" B">① NUFS™ 기술&cr;</SPAN>
</P>

<P>NUFS™ (Nanoparticulation Using Fat and Supercritical fluid) 나노기술은 ㈜바이오시네틱스의 특허화된 나노 원천기술로, 고형지질(상온에서 고체상태, 활성물질을 녹이는 용매로 사용 가능)과 액상 이산화탄소(고형지질을 제거하는 용매로 사용됨)를 사용하여 활성물질을 나노화 하는 기술입니다.&cr;&cr;
<SPAN USERMARK=" B">[NUFS™ 기술 소개]&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="138" ALIGN="CENTER" HSPACE="0">nufs 기술소개.jpg</IMG>
<IMG-CAPTION ATOC="N">.</IMG-CAPTION>
</IMAGE>
<P>나노입자를 제조하는 한 예는 다음과 같습니다. 1) 난용성 활성물질, 부형제(응집방지제 역할), 고형지질 (용매로 사용. 상온에서 고체상태이며 약 40 ℃이상의 온도에서는 액체상태)을 함께 녹이고 굳혀 고체분산체를 형성시킵니다. 이 때, 용매로 사용한 고형지질이 상온에서는 고체상태이기에, 혼합물의 온도를 40℃ 이상에서 약 30℃ 이하로 변화시켜주면, 혼합물 속에 녹아있던 고형지질이 굳으면서, 활성물질의 입자 성장이 나노 단위에서 멈춰지게 됩니다. 2) 고체분산체 내에 존재하는 고형지질을 액상 이산화탄소를 사용하여 녹여내서, 활성물질과 부형제만이 존재하는 분말을 수득하게 됩니다.&cr;</P>
<P>이러한 NUFS™ 나노기술을 적용함으로써 얻을 수 있는 효과는 다음과 같습니다.&cr;</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="384" ALIGN="CENTER" HSPACE="0">나노기술 효과.jpg</IMG>
<IMG-CAPTION ATOC="N">.</IMG-CAPTION>
</IMAGE>
<P>1) 난용성 약물을 아주 작은 나노입자로 만들어서 물에서 잘 분산되게 만들어 체내에서 흡수율이 증가</P>
<P>2) 나노입자의 경우, 음식의 영향을 덜 받을 수 있기에 꼭 공복에 또는 꼭 음식과 함께 약물을 복용해야 하는 불편함 없이, 환자들이 편하게 약물을 복용할 수 있음</P>
<P>3) 나노입자의 경우, 균일한 속도로 녹아 나오기 때문에 녹는 속도를 예측하여 서방형 제제(주약물을 천천히 방출해서 일정한 혈중농도를 유지할 수 있도록 설계된 제품)로 사용하는 것이 용이할 뿐만 아니라 개체편차도 줄일 수 있기에 환자간 약효 편차가 덜 발생할 수 있음</P>
<P>4) 물에서도 쉽게 분산되기에, 현탁액, 주사제, 점안제 등 다양한 제형에 적용이 가능하여 개발사가 다양한 마케팅 전략을 세울 수 있음</P>

<P>&cr;
<SPAN USERMARK=" B">② 경쟁 기술 비교</SPAN>
</P>
<P>당사가 현재 영위하는 사업의 주요 경쟁기술은 Alkermes사의 NanoCrystal?과 Leon-nanodrugs사의 MJR? (Micro JetReactor)로, 이는 유기화합물을 나노입자로 제조하는 대표적 기술입니다. 당사의 기술은 Alkermes사의 나노크리스탈 (NanoCrystal?)기술과 같이 부형제를 사용하여 나노입자를 안정화시킨 결정형 나노입자를 제조하는 기술입니다.</P>
<P>나노입자를 제조하는 방법은 크게 하향식(Top-down)과 상향식(Bottom-up)으로 나뉘는데, 하향식은 본래의 큰 입자를 물리적인 힘을 가해 작은 나노입자로 작게 분쇄하는 방식이며, 상향식은 분자단위까지 물질을 녹인 후에 입자성장 속도를 제어하여 나노입자 크기의 물질을 제조하는 방식입니다. 보통 상향식 방식으로 입도를 제조하는 것이 더욱 균일하고 안정된 나노입자를 제조할 수 있으나, 대량 생산시 입자 성장을 균일하게 제어하는 것이 쉽지 않아 스케일업이나 상업화가 어렵다고 알려져 있습니다.</P>

<P>&cr;
<SPAN USERMARK=" B">[주요 경쟁업체 현황]</SPAN>
</P>

<TABLE BORDER="1" WIDTH="798" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="97"></COL>
<COL WIDTH="222"></COL>
<COL WIDTH="222"></COL>
<COL WIDTH="221"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">바이오시네틱스</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">Alkermes(Elan)</P>
</TD>

<TD WIDTH="230" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">Leon-nanodrugs</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">기술명</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">NUFS™ &　SENS™</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">NanoCrystal?</P>
</TD>

<TD WIDTH="230" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">MJR?</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">입도(㎛)</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">Below 1</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">Below 1</P>
</TD>

<TD WIDTH="230" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">Below 1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">제조방식</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">Bottom-up </P>
<P USERMARK="F-BT12">&　Top-down </P>
<P USERMARK="F-BT12">& Combination</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">Top-down</P>
</TD>

<TD WIDTH="230" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">Bottom-up</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">제품형태</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">분말</P>
<P USERMARK="F-BT12">(휘산성, 정전기 우려 없음)</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">액상 ⇒ 분말</P>
<P USERMARK="F-BT12">(추가 건조 공정 필요)</P>
</TD>

<TD WIDTH="230" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">액상 ⇒ 분말</P>
<P USERMARK="F-BT12">(추가 건조 공정 필요)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">오염우려</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">없음</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">분쇄 매체로 인한 &cr;오염 우려 존재</P>
</TD>

<TD WIDTH="230" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">잔존 유기 용매로 인한 &cr;오염 우려 존재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">부형제&cr;(약물대비)</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">1↓</P>
</TD>

<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">1↓</P>
</TD>

<TD WIDTH="230" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">1↑</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>주1. 약물대비 부형제량이 1배 이상으로 많아질 경우, 최종 의약품의 크기가 커지게 되어 환자의 복용편의성이 저하됨&cr;</P>
<P>Alkermes사의 NanoCrystal?은 2000년도에 최초 나노 결정(NanoCrystal) 의약품으로 미국 FDA 승인을 받은 라파뮨(Rapamune?)에 사용된 기술로, 하향식 방식으로 나노입자를 제조하는 기술입니다. 이는 수환경 속에 약물과 부형제를 넣어주고 분쇄 매체 (grinding media)로 약물을 분쇄하여 나노입자를 제조하는 기술입니다. 때문에 엘로티닙(Erlotinib) 염과 같이 물에서 안정하지 못한 약물이나 분쇄 열로 인해 구조가 깨지거나, 너무 무른 성질로 분쇄가 용이하지 않은 약물들의 경우에는 기술 적용이 어렵습니다. 더욱이 분쇄 매체로 인한 오염우려 또한 존재하기에 주사제나 안약과 같은 제형에는 적용이 용이하지 않을 수 있습니다. 더욱이 최종 제품이 액상형태이기에 정제나 캡슐로 제조하기 위해서는 추가 건조 공정이 필요하며 이때 입자 크기 증가가 일어날 수 있기에 추가 부형제 (응집 방지제)를 과량 첨가해야 할 수 있습니다.</P>
<P>Leon-nanodrugs사의 MJR? 기술은 상향식 방식으로 나노입자를 제조하는기술로, 약물을 유기용매에 녹이고, 입자 응집방지제와 같은 부형제를 물에 녹인 후, 미세한 노즐로 두 용매를 고속충돌시켜 분자단위의 약물을 석출시켜 나노입자로 제조하는 기술입니다. 때문에 유기용매 잔존에 대한 우려가 있으며, Alkermes사의 기술과 같이 최종제품이 액상형태이기에 분말로 제조하기 위해 추가 건조 공정이 필요하여 시간 및 비용이 더 발생할 수 있습니다. 더욱이 Alkermes사나 당사의 기술과 달리 사용하는 부형제량이 보통 5배이상이기에 최종 의약품의 크기가 커질 수 밖에 없고, 이는 환자의 복용 편의성을 저해하는 요소가 됩니다.</P>
<P></P>
<P>이에 반해, 당사의 나노기술 NUFS™ 는 약물대비 1배 이하 (보통 0.5배)의 소량의 부형제만을 사용하여 의약품을 제조하기에 최종 제형의 크기나 개수를 줄여 환자의 복용 편의성을 높일 수 있으며, 최종 제품 형태가 분말이기에 추가 공정이 필요없는 경제적인 기술입니다. 뿐만 아니라 MJR? 기술과 달리, 약물을 녹이는 용매가 FDA에서 부형제로 승인되어 섭취해도 무해한 물질이며, 사용한 용매도 또한 재사용이 가능한 친환경 기술입니다. 더욱이 NanoCrystal? 기술과 달리 분쇄 매체에 대한 우려가 없기에, 주사제 및 안약에도 적용 가능합니다.</P>
<P></P>
<P>현재 국내에는 상업화 가능한 약물전달시스템(Drug Delivery System) 기술로서 의약품과 같은 유기화합물을 나노 입자화 하는 원천 나노기술을 보유한 회사는 당사가 유일합니다. 국내 일부 제약 회사에서 특허가 끝난 NanoCrystal? 기술을 활용하여 의약품을 개발하고자 시도하였으나, 앞서 언급된 바와 같이, NanoCrystal? 기술을 적용할 경우 정제화 또는 캡슐화 하기 위해서는 추가 건조 공정이 필요하고, pre-milling이라는 전처리 단계도 필요하며, 특히 수 환경에서 안정하지 못한 약물들에는 NanoCrystal? 기술의 적용이 어렵기에, 당사의 기술을 대체 사용해보고자 하는 의뢰가 증가하고 있습니다.</P>
<P></P>
<P USERMARK=" B">③ 파이프라인</P>
<P> 기술 이전이 완료된 제품은 BS-101, BS-OXL, BS-108로, BS-101의 경우 시판되고 있는 MSD사 나노 항구토제의 나노 제형 특허를 회피하고자, 당사의 NUFS™ 나노 기술을 이용하여 제조한 나노 의약품(복제약)이며, 현재 대웅제약에 기술이전이 완료되었습니다. BS- OXL은 Sanofi-Aventis사 대장암 주사제를 경구제로 변형시켜 환자의 복용 편의성을 향상시킨 제품으로 JW중외제약에 기술이전 하였습니다. BS-108은 MSD사 천식치료제의 개량신약으로, 전임상 시험을 통해 기존제품 대비 동등 이상의 흡수율 및 감소된 개체편차를 확인할 수 있었으며 파마킹에 기술이전을 완료하였습니다. &cr;</P>
<P>BS-104는 NUFS™ 나노 기술을 이용하여 생체이용률을 향상시킨 표적항암제입니다. 향상된 생체이용률을 보이는 동물 시험 및 임상 1상(Pilot) 결과를 바탕으로 2021년 허가용 임상1상을함께 수행할 파트너를 물색 중에 있습니다. </P>
<P>BS-102의 경우 시판제제대비 독성을 감소한 제품으로, 현재 미국 국립암연구소(NCI) 산하 NCL에서 독성 및 PK 실험을 진행하고 있습니다. </P>
<P>나노 항응고제 BS-112는 비임상시험(비글견)을 통해 음식물에 의한 생체이용률 편차가 감소되었음을 확인하였으며, 해당 결과를 바탕으로2021년 하반기에 임상 1상을 수행하고자 준비 중에 있습니다. &cr;</P>
<P> 나노 코로나19 치료제 BS-120은 기존에 구충제로 40년이상 사람에게 사용되고 있는 안전한 의약품을 코로나19 치료제로 신약재창출(Drug Repositioning)한 제품입니다. 해당 주원료는 니클로사마이드로, 기존에 암, 당뇨병, 자궁내막증, 동맥 협착, 류마티스관절염 등에 효능을 보였던 니클로사마이드가 코로나19 항바이러스 효능(에볼라치료제 렘데시비르보다 40배, 말라리아 치료제 클로로퀸보다 26배 높은 코로나19 항바이러스 활성도)까지 있다는 것이 최근 실험실관 내 실험(in vitro)으로 확인되었습니다. 하지만 니클로사마이드의 난용성 성질 때문에 알려진 효능들을 생체 내 (in vivo) 실험에서는 구현하기 어려운 것이 현실이었습니다. 때문에 당사는 니클로사마이드의 나노화를 통해 생체이용률을 향상시킴으로써 해당 난용성 문제를 해결하여 코로나19 치료 효과를 증대시키고자 합니다. 최근 비임상시험을 통해 기존 니클로사마이드 제제대비 생체이용률이 10배이상, 최고혈중농도가 60배 이상 향상된 것을 확인하였으며, BS-104의 임상시험을 통해 NUFS™ 나노기술이 생체이용률을 향상시킬 수 있다는 것을 인체 내에서 확인했기에, 니클로사마이드의 나노화를 통한 생체이용률 향상 또한 가능할 것으로 기대되고 있습니다. 더욱이 해당 제제는 경구용 고형제로 제품화할 예정이기에 주사제로 개발되고 있는 제제들 대비 높은 복용 편의성을 바탕으로 경증환자들의 치료 또는 정상인을 대상으로 한 예방약으로도 활용될 수 있을 것으로 기대됩니다.</P>
<P>   </P>
<P USERMARK=" B">[주요 파이프라인 현황]</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="807">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="434"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">제품명</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">효능</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">단계</P>
</TD>

<TD WIDTH="443" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">주요 내용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="237">
<P USERMARK="F-BT12">이전 완료</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">BS-101</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">항구토제</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="443" VALIGN="MIDDLE" HEIGHT="79">
<P USERMARK="F-BT12">MSD사 항구토제 나노의약품의 복제약으로, 당사의 나노기술을 적용하여, MSD사의 나노 제형 특허를 회피할 수 있었음. 현재 대웅제약에 기술이전을 마침</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">BS-OXL</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">세포 독성 &cr; 항암제</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="443" VALIGN="MIDDLE" HEIGHT="79">
<P USERMARK="F-BT12">Sanofi-Aventis사 대장암 주사제를 경구제로 변형시켜 환자의 복용 편의성을 향상시킨 제품으로 JW 중외제약에 기술이전 완료 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">BS-108</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">천식 치료제</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="443" VALIGN="MIDDLE" HEIGHT="79">
<P USERMARK="F-BT12">MSD사 천식치료제의 개량신약으로, 전임상 시험을 통해 기존제품 대비 동등 이상의 흡수율 및 감소된 개체편차를 확인할 수 있었음. 파마킹에 기술이전 후 현재 임상 1상을 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">공동연구</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">BS-105</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">항진균제</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">국내</P>
<P USERMARK="F-BT12">임상 1상</P>
</TD>

<TD WIDTH="443" VALIGN="MIDDLE" HEIGHT="103">
<P USERMARK="F-BT12">MSD사 항진균제의 제네릭으로, MSD사의 제품 대비 소량의 부형제를 사용하여 정제 크기 감소. 환자들의 복용 편의성 향상 가능. &cr;2019년 임상 1상 (탐색적 생동) 완료 후 제제개선 진행 중 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="508">
<P USERMARK="F-BT12">자체연구</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">BS-104</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">표적 항암제</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">국내</P>
<P USERMARK="F-BT12">임상 1상</P>
</TD>

<TD WIDTH="443" VALIGN="MIDDLE" HEIGHT="103">
<P USERMARK="F-BT12">Bayer사 간암치료제의 개량신약으로, 당사의 나노 기술을 적용하여, 흡수율을 향상시킨 제품. 결정형 특허 및 우판권 회피 가능하기에 타 제품대비 조기 제품 출시 가능. 임상 1상 (Pilot) 완료 후, 허가용 임상 1상을 위한 파트너 물색 중 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">BS-102</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">세포 독성 &cr; 항암제</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">국내</P>
<P USERMARK="F-BT12">비임상</P>
</TD>

<TD WIDTH="443" VALIGN="MIDDLE" HEIGHT="79">
<P USERMARK="F-BT12">여러 암 종에 사용이 가능한 나노 항암제로, Sanofi-Aventis사의항암제 대비 동등이상의 항암효과에도 불구하고 독성작용이 크게 감소함. NCL과 공동연구 수행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127" USERMARK="F-BT12">BS-112</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127">
<P USERMARK="F-BT12">항응고제</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127">
<P USERMARK="F-BT12">국내 </P>
<P USERMARK="F-BT12">비임상</P>
</TD>

<TD WIDTH="443" VALIGN="MIDDLE" HEIGHT="127">
<P USERMARK="F-BT12">당사의 나노 기술을 통해 식전 생체이용률을 향상시킴으로써 식전식후 흡수율 편차가 감소될 것으로 기대됨. In vitro 실험을 통해 식전식후 흡수율 편차감소를 확인하였으며, 2020년 비임상 시험을 통해 식전식후 흡수율 편차 감소를 확인하였으며, 2021년 하반기에 임상 1상을 수행하고자 준비 중 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="199" USERMARK="F-BT12">
<P>BS-120</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="199">
<P USERMARK="F-BT12">코로나19 치료제</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="199">
<P USERMARK="F-BT12">제제 연구</P>
</TD>

<TD WIDTH="443" VALIGN="MIDDLE" HEIGHT="199">
<P USERMARK="F-BT12">Bayer사에서 구충제로 판매하고 있는 약물을 코로나19 치료제로 drug repositioning (신약 재창출)한 제품으로, 해당 물질의 코로나19치료제 효능은 in vitro 실험을 통해 확인 완료된 상태임. 하지만 매우 낮은 난용성 성질로 인해 in vivo상 해당 효능을 기대하기 어렵기에, 나노화를 통해 난용성 문제를 해결하여 생체내 코로나19 치료 효능을 증대하고자 함. 현재 비임상 시험을 통해 기존제제 대비10배 이상 향상된 생체이용률을 지님을 확인함      </P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">④ 기술이전&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">1) 파이프라인 약물&cr;</SPAN>
</P>
<P>의약품 사업의 경우, 의약품 별로  (더욱 세부적으로는 지역별로) 각 나노의약품을 제조하는데 사용되는 당사 나노 원천기술을 기술이전하는 것을 주 사업으로 진행하고 있습니다. 그리하여 앞서 언급된 자체 연구를 진행하고 있는 제품을 포함하여, 현재 2021-2024년 사이에 물질 특허가 만료되는 시장성이 뛰어난 5종의 의약품에 대해 자체적으로 나노화 연구를 진행하고 있으며 약물 파이프라인을 지속적으로 늘려가고자 노력하고 있습니다.</P>
<P>이렇게 구축된 파이프라인 약물들의 경우, 기술이전을 진행하기 전, 용출 및 간이 제형 연구를 진행하여 목표로 한 효과를 달성하였는지 1차적으로 확인을 진행합니다. 그 이후, BioKorea, BioUSA, Interbiz, CPhI, AAPS 등에 참석하여 파트너링 미팅과 포스터 발표 등을 통해 연구한 내용을 발표, 홍보하며 나노 의약품의 기술이전을 추진합니다.</P>
<P></P>
<P USERMARK=" B">2) 나노원천기술&cr;</P>
<P>앞서 언급된 자체 개발 중인 파이프라인 약물들의 기술이전과는 별개로, 파이프라인 모델 약물들의 성공사례를 바탕으로, 나노 원천 기술 자체의 특장점을 홍보하며 국내외 제약사에서 자체 개발하고 있는 약물에 당사의 기술을 적용할 수 있도록, 약물 별로 나노원천기술 자체를 기술이전하는 사업또한 추진하고 있습니다. 현재 2종 이상의 신약후보물질에 대해, 당사의 원천 나노기술을 약물전달시스템(Drug Delivery System)으로 사용하여 용해도 및 용해 속도를 향상시키는 연구를 진행하고 있습니다. 뿐만 아니라 기존제품의 제품 수명 주기관리(life cycle management)를 위한 도구로써 나노원천기술을 사용할 수 있기에, 파이프라인 약물들의 성공사례를 바탕으로, 당사의 나노기술을 적용하여 기존 제품의 문제점을 개선한 개량신약을 제조하여 제품의 수명주기를 늘리는 것이 가능함을 홍보하며, 기술이전을 추진하고 있습니다</P>
<P></P>

<TABLE BORDER="1" WIDTH="614" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="605"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="614" VALIGN="MIDDLE" HEIGHT="703">
<P USERMARK="F-BT12 B">[참조] 신약 개발 및 제품 허가 과정</P>

<P USERMARK="F-BT12">①
<SPAN USERMARK=" B"> 비임상 (Non-clinical study)</SPAN> : 새로 개발한 약을 사람에게 사용하기 전에 여러 종류의 동물에게 사용하여 부작용／독성 및 유효성 등을 확인하고 임상 시험에 사용할 제제에 대한 제제화 연구를 병행하여 제형/처방 등을 결정하는 시험
</P>

<P USERMARK="F-BT12">② 
<SPAN USERMARK=" B">신약 임상시험 승인 신청 (IND, Investigational New Drug Application)</SPAN> : 신약 후보 물질을 사람에게 투여하는 시험을 허가할 것인지를 결정하기 위해 전임상 시험 자료를 심사하는 제도로 임상시험용 의약품 허가를 받기 위하여 동물시험까지의 전임상자료와 임상시험계획서를 취합하여 신청/승인하는 절차
</P>

<P USERMARK="F-BT12">③
<SPAN USERMARK=" B"> 임상 1상 (Phase 1 clinical trial) </SPAN>: 처음으로 인체에 약품을 투여하는 연구로 건강한 피험자(보통 건강한 성인 남자 20~80명 정도가 대상)에 투여해 대사, 배설 과정에서 전임상에서 발견하지 못한 독성이 있는지 여부를 관찰함.
</P>

<P USERMARK="F-BT12">④
<SPAN USERMARK=" B"> 임상 2상 (Phase 2 clinical trial)</SPAN>
</P>
<P USERMARK="F-BT12">-  임상 2a상 (Phase 2a clinical trial) : 사용할 의약품의 용량을 단계적으로 높여주며 시험대상인 약이 효과가 있는지 여부를 결정하는 과정임.</P>
<P USERMARK="F-BT12">-  임상 1/2a상 (Phase 1/2a clinical trial) : 치료제로 환자에게만 적용되는 신약 중 비임상 시험 결과 등을 통해 임상 1상 단계의 결과에 대한 충분한 근거가 확보된 경우 2a 단계까지 동시에 관리기관(식약처)의 승인을 받아 임상시험을 진행할 수 있으며, 임상 1/2a상 승인을 받아 임상을 진행할 경우 관리기관과의 협의 및 임상 절차 진행에 소요되는 시간, 비용 및 인력 투입 등의 전반적 절감이 가능함.</P>
<P USERMARK="F-BT12">-  임상 2b상 (Phase 2b clinical trial) : 임상2b에서는 2a의 결과에 따라 설계된 용량을 갖고 다시 환자에 투여, 어떤 용량이 가장 효과가 있을지 적정 투여용량의 범위를 정하는 연구 단계임.</P>

<P USERMARK="F-BT12">⑤ 
<SPAN USERMARK=" B">임상 3상 (Phase 3 clinical trial) </SPAN>: 2상 결과 가장 효과적이라고 생각되는 용량, 용법대로 다수의 환자들에 약품을 투여, 약품의 안전성 및 유효성에 대해 관찰하는 단계임. 3상은 1상과 2상에서 안전성에 대한 자료가 어느 정도 확보되었기 때문에 2상 보다 환자의 수를 늘려 안전성과 유효성을 함께 관찰함.
</P>

<P>
<SPAN USERMARK="F-BT12">⑥ </SPAN>
<SPAN USERMARK="F-BT12 B">신약승인신청 (NDA, New Drug Application) </SPAN>
<SPAN USERMARK="F-BT12">: 전임상시험결과와 인체를 대상으로 하는 임상시험결과를 종합하여 관리기관에 의약품 시판허가를 신청하는 절차임</SPAN>.
</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">(나) 소재(식품/화장품)사업&cr;</SPAN>
<SPAN> 기능성 식품이나 화장품에 사용되는 다양한 기능성 소재들 중에도 난용성 소재가 많이 있습니다. &cr; 바이오시네틱스는 기능성이 과학적으로 입증되고 널리 사용되고 있는 소재 중에서 물에 대한 용해도가 극히 낮아서 그 효능을 충분히 발휘</SPAN>하지 못하거나 다양한 완제품 제형에 적용이 어려운 소재들을 엄선하여 나노수분산이 가능한 제형으로 개발하고 하이드로파티클(HydroParticle) 시리즈 브랜드로 제품화 하였습니다.&cr;&cr;
<SPAN USERMARK=" B">① 기능성식품 소재 </SPAN>
</P>
<P>건강기능식품 소재 하이드로파티클 제품들은 난용성 소재의 생체이용율을 크게 올려줄 수 있고 또한 음료 등 다양한 형태의 건강기능식품을 용이하게 제조할 수 있도록 해줍니다. 당사는 식품의약품 안전처로부터 인증받은 우수건강기능식품 제조기준 (GMP) 설비를 갖추고 하이드로파티클 제품을 제조·판매하고 있습니다. 국내는 건강기능식품회사에 직접 또는 소재전문 유통회사를 통하여 제품을 공급하고 있으며 Vitafoods, Hi 등 해외전시회에 지속적으로 참가하여 해외 고객들을 발굴하고 있습니다. 현재 대만과 베트남, 말레이시아에 대리점 망을 구축하였으며 아직 소량이지만 제품이 수출되고 있습니다.&cr;</P>

<P>
<SPAN USERMARK=" B">1) 하이드로커큐민(HydroCurcumin)&cr;</SPAN>
</P>
<P>하이드로커큐민(HydroCurcumin)은 항산화 작용 및 항암효과, 면역력 증진, 치매 예방 및 기억력 향상에 탁월한 강황의 주성분인 커큐민을 나노화한 분말 제품으로, 물에 잘 분산되는 분말로 제조하여 음료를 포함한 다양한 식품에 적용이 용이한 제품입니다.</P>

<IMAGE>
<IMG WIDTH="439" HEIGHT="215" ALIGN="CENTER" HSPACE="0">커큐민 분산.jpg</IMG>
<IMG-CAPTION ATOC="N">.</IMG-CAPTION>
</IMAGE>
<P>전문 연구기관에 의뢰하여 비임상 실험을 한 결과 HydroCurcumin™ 이 curcumin의 흡수율을 크게 향상시켜 줌을 확인하였습니다. (Cmax 12배, AUC 9배)</P>
<P>또한 HydroCurcumin™ 은 에탄올의 대사 산물인 아세트알데하이드를 크게 낮추어 줌으로서 숙취해소 효과가 있다는 것을 확인하였습니다.&cr;</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="290" ALIGN="CENTER" HSPACE="0">hydrocurcumin_new03.jpg</IMG>
<IMG-CAPTION ATOC="N">.</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK=" B">[Figure1] Mean plasma concentration-time profiles of total curcumin in rats after administration of raw curcumin and HydroCurcumin™ (50mg/kg body weight of curcumin, mean ± SD, n=5)&cr;&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="290" ALIGN="CENTER" HSPACE="0">hydrocurcumin_new04-1.jpg</IMG>
<IMG-CAPTION ATOC="N">.</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK=" B">[Figure2] Mean plasma concentration of acetaldehyde in SD rats(n=8) with or without intake of HydroCurcumin™ (50mg/kg by curcumin) and successive intake of 30% ethanol(10ml/kg)&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">2) 하이드로코큐텐(HydroCoQ10)&cr;</SPAN>
<SPAN>&cr;</SPAN>코큐텐(코엔자임Q10)은 인체의 모든 세포에 존재하여 에너지 생성에 관여하는 물질입니다. 코큐텐은 간에서 생성되지만 나이가 들수록 그 양이 줄어듭니다. 코큐텐은 식품의약품안전처가 지정한 건강기능식품 소재로서 항산화 및 고혈압 감소에 도움을 줍니다. 코큐텐은 매우 난용성이서 인체 흡수율이 낮은 것으로 알려져 있습니다.
</P>
<P>HydroCoQ10™ 은 코큐텐의 난용성 문제를 극복할 수 있도록 바이오시네틱스가 나노입자화 기술로 탄생시킨 혁신 소재입니다.</P>
<P>동물시험 결과 단순히 물에 분산시킨 HydroCoQ10™이 식물성기름에 완전히 녹인 CoQ10에 비해 동등이상의 흡수율을 나타냈습니다. (Hyang-Mok OK et al. 2012. J Korean Soc Appl Biol Chem 55, 619-623).</P>

<P>
<SPAN></SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="283" ALIGN="CENTER" HSPACE="0">hydrocoq10.jpg</IMG>
<IMG-CAPTION ATOC="N">.</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK=" B">[Figure] Time curves of total CoQ10 in plasma of rats after oral administration (60mg Coenzyme Q10/kg body weight of rat as a single dose, n=9)&cr;</SPAN>
<SPAN>&cr;바이오시네틱스는 코큐텐이 40% 함유된 하이드로코큐텐 HQ40을 식약처에 품목제조보고를 완료하고 건강기능식품(원료성)으로 출시하여 국내외 고객들에게 공급하고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">3) 하이드로밀크씨슬(HydroMilkThistle)&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>하이드로밀크씨슬(HydroMilkThistle)</SPAN>은 간건강에 탁월한 성분인 밀크씨슬을 나노화한 제품이며, 밀크씨슬은 엉겅퀴라고도 불리는 국화과 식물로써 전통적으로 간질환의 치료제로 사용되어 왔습니다. 밀크씨슬 추출물의 주성분은 실리마린으로서, 우리나라의 건강기능식품 기준에 따르면 하루에 실리마린 130mg 이상을 섭취하면 간건강에 도움을 줄 수 있습니다. 
</P>
<P>HydroMilkthistle™은 밀크씨슬 추출물에 하이드로파티클 기술을 적용하여 나노수분산이 가능하도록 개발한 원료성 제품입니다. 캡슐이나 타블렛 등 전통적인 형태뿐 아니라 음료 등 다양한 형태로 생체이용율이 증가된 밀크씨슬 추출물 함유 건강기능식품을 제품화 할 수 있도록 해줍니다. </P>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">② 화장품 소재&cr;</SPAN>
<SPAN>&cr;항산화, 주름개선, 미백 등 다양한 기능성을 가진 화장품 소재 등에도 물에 대한 용해도가 매우 낮아서 완제품 적용이 까다롭고 따라서 기능성을 충분히 발휘하기 어려운 경우가 많습니다.&cr;</SPAN>
</P>
<P>바이오시네틱스의 하이드로파티클 기술이 적용된 화장품 소재 제품들은 고농도로 수분산이 가능하므로 유기용매나 오일에 녹이지 않고도 고함량의 유용성분이 함유된 다양한 제형의 화장품 제조를 가능하게 합니다.</P>
<P>하이드로파티클 소재가 함유된 화장품을 피부에 적용하면, 수백 나노미터 크기의 지질 친화적인 기능성 소재 입자들로 피부 접촉면적을 크게 넓힐 수 있으며 따라서 수동 확산을 통한 피부 흡수율이 크게 증가합니다.</P>

<P>&cr;
<SPAN USERMARK=" B">1) 하이드로세라마이드50(DS-HydroCeramide50)&cr;</SPAN>
</P>
<P>DS-HydroCeramide50는 피부개선, 노화방지 등의 피부 미용뿐만 아니라 아토피성 피부염을 억제 하는 등 피부 질환에도 효과가 있는 세라마이드를 주 원료로 50% 함유한 분말입니다. 나노기술을 적용하여 기존에는 적용할 수 없었던 수(水) 함량이 높은 스킨/에센스 등과 같은 투명한 제형에도 적용이 가능하고, 재결정(Recrysatlization)문제로 기존에 크림이나 로션에 고함량 첨가할 수 없었던 제품의 문제점도 해결하였습니다. 뿐만 아니라 나노화를 통해 기존 제형 대비 보습 기능도 향상시킨 제품입니다.</P>
<P>&cr;당사에서 사용하고 있는 DS-HydroCeramide50의 세라마이드 원료는 독일의 Evonik사에 이어 세계 두 번째로 천연 세라마이드를 개발한 솔루스첨단소재㈜((구)두산 솔루스㈜)의 세라마이드로, 기존에 많이 유통되고 있었던 유사(pseudo) 세라마이드가 아닌 천연 세라마이드 원료를 사용하였다는 것에서 차별성을 지닙니다. 또한 DS-HydroCeramide50의 경우, 나노화를 통해 로션이나 크림과 같이 유지(oil)성분이 많은 제형에서 스킨이나 에센스와 같이 수(water) 성분이 많은 제형까지 모두 적용이 가능하기에 경쟁제품 대비 더 다양한 제형에 적용이 가능할 뿐만 아니라 고함량을 첨가하여도 제품 생산에 어려움이 없으며 완제품상의 안정성 향상으로 품질을 장시간 유지할 수 있다는 강점이 있습니다.</P>
<P>당사의 제품인 DS-HydroCeramide50의 국내외 마케팅은 협력사인 솔루스첨단소재㈜가 담당하고 있으며, 현재 중국과 유럽의 몇몇 화장품 회사들이 이 DS-HydroCeramide50를 첨가한 화장품을 판매하고 있습니다. 더불어 세계적 화장품 회사인 라프레리, 에스티로더, 존슨앤존슨 등에 마케팅 하여 매출 확대를 추진하고 있습니다.</P>

<P>&cr;
<SPAN USERMARK=" B">2) 하이드로코큐텐(HydroCoQ10)&cr;</SPAN>&cr;코엔자임Q10 (코큐텐)은 강력한 항산화제로서 피부노화 방지 및 개선효과가 있는 우수한 화장품 소재이지만 난용성이 매우 심하여 화장품으로 적용 시에 제형화에 어려움이 많이 있습니다.&cr;당사가 개발한 HydroCoQ10은 이러한 CoQ10의 단점을 극복한 제품으로서 나노입자로 수분산이 가능한 분말 제형입니다.
</P>
<P>특히 HydroCoQ10은 액상제형에서 탁월한 안정성을 보이기 때문에 크림, 로션 등 오일 성분이 많은 완제품 제형뿐 아니라 스킨, 토너 등 수분이 주성분인 완제품 제형에도 용이하게 적용할 수 있고 강력한 항산화제인 CoQ10을 고함량으로 함유한 화장품을 개발하는데 매우 유용하게 활용될 수 있습니다.</P>

<P>&cr;
<SPAN USERMARK=" B">다. 경영상의 주요계약&cr;</SPAN>
</P>
<P USERMARK=" B"> (가) 라이센스아웃 (License-out) 계약&cr;</P>
<P>기업현황보고서 작성일 기준 현재 당사가 체결 중인 라이센스아웃(License-out) &cr;계약의 현황은 다음과 같습니다.</P>
<P> </P>
<P><라이센스아웃 계약 총괄표></P>

<TABLE BORDER="1" WIDTH="1055" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="219"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">품목</P>
</TD>

<TD WIDTH="140" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">계약상대방</P>
</TD>

<TD WIDTH="161" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">대상지역</P>
</TD>

<TD WIDTH="102" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">계약체결일</P>
</TD>

<TD WIDTH="228" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">계약종료일</P>
</TD>

<TD WIDTH="104" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">총 계약금액</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">수취금액</P>
</TD>

<TD WIDTH="123" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">진행단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">BS-OXL</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">중외제약</P>
</TD>

<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">전세계</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2007.04.24</P>
</TD>

<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">제품발매 혹은 개발위원회가 &cr;결정한 종료시점까지</P>
</TD>

<TD COLSPAN="2" WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12"> 전임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">BS-108</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">파마킹</P>
</TD>

<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">대한민국</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2009.08.24</P>
</TD>

<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">특허기술 존속기간 만료시까지</P>
</TD>

<TD COLSPAN="2" WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">임상1상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">BS-101</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">대웅제약</P>
</TD>

<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">전세계</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2013.11.01</P>
</TD>

<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">특허권 존속기간 만료 시까지</P>
</TD>

<TD COLSPAN="2" WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">전임상</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">BS-104</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">삼양바이오팜</P>
</TD>

<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">대한민국,</P>
<P USERMARK="F-BT12">인도네시아, &cr;베트남 및 인도</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2017.12.15</P>
</TD>

<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2019.05.31</P>
</TD>

<TD COLSPAN="2" WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">임상1상</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P> (1) 품목 : BS-OXL</P>

<TABLE BORDER="1" WIDTH="739" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="575"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">① 계약상대방</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">중외제약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">② 계약내용</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">나노 입자 제조 기술을 기반으로 BS-OXL을 제품화하여 산업화 및 사업화</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">③ 대상지역</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">④ 계약기간</P>
</TD>

<TD WIDTH="584" HEIGHT="55">
<P USERMARK="F-BT12">계약체결일 : 2007.04.24</P>
<P USERMARK="F-BT12">계약종료일 : 제품발매 혹은 개발위원회가 결정한 종료시점까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑤ 총 계약금액</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑥ 수취금액</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑦ 계약조건</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑧ 회계처리방법</P>
</TD>

<TD WIDTH="584" HEIGHT="55">

<P USERMARK="F-BT12">1. 계정과목 : 용역매출&cr;
<SPAN></SPAN>
<SPAN>2. 회계처리 : 계약금은 계약기간 기준으로 안분 수익 인식</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" HEIGHT="79" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑨ 대상기술</P>
</TD>

<TD WIDTH="584" HEIGHT="79">
<P USERMARK="F-BT12">NUFS™기술 (NUFS™기술은 Nanoparticulation Using Fat and Supercritical Fluid의 줄임말로 고체상 지질과 CO₂를 이용하여 나노입자를 제조하는 ㈜바이오시네틱스 고유의 나노기술을 의미)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑩ 개발 진행경과</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">기술이전을 받은 중외제약의 사업적 전략에 의해 현재 개발이 Hold된 상황임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑪ 기타사항</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(2) 품목 : BS-108</P>

<TABLE BORDER="1" WIDTH="739" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="143"></COL>
<COL WIDTH="578"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">① 계약상대방</P>
</TD>

<TD WIDTH="587" HEIGHT="31">
<P USERMARK="F-BT12">파마킹</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">② 계약내용</P>
</TD>

<TD WIDTH="587" HEIGHT="31">
<P USERMARK="F-BT12">BS-108 연구개발 및 사업화</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">③ 대상지역</P>
</TD>

<TD WIDTH="587" HEIGHT="31">
<P USERMARK="F-BT12">대한민국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">④ 계약기간</P>
</TD>

<TD WIDTH="587" HEIGHT="55">
<P USERMARK="F-BT12">계약체결일 : 2009.08.24</P>
<P USERMARK="F-BT12">계약종료일 : 특허기술 존속기간 만료 시까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑤ 총 계약금액</P>
</TD>

<TD WIDTH="587" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑥ 수취금액</P>
</TD>

<TD WIDTH="587" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑦ 계약조건</P>
</TD>

<TD WIDTH="587" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑧ 회계처리방법</P>
</TD>

<TD WIDTH="587" HEIGHT="55">

<P USERMARK="F-BT12">1. 계정과목 : 용역매출&cr;
<SPAN></SPAN>
<SPAN>2. 회계처리 : 계약금은 계약기간 기준으로 안분 수익 인식</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="79" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑨ 대상기술</P>
</TD>

<TD WIDTH="587" HEIGHT="79">
<P USERMARK="F-BT12">NUFS™기술 (NUFS™기술은 Nanoparticulation Using Fat and Supercritical Fluid의 줄임말로 고체상 지질과 CO₂를 이용하여 나노입자를 제조하는 ㈜바이오시네틱스 고유의 나노기술을 의미)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑩ 개발 진행경과</P>
</TD>

<TD WIDTH="587" HEIGHT="55">
<P USERMARK="F-BT12">임상 1상 진행하였으나, 기술이전을 받은 파마킹의 내부사정에 의해 현재 개발이 Hold된 상황임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑪ 기타사항</P>
</TD>

<TD WIDTH="587" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(3) 품목 :  BS-101</P>

<TABLE BORDER="1" WIDTH="737" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="575"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">① 계약상대방</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">대웅제약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">② 계약내용</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">BS-101 공동연구 및 기술이전 계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">③ 대상지역</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">④ 계약기간</P>
</TD>

<TD WIDTH="584" HEIGHT="55">
<P USERMARK="F-BT12">계약체결일 : 2013.11.01</P>
<P USERMARK="F-BT12">계약종료일 : 특허권 존속기간 만료 시까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑤ 총 계약금액</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑥ 수취금액</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑦ 계약조건</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑧ 회계처리방법</P>
</TD>

<TD WIDTH="584" HEIGHT="55">

<P USERMARK="F-BT12">1. 계정과목 : 용역매출&cr;
<SPAN></SPAN>
<SPAN>2. 회계처리 : 계약금은 계약기간 기준으로 안분 수익 인식</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" HEIGHT="79" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑨ 대상기술</P>
</TD>

<TD WIDTH="584" HEIGHT="79">
<P USERMARK="F-BT12">NUFS™기술 (NUFS™기술은 Nanoparticulation Using Fat and Supercritical Fluid의 줄임말로 고체상 지질과 CO₂를 이용하여 나노입자를 제조하는 ㈜바이오시네틱스 고유의 나노기술을 의미)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑩ 개발 진행경과</P>
</TD>
<TD WIDTH="584" HEIGHT="31" USERMARK="F-BT12">시장 상황의 변화로 현재 개발이 Hold된 상황임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑪ 기타사항</P>
</TD>

<TD WIDTH="584" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(4) 품목 : BS-104</P>

<TABLE BORDER="1" WIDTH="733" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="139"></COL>
<COL WIDTH="576"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">① 계약상대방</P>
</TD>

<TD WIDTH="585" HEIGHT="31">
<P USERMARK="F-BT12">삼양바이오팜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">② 계약내용</P>
</TD>

<TD WIDTH="585" HEIGHT="31">
<P USERMARK="F-BT12">BS-104 공동연구 및 기술이전 계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">③ 대상지역</P>
</TD>

<TD WIDTH="585" HEIGHT="31">
<P USERMARK="F-BT12">대한민국, 인도네시아, 베트남 및 인도</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">④ 계약기간</P>
</TD>

<TD WIDTH="585" HEIGHT="55">
<P USERMARK="F-BT12">계약체결일 : 2017.12.15</P>
<P USERMARK="F-BT12">계약종료일 : 2019.05.31</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑤ 총 계약금액</P>
</TD>

<TD WIDTH="585" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑥ 수취금액</P>
</TD>

<TD WIDTH="585" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑦ 계약조건</P>
</TD>

<TD WIDTH="585" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑧ 회계처리방법</P>
</TD>

<TD WIDTH="585" HEIGHT="55">

<P USERMARK="F-BT12">1. 계정과목 : 로
<SPAN></SPAN>
<SPAN>열티 매출&cr;</SPAN>
<SPAN></SPAN>
<SPAN>2. 회계처리 : 계약금은 계약기간 기준으로 안분 수익 인식</SPAN>
<SPAN></SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" HEIGHT="79" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑨ 대상기술</P>
</TD>

<TD WIDTH="585" HEIGHT="79">
<P USERMARK="F-BT12">NUFS™기술 (NUFS™기술은 Nanoparticulation Using Fat and Supercritical Fluid의 줄임말로 고체상 지질과 CO₂를 이용하여 나노입자를 제조하는 ㈜바이오시네틱스 고유의 나노기술을 의미)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" HEIGHT="103" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑩ 개발 진행경과</P>
</TD>
<TD WIDTH="585" HEIGHT="103" USERMARK="F-BT12">임상1상 dose-finding 임상을 통해 기존제제대비 1.6배 향상된 흡수율을 보이는 것을 확인할 수 있었으나,기술이전을 받은 삼양바이오팜의 사업적 판단에 의해서 계약 해지된 상황임.바이오시네틱스 자체적으로 허가용 임상 1상을 진행하고자 준비 중에 있으며, 이를 함께 수행할 파트너를 물색 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑪ 기타사항</P>
</TD>

<TD WIDTH="585" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">  (나) 판매계약</P>

<TABLE BORDER="1" WIDTH="942" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="249"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">품목</P>
</TD>

<TD WIDTH="111" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">계약상대방</P>
</TD>

<TD WIDTH="80" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">대상지역</P>
</TD>

<TD WIDTH="103" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">계약체결일</P>
</TD>

<TD WIDTH="258" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">계약종료일</P>
</TD>

<TD WIDTH="112" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">총 계약금액</P>
</TD>

<TD WIDTH="87" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">수취금액</P>
</TD>

<TD WIDTH="98" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">진행단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">나노</P>
<P USERMARK="F-BT12">세라마이드</P>
</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">솔루스첨단소재(주)</TD>

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">전세계</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2011.11</P>
</TD>

<TD WIDTH="258" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">계약일로부터 7년, &cr;계약해지 의사를 나타내지 않으면 1년씩 자동갱신됨</P>
</TD>

<TD COLSPAN="2" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">제품</P>
<P USERMARK="F-BT12">출시 완료</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">  (다) 연구개발 계약</P>

<TABLE BORDER="1" WIDTH="936" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="183"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">품목</P>
</TD>

<TD WIDTH="172" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">계약상대방</P>
</TD>

<TD WIDTH="132" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">계약체결일</P>
</TD>

<TD WIDTH="192" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">계약종료일</P>
</TD>

<TD WIDTH="118" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">총 계약금액</P>
</TD>

<TD WIDTH="83" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">수취금액</P>
</TD>

<TD WIDTH="89" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">진행단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">나노 표적항암제</P>
</TD>

<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">산업통상자원부</P>
</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2016.09</P>
</TD>
<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2019.12</TD>

<TD COLSPAN="2" WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">임상1상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">BS-102</P>
</TD>

<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">美국립암연구소 </P>
<P USERMARK="F-BT12">산하 NCL (나노기술</P>
<P USERMARK="F-BT12">특성분석 연구소)</P>
</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2018.08</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">-</P>
</TD>

<TD COLSPAN="2" WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">비임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">HydroCurcumin</P>
</TD>

<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">아리조나 대학교</P>
</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.10</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD COLSPAN="2" WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">사업상 기밀사항</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">비임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>BS-119</P>
</TD>

<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>가톨릭대학교</P>
</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>2020.03</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>-</P>
</TD>

<TD COLSPAN="2" WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>사업상 기밀사항</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>In-vitro</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>BS-112</P>
</TD>

<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>유럽 Z사</P>
</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>2020.04</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>-</P>
</TD>

<TD COLSPAN="2" WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>사업상 기밀사항</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>In-vitro</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>신약후보물질</P>
</TD>

<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>국내 S사</P>
</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>2020.05</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>-</P>
</TD>

<TD COLSPAN="2" WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>사업상 기밀사항</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>비임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>신약후보물질</P>
</TD>

<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>국내 A사</P>
</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>2020.12</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>-</P>
</TD>

<TD COLSPAN="2" WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>사업상 기밀사항</P>
</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>In-vitro</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">2. 주요 제품에 관한 사항&cr;</SPAN>                                                                                                       (단위: 천원)
</P>

<TABLE BORDER="1" WIDTH="985" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="48"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="422"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="195" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">제 품 명</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">생산(판매) &cr;개 시 일</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">주요상표</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">매출액</P>
<P USERMARK="F-BT12 B">(비율)</P>
</TD>

<TD WIDTH="431" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">제 품 설 명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="213">
<P USERMARK="F-BT12">제품</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">화장품 소재</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2014.01</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">HydroCeramide,</P>
<P USERMARK="F-BT12">HydroCoQ10</P>
</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-BT12">209,205&cr;(66.33%)</TD>

<TD WIDTH="431" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">- Ceramide  또는 CoQ10 를 함유한 분말제형</P>
<P USERMARK="F-BT12">- 물에 잘 분산되어 화장품 소재로 적용가능함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">식품 소재</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2016.12</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">HydroCurcumin</P>
</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="79" USERMARK="F-BT12">93,600&cr;(29.68%)</TD>

<TD WIDTH="431" VALIGN="MIDDLE" HEIGHT="79">
<P USERMARK="F-BT12">- Curcumin을 함유한 분말 제형</P>
<P USERMARK="F-BT12">- 생체이용률 향상가능</P>
<P USERMARK="F-BT12">- 음료 등 다양한 기능성 식품 및 화장품에 고농도로 적용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">건강기능식품소재</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">2019.09</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">HydroMilkThistle</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="79" USERMARK="F-BT12">12,600&cr;(3.99%)</TD>

<TD WIDTH="431" VALIGN="MIDDLE" HEIGHT="79">
<P USERMARK="F-BT12">- MilkThistle을 함유한 분말 제형</P>
<P USERMARK="F-BT12">- 생체이용률 향상가능</P>
<P USERMARK="F-BT12">- 음료 등 다양한 건강기능성 식품에 고농도로 적용</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>주1. 제품 매출액 및 비율은 
<SPAN>2020</SPAN>년 기준 입니다.
</P>

<P>
<SPAN>주2. </SPAN>회사는 솔루스첨단소재(주)에서 원재료를 유상사급방식으로 매입하여 가공 후 공급하고 있으므로 유상사급에 의한 원재료 매입액을 매출액과 매출원가에서 각각 차감하여 표시하고 있습니다.
</P>
<P>당기와 전기  솔루스첨단소재㈜관련 매출액 내역은 다음과 같으며, 재무제표에는 순액으로 표시하고 있습니다.</P>
<P>                                                                                                    (단위: 천원)</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="159"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구   분</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">제17기</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">
<P>제16기</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">제15기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">총 매출액</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">190,685</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">532,725</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<P>380,588</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">유상사급 차감</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">(102,506)</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">(292,378)</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<P>(202,979)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">순 매출액</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">88,179</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">240,347</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<P>177,609</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">3. 주요 원재료에 관한 사항&cr;</SPAN>                                                                                                      (단위: 천원)
</P>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">매입유형</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">품목</P>
</TD>

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">2020년&cr;(제17기)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">2019년&cr;(제16기)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">2018년&cr;(제15기)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="6" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="186">
<P USERMARK="F-BT12">원재료</P>
</TD>

<TD ROWSPAN="2" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62">
<P USERMARK="F-BT12">화장품 원료</P>
</TD>

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">국내</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">41,750</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">345,400</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">276,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">수입</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62">
<P USERMARK="F-BT12">식품 원료</P>
</TD>

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">국내</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">36,050</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">24,235</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">5,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">수입</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,117</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62">
<P USERMARK="F-BT12">기타</P>
</TD>

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">국내</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">10,143</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">29,893</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">27,737</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">수입</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="2" WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62">
<P USERMARK="F-BT12">기타</P>
</TD>

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">국내</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">수입</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="3" WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="93">
<P USERMARK="F-BT12">총 합 계</P>
</TD>

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">국내</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">89,060</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">399,528</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">309,937</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">수입</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">합계</P>
</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">89,060</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">399,528</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">309,937</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X1814FF"></P>

<P USERMARK=" B">4. 생산 및 생산설비에 관한 사항&cr;&cr;
<SPAN></SPAN>
<SPAN>가. 생산능력 및 생산실적</SPAN>
</P>

<P>
<SPAN>                                            </SPAN>                                                         (단위 : 천원)
</P>

<TABLE BORDER="1" WIDTH="661" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">제품</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">2020년&cr;(제17기)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">2019년&cr;(제16기)</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">2018년&cr;(제15기)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="124">
<P USERMARK="F-BT12">HydroCurcumin</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산능력</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">213,720</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">187,200</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">154,242</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산실적</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">133,284</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">23,640</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">19,160</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">가동율</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">62.36%</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">12.63%</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">12.42%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">기말재고</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">67,475</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">14,801</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">11,797</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="124">
<P USERMARK="F-BT12">HydroCeramide</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산능력</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">577,200</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">577,200</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">575,837</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산실적</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">132,368</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">612,720</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">429,240</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">가동율</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">22.93%</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">106.15%</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">74,54%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">기말재고</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">15,731</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">57,667</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">50,921</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="124">
<P USERMARK="F-BT12">HydroCoQ10</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산능력</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">96,096</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">87,360</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">90,489</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산실적</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">21,450</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">24,360</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">7,040</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">가동율</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">22.32%</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">27.88%</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">7.78%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">기말재고</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">20,971</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">8,667</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">2,435</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="124" USERMARK="F-BT12">HydroMilkThistle</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산능력</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">37,440</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">37,440</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산실적</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">32,400</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">가동율</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">86.54%</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">기말재고</P>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">7,991</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">2,138</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">나. 생산설비에 관한 사항&cr;</P>
<P>(1) 현황</P>
<P>                                                                                                    (단위 : 천원)</P>

<TABLE BORDER="1" WIDTH="835" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="67"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="66"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT12 BC0XD7D7D7 B">자산별</P>
</TH>

<TH ROWSPAN="2" WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT12 BC0XD7D7D7 B">소재지</P>
</TH>

<TH ROWSPAN="2" WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT12 BC0XD7D7D7 B">기초&cr;가액</P>
</TH>

<TH COLSPAN="2" WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT12 BC0XD7D7D7 B">당기증감</P>
</TH>

<TH ROWSPAN="2" WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT12 BC0XD7D7D7 B">정부</P>
<P USERMARK="F-BT12 BC0XD7D7D7 B">보조금</P>
</TH>

<TH ROWSPAN="2" WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT12 BC0XD7D7D7 B">당기상각</P>
</TH>
<TH ROWSPAN="2" WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12 B" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유형자산&cr;손상차손누계액</TH>

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT12 BC0XD7D7D7 B">기말가액</P>
</TH>

<TH ROWSPAN="2" WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT12 BC0XD7D7D7 B">비고</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="48" USERMARK=" BC0XD7D7D7" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT12 B">증가</P>
</TH>

<TH WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="48" USERMARK=" BC0XD7D7D7" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P USERMARK="F-BT12 B">감소</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="48">
<P USERMARK="F-BT12">구축물</P>
</TD>

<TD ROWSPAN="2" WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="94">
<P USERMARK="F-BT12">서울시 금천구 가마산로 96,&cr;710호</P>
</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="48" USERMARK="F-BT12">117,668</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="48" USERMARK="F-BT12">-</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="48" USERMARK="F-BT12">-</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="48" USERMARK="F-BT12">-</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="48" USERMARK="F-BT12">(39,800)</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="48">(77,868)</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="48" USERMARK="F-BT12">-</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="48">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">
<P USERMARK="F-BT12">기계장치</P>
</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="46" USERMARK="F-BT12">441,902</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="46" USERMARK="F-BT12">9,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46" USERMARK="F-BT12">-</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="46" USERMARK="F-BT12">13,311</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="46" USERMARK="F-BT12">(138,515)</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="46" USERMARK="F-BT12">325,698</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN></SPAN>
<SPAN>(2) 최근 3년간 변동사항&cr;</SPAN>                                                                                                      (단위 : 천원)
</P>

<TABLE BORDER="1" WIDTH="936" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="260"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">설비자산명</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">취득(처분)가액</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">취득(처분)일</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">취득(처분)사유</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">용도</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">취득(처분)처</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">고압균질기</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">20,000</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.09.11</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">㈜일신오토클레이브</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">나노입도분석기</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">39,400</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.09.29</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">㈜엔솔인스트루먼트</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">용출기</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">19,480</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.09.30</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">㈜영화과학</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">혼합기</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">26,000</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.12.04</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">경용기계㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">진공건조기</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">5,000</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.12.30</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">엠지산업</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">PH측정기</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">2,150</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.03.05</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">㈜신성계기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">흄후드</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">7,740</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.03.19</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">㈜제이오텍</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">Karl Fisher &cr;수분측정기</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55">
<P USERMARK="F-BT12">11,264</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2015.03.23</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">연구시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">㈜신성계기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">Water Chiller</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">4,000</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.03.25</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">㈜영화과학</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">HPLC/SIL20A</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">18,000</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.03.27</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">한국크로마토그래피</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">클린벤치</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">8,500</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.03.31</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">경용기계㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">분쇄기</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">8,000</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2016.11.03</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">㈜덕산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">분쇄기</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">6,000</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2016.12.05</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">㈜덕산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">고속건조진공건조기</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">26,000</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2016.12.23</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">㈜엠지산업</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">Low &cr;Temperature bath &cr;Circulator</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="79">
<P USERMARK="F-BT12">7,800</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2016.12.23</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">연구시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">(주)영진코퍼레이션</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">가열교반기</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">619</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2017.02.07</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">(주)영진코퍼레이션</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">혼합기</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">16,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2017.03.02</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">인텍시스템</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">초미립자분쇄기</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">19,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2017.03.08</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">(주)덕산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">HPLC Auto sampler</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">27,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2017.03.13</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">(주)유엠씨사이언스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">수동타정기</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">2,500</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2017.03.12</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">코리아메디 주식회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">Stand Mixer </TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">409</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2017.05.01</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">(주)중산물산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">Hanson SR8 Plus Automated &cr;Dissolution System（중고）</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-BT12">4,200</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2018.05.16</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">연구시설 확대</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">연구시설</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">(주)정일사이언스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">혼합기</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">18,500</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.05.17</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">생산시설 확대</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">생산시설</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">인텍시스템</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">호리바(SZ-100Z)나노입자분석장치</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">27,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.06.02</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">연구시설확대</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">연구시설</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">호리바코리아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">혼합기</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">38,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.07.25</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">생산시설 확대</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">생산시설</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">(주)비티비솔루션</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">스파믹서 SP+22HA 및 &cr;혼합기부품(STS316L)</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-BT12">6,050</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2018.08.17</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">연구시설 확대</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">연구시설</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">효성제작소</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">진공챔버 VC-125</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">16,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.08.28</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">연구시설 확대</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">이레테크</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">HHM-08, 혼합기</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">100,900</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.10.15</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">연구시설 확대</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">세진엠텍 주식회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">10Liter 초임계 CO2 추출 장치</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">275,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.11.28</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">연구시설 확대</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">(주)일신오토클레이브</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">Liquid CO2 system 장비 제작</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">23,320</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.11.29</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">연구시설 확대</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">(주)일신오토클레이브</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">Autoclave DAC811 45리터</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,300</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.12.27</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">연구시설 확대</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">D.S 정공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">동결건조기</P>
<P USERMARK="F-BT12">(FDB-5503)</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55">
<P USERMARK="F-BT12">9,455</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2019.01.18</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">연구시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">연구시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12"> (주)오페론</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">공장시설 (709호)</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">67,000</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2019.05.15</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">브룩필드</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">선별기</P>
<P USERMARK="F-BT12">(진동체SCT800-1)</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55">
<P USERMARK="F-BT12">5,600</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2019.05.29</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">생산시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">(주)성창기계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">반죽기히팅자켓 및 컨트롤러</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">1,100</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2019.06.03</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">(주)글로벌랩 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">식품용분말혼합기</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">1,650</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2019.07.25</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12"> (주)대광건설기계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">산업용진공건조기(판열)set 및 &cr;콜드트랩</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55">
<P USERMARK="F-BT12">19,500</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2019.10.02</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">생산시설</P>
</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">에스씨이앤지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">반응기 70</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">15,300</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2019.10.02</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">생산시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12"> "</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">수분측정기</P>
<P USERMARK="F-BT12">(xc-63)CAS</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55">
<P USERMARK="F-BT12">1,700</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2019.11.29</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">생산시설확대</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">생산시설</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12"> (주)뉴텍계기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="34" USERMARK="F-BT12">중고타정기</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="34" USERMARK="F-BT12">9,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="34" USERMARK="F-BT12">2020.06.25</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="34" USERMARK="F-BT12">연구시설확대</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="34" USERMARK="F-BT12">연구시설</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="34" USERMARK="F-BT12">청진 엔지니어링</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">다. 외주생산에 관한 사항</SPAN>
</P>
<P>당사는 보고서 제출일 현재까지 해당 사항 없습니다.</P>

<P>&cr;
<SPAN USERMARK=" B">5. 매출에 관한 사항</SPAN>
</P>
<P>                                                                                                   (단위 : 천원)</P>

<TABLE BORDER="1" WIDTH="618" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="63"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">매출&cr;유형</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">품목</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">2020년&cr;(제17기)</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">2019년&cr;(제16기)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">2018년&cr;(제15기)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="6" WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="186">
<P USERMARK="F-BT12">제품</P>
</TD>

<TD ROWSPAN="3" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="93">
<P USERMARK="F-BT12">화장품 소재</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">수출</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">188,565</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">530,205</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">376,335</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">내수</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">20,640</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">14,270</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">13,043</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">합계</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">209,205</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">544,475</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">389,378</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="93">
<P USERMARK="F-BT12">식품 소재</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">수출</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">39,165</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">3,024</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">3,435</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">내수</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">67,035</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">19,980</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">5,845</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">합계</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">106,200</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">23,004</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">9,280</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="3" WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="93">
<P USERMARK="F-BT12">연구용역</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">수출</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">내수</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">16,200</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">103,495</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">29,538</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">합계</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">16,200</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">103,495</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">29,538</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="3" WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="93">
<P USERMARK="F-BT12">합 계</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">수출</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">227,730</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">533,229</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">379,770</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">내수</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">103,875</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">137,745</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">48,426</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">합계</P>
</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">331,605</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">670,974</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">428,196</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>주1. </SPAN>회사는 (주)솔루스 첨단소재에서 원재료를 유상사급방식으로 매입하여 가공 후 공급하고 있으므로 유상사급에 의한 원재료 매입액을 매출액과 매출원가에서 각각 차감하여 표시하고 있습니다.
</P>
<P>당기와 전기 (주)솔루스 첨단소재 관련 매출액 내역은 다음과 같으며, 재무제표에는 순액으로 표시하고 있습니다.</P>
<P>                                                                                                    (단위: 천원)</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="159"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구   분</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">제17기</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">
<P>제16기</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">제15기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">총 매출액</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">190,685</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">532,725</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<P>380,588</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">유상사급 차감</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">(102,506)</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">(292,378)</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<P>(202,979)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">순 매출액</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">88,179</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">240,347</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<P>177,609</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF"></SPAN>&cr;
<SPAN USERMARK=" B">6. 판매에 대한 사항&cr;</SPAN>
</P>
<P USERMARK=" B">가. 판매조직</P>
<P>당사는 별도의 판매조직을 가지고 있지 않으나, 회사의 직제 구분상 개량신약/나노 DDS 기술 라이센싱은 전략기획팀이 담당하며, 기능성소재 제품은 소재사업팀이 담당하여 B2B 영업을 전문적으로 수행하고 있습니다.</P>
<P></P>
<P USERMARK=" B">나. 판매경로</P>
<P>당사가 개발중인 개량신약 및 나노약물전달기술(DDS기술)의 고객은 국내외 제약회사들로서 당사는 Bio-USA, Bio-Korea 등 주요 전시회에 참가하여 기술발표, 파트너링등을 통하여 고객발굴을 위한 노력을 지속적으로 진행하고 있습니다. </P>
<P>당사의 기능성소재 중 화장품소재인 HydroCeramide는 협력회사인 솔루스 첨단소재(주)가 유럽, 미국, 일본, 중국 등 주요 화장품시장을 공략하고 있습니다. 각 시장의 현지 솔루스 첨단소재(주) 대리점망을 통하여 고객사인 화장품회사들에 공급되고 있습니다. 기능성식품 소재인 하이드로커큐민, 하이드로코큐텐, 하이드로밀크씨슬은 국내는 식품회사에 직접 또는 소재 전문 유통사를 경유하여 판매하며 해외는 각 지역에 전문 distributor와 협력 관계를 구축하여 판매를 추진하고 있는데, 현재 베트남, 말레이지아, 대만에 대리점 계약을 맺고 제품을 수출하고 있습니다.</P>
<P>                                                                                                  (단위 : 천원)</P>

<TABLE BORDER="1" WIDTH="606" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="78"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">매출유형</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">품목</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>

<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">판매경로</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">매출액</P>
</TD>

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">비중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="124">
<P USERMARK="F-BT12">제 품</P>
</TD>

<TD ROWSPAN="2" WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62">
<P USERMARK="F-BT12">화장품 소재</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">수출</P>
</TD>

<TD ROWSPAN="2" WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62">
<P USERMARK="F-BT12">수주 → 발주처</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<SPAN>188,565</SPAN>
</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">59.79%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">내수</TD>

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<SPAN>20,640</SPAN>
</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">6.54%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62">
<P USERMARK="F-BT12">식품 소재</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">수출</P>
</TD>

<TD ROWSPAN="2" WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62">
<P USERMARK="F-BT12">수주 → 발주처</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<SPAN>39,165</SPAN>
</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">12.42%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">내수</TD>

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<SPAN>67,035</SPAN>
</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">21.25%</TD>
</TR>
</TBODY>
</TABLE>

<P>주1. 매출액 및 비중은
<SPAN USERMARK=" 0X0000FF"> </SPAN>
<SPAN>2020</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>년 기준 입니다.
</P>

<P>
<SPAN>주2. </SPAN>회사는 솔루스첨단소재(주)에서 원재료를 유상사급방식으로 매입하여 가공 후 공급하고 있으므로 유상사급에 의한 원재료 매입액을 매출액과 매출원가에서 각각 차감하여 표시하고 있습니다.
</P>
<P>당기와 전기 솔루스첨단소재(주) 관련 매출액 내역은 다음과 같으며, 재무제표에는 순액으로 표시하고 있습니다.</P>
<P>                                                                                                     (단위: 천원)</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="159"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구   분</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">제17기</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">
<P>제16기</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">제15기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">총 매출액</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">190,685</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">532,725</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<P>380,588</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">유상사급 차감</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">(102,506)</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">(292,378)</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<P>(202,979)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">순 매출액</P>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">88,179</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P USERMARK="F-BT12">240,347</P>
</TD>

<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<P>177,609</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF"></SPAN>&cr;
<SPAN USERMARK=" B">다. 판매전략&cr;</SPAN>개량신약 라이센싱을 위해서는 개발중인 파이프라인의 진행 성과를 지속적으로 국내외제약사들에게 알리고 꾸준히 홍보하는 과정이 중요합니다. 당사는 Bio-USA 등 국내외 주요 전시회 및 파트너링 행사에 지속적으로 참가하여 잠재 고객들을 발굴하고 그들에게 전임상, 임상 등 개량신약 개발 현황을 알리고 홍보함으로써 라이센싱을 위한 이루기 위한 노력을 펼쳐나가고 있습니다. 
</P>

<P>식품 및 화장품 소재에 있어서도 신규 고객 발굴을 위하여 Vitafoods, FI Korea 등 주요 전문 전시회를 꾸준히 참가하고 있습니다. 특히 동남아, 중국 등 새롭게 떠오르는 아시아 시장에 수출을 위하여 각국의 주요 기능성 원료 취급 회사들과 대리점망을 구축 및 고객 발굴을 위한 노력을 진행하고 있습니다.&cr;&cr;
<SPAN USERMARK=" B">7. 연구개발활동&cr;</SPAN>
</P>
<P USERMARK=" B"> 가. 연구개발활동의 개요</P>
<P>당사는 연구개발활동을 담당하는 부설 연구소를 운영하고 있습니다. 명칭은 ' 바이오시네틱스 연구소'이며 2004년에 설립된 이래 나노입자화 원천기술 개발 및 나노약물 전달기술개발, 나노 기능성 소재 개발 등 당사의 모든 연구개발을 주관하고 있습니다.</P>
<P>  </P>
<P USERMARK=" B">나. 연구개발 담당조직</P>
<P>(1) 연구개발 조직 개요</P>
<P>당사의 연구개발조직은 연구소 산하 3개팀으로 구성되어 있으며, 그 현황은 다음과 같습니다.&cr; </P>

<P>                                         
<SPAN USERMARK=" B">   <연구개발 조직 구성></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="610">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">부서</P>
</TD>

<TD WIDTH="105" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">팀</P>
</TD>

<TD WIDTH="400" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">주요업무</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="93">
<P USERMARK="F-BT12">연구소</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구기획팀</P>
</TD>

<TD WIDTH="400" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">-  정부과제 및 비임상/임상 관련 업무 수행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">의약연구팀</P>
</TD>

<TD VALIGN="MIDDLE" WIDTH="400" HEIGHT="31">
<P USERMARK="F-BT12">-  나노항응고제, 나노항암제 등 의약품 관련 연구</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">소재연구팀</P>
</TD>

<TD VALIGN="MIDDLE" WIDTH="400" HEIGHT="31">
<P USERMARK="F-BT12">-  화장품 및 건강기능식품 소재관련 나노화 연구</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X1814FF">                                                  &cr;                                                   
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" 0X000000 B">< 조 직 도 ></SPAN>
</P>
<P USERMARK=" 0X1814FF"></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="390" ALIGN="CENTER" HSPACE="0">연구개발 담당조직도.jpg</IMG>
<IMG-CAPTION ATOC="N">.</IMG-CAPTION>
</IMAGE>
<P>(2) 연구개발 인력 현황</P>
<P>연구개발 담당 조직은 총 6명으로 이루어져 있으며 박사급 1명, 석사급 5명 등으로 그 현황은 다음과 같습니다.&cr;</P>

<P>                                           
<SPAN USERMARK=" B"><연구개발 인력 현황></SPAN>
</P>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="2" WIDTH="238" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구   분</P>
</TD>

<TD COLSPAN="3" WIDTH="363" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">인   원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">박사</P>
</TD>

<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">석사</P>
</TD>

<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">합계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="93">
<P USERMARK="F-BT12">연구소</P>
</TD>

<TD WIDTH="133" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">연구기획팀</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="93" ROWSPAN="3" VALIGN="MIDDLE">
<P USERMARK="F-BT12">1</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">3</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="133" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">의약연구팀</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="133" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">
<P>소재연구팀</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">1</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="238" ALIGN="CENTER" HEIGHT="31" COLSPAN="2">
<P USERMARK="F-BT12">합     계</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">1</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">5</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">6</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(3) 핵심 연구인력</P>
<P>당사의 핵심연구인력은 대표이사인 김갑식 박사입니다.</P>

<P>&cr;                                            
<SPAN USERMARK=" B">   <핵심연구인력 현황> </SPAN>
</P>

<TABLE BORDER="1" WIDTH="962" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="80"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="397"></COL>
<COL WIDTH="296"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="89" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">직위</P>
</TD>

<TD WIDTH="73" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">성명</P>
</TD>

<TD WIDTH="89" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">담당업무</P>
</TD>

<TD WIDTH="406" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">주요경력</P>
</TD>

<TD WIDTH="305" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">주요 연구실적</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="89" ALIGN="CENTER" HEIGHT="150" VALIGN="MIDDLE" USERMARK="F-BT12">대표이사</TD>
<TD WIDTH="73" ALIGN="CENTER" HEIGHT="150" VALIGN="MIDDLE" USERMARK="F-BT12">김갑식</TD>
<TD WIDTH="89" ALIGN="CENTER" HEIGHT="150" VALIGN="MIDDLE" USERMARK="F-BT12">업무총괄&cr;및&cr;연구총괄</TD>

<TD WIDTH="406" HEIGHT="150" VALIGN="MIDDLE">
<P USERMARK="F-BT12">- 88.02 경북대학교 화학과 학사</P>
<P USERMARK="F-BT12">- 92.02 경북대학교 대학원 화학과 석사</P>
<P USERMARK="F-BT12">- 99.02 서울대학교 대학원 화학과 박사</P>
<P USERMARK="F-BT12">- 92.01~95.02 C&C 신약개발 연구소</P>
<P USERMARK="F-BT12">- 98.12~03.11 ㈜유진사이언스 바이오텍 연구소 팀장</P>
<P USERMARK="F-BT">- 04.01~현재 ㈜바이오시네틱스 대표이사</P>
</TD>
<TD WIDTH="305" HEIGHT="150" USERMARK="F-BT12" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>

<P USERMARK=" B">
<SPAN>다. 연구개발비용&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" !B">당사의 최근 3년간 연구개발비용은 다음과 같습니다.</SPAN>
</P>
<P>                                                                                                  (단위: 천원)</P>

<TABLE BORDER="1" WIDTH="699" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="273" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">2020년&cr;(제17기)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7 B">2019년&cr;(제16기)</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">2018년</P>
<P USERMARK="F-BT12 B">(제15기)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="155" USERMARK="F-BT12">자산 처리</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">원재료비</P>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">인건비</P>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">감가상각비</P>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">위탁용역비</P>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">기타 경비</P>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK="F-BT12">비용 처리</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">제조원가</P>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">판관비</P>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">721,304</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,188,589</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">981,036</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="273" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">연구개발비용 계</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">721,304</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">
<SPAN USERMARK=" BC0X31FFFF">1,188,589</SPAN>
</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">981,036</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="273" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">정부보조금</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(345,335)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(330,665)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="273" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">연구개발비/매출액 비율&cr;[연구개발비용계/당기매출액 *100]</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-BT12">314.72%</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-BT12">313.95%</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-BT12">435.60%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">라. 연구개발실적&cr;</SPAN>(1) 연구개발 진행 현황 및 향후 계획
</P>
<P>보고서 제출일 현재 당사가 연구개발 진행의 현황은 다음과 같습니다.</P>
<P><연구개발 진행 총괄표></P>

<TABLE BORDER="1" WIDTH="917" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="80"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="173"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>

<TD ROWSPAN="2" WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">품목</P>
</TD>

<TD ROWSPAN="2" WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">치료제 종류</P>
</TD>

<TD ROWSPAN="2" WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">연구</P>
<P USERMARK="F-BT12 B">시작일</P>
</TD>

<TD COLSPAN="2" WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">현재 진행단계</P>
</TD>

<TD ROWSPAN="2" WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">연구</P>
<P USERMARK="F-BT12 B">중단일</P>
</TD>

<TD ROWSPAN="2" WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">비고</P>
<P USERMARK="F-BT12 B">(연구중단 사유기재)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">단계(국가)</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">승인일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="134">
<P USERMARK="F-BT12">의약품</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="33">
<P USERMARK="F-BT12">BS-102 (개량신약)</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="33">
<P USERMARK="F-BT12">세포독성항암제</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12">2009년</P>
</TD>

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12">비임상</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12"> -</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12">- </P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12"> -</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="33">
<P USERMARK="F-BT12">BS-104 (개량신약)</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="33">
<P USERMARK="F-BT12">표적항암제</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12">2015년</P>
</TD>

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12">임상1상</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12">2018년</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12"> -</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12"> -</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="33">
<P USERMARK="F-BT12">BS-112 (개량신약)</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="33">
<P USERMARK="F-BT12">항응고제</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12">2017년</P>
</TD>

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12">비임상</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12"> -</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12"> -</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12"> -</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="35">
<P USERMARK="F-BT12">BS-120 (개량신약)</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="35">
<P USERMARK="F-BT12">코로나19 치료제</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35">
<P USERMARK="F-BT12">2020년</P>
</TD>

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35">
<P USERMARK="F-BT12">제제연구</P>
</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35"> -</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35"> -</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35"> -</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>(가) 품목 : BS-102</P>

<TABLE BORDER="1" WIDTH="697" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="559"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">①구분</P>
</TD>

<TD WIDTH="568" HEIGHT="31">
<P USERMARK="F-BT12">개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">②적응증</P>
</TD>

<TD WIDTH="568" HEIGHT="31">
<P USERMARK="F-BT12">다양한 암종 (폐암, 유방암, 위암, 두경부암 등)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">③작용기전</P>
</TD>

<TD WIDTH="568" HEIGHT="55">
<P USERMARK="F-BT12">Free tubulin에 결합하여 Tubulin이 안정화된 microtubule로 되는 것을 촉진함과 동시에 microtubule의 분해를 억제하여 유사분열을 억제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">④제품의 특성</P>
</TD>

<TD WIDTH="568" HEIGHT="55">
<P USERMARK="F-BT12">시판제제의 가용화 문제를 해결하고자 유독한 가용화제의 사용이 없이 활성물질을 200 nm 대의 입자로 제조한 동결건조 분말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑤진행경과</P>
</TD>

<TD WIDTH="568" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">안정적인 동결건조 분말 제형을 완성하고, 현재 미국 NCL에서 in-vitro연구 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑥향후계획</P>
</TD>
<TD WIDTH="568" HEIGHT="31" USERMARK="F-BT12">NCL과 서울아산병원의 in-vivo연구 결과를 바탕으로 유럽 임상 1상 수행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑦경쟁제품</P>
</TD>

<TD WIDTH="568" HEIGHT="55">
<P USERMARK="F-BT12">현재 다양한 제네릭 의약품들이 출시되었으나, 근본적인 유독한 가용화제 문제는 해결하지 못한 상황임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑧관련논문 등</P>
</TD>

<TD WIDTH="568" HEIGHT="31">
<P USERMARK="F-BT12">International Journal of Nanomedicine 2015:10 6121-6132</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑨시장규모</P>
</TD>
<TD WIDTH="568" HEIGHT="31" USERMARK="F-BT12">2019년 국내 시장: 451억원, 세계시장은 약 2조원 정도로 추정됨</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑩기타사항</P>
</TD>

<TD WIDTH="568" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> &cr;(나) 품목 : BS-104</P>

<TABLE BORDER="1" WIDTH="689" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="555"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">①구분</P>
</TD>

<TD WIDTH="564" HEIGHT="31">
<P USERMARK="F-BT12">개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">②적응증</P>
</TD>

<TD WIDTH="564" HEIGHT="31">
<P USERMARK="F-BT12">간암, 신장암</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">③작용기전</P>
</TD>

<TD WIDTH="564" HEIGHT="55">
<P USERMARK="F-BT12">Raf kinase 및 혈관내피성장인자 수용체 억제제로서 암세포의 증식 및 혈관신생을 억제함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" HEIGHT="103" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">④제품의 특성</P>
</TD>

<TD WIDTH="564" HEIGHT="103">
<P USERMARK="F-BT12">시판제제의 결정형과 다른 결정형을 이용하여 나노입자를 제조함으로써 결정형 특허 및 제형특허를 회피하여 조기 시장 진입을 가능하게 함. 기존제제 대비 향상된 생체이용률 및 위장관 내 잔류하는 약물 감소 등을 바탕으로 부작용 감소 및 개체 편차 감소 예상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑤진행경과</P>
</TD>

<TD WIDTH="564" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">현재 dose finding 임상을 통해 인체 내 향상된 생체이용률 확인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑥향후계획</P>
</TD>

<TD WIDTH="564" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">허가용 임상을 1년 내에 함께 수행할 국내외 제약사 물색 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑦경쟁제품</P>
</TD>

<TD WIDTH="564" HEIGHT="31">
<P USERMARK="F-BT12">오리지날 의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑧관련논문 등</P>
</TD>

<TD WIDTH="564" HEIGHT="55">
<P USERMARK="F-BT12">International Journal of Pharmaceutics Volume 566, 20 July 2019, Pages 229-238</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑨시장규모</P>
</TD>
<TD WIDTH="564" HEIGHT="31" USERMARK="F-BT12">2019년 세계 시장: ?706mil, 국내 시장: 약 266억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑩기타사항</P>
</TD>

<TD WIDTH="564" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(다) 품목 : BS-112</P>

<TABLE BORDER="1" WIDTH="682" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="552"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">①구분</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">②적응증</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">정맥혈전색전증</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">③작용기전</P>
</TD>

<TD WIDTH="561" HEIGHT="55">
<P USERMARK="F-BT12">factor Xa를 직접적, 선택적, 가역적으로 저해→혈소판 활성화, fibrin clot 형성 저해</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">④제품의 특성</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">활성물질의 용해도 및 용해속도를 개선함으로 식전식후 편차를 개선한 제제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑤진행경과</P>
</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">제형연구 완료 단계. 비임상 연구를 통해 식전식후 편차 감소 확인 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑥향후계획</P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">임상 시험 수행 후 국내외 제약사에 기술이전</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑦경쟁제품</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">오리지날 의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑧관련논문 등</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑨시장규모</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">2019년 미국 시장: $2,313 million, 국내 시장: 약 538억</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">⑩기타사항</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  &cr;(라) 품목 : BS-120</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="682">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="552"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 BC0XD7BFCB B">①구분</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 BC0XD7BFCB B">②적응증</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">코로나19 치료제 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="55" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 BC0XD7BFCB B">③작용기전</P>
</TD>

<TD WIDTH="561" HEIGHT="55">
<P USERMARK="F-BT12">COVID-19 바이러스가 작용하는 ACE2(Angiotensin- converting enzyme Ⅱ) 수용체에 작용하여, 코로나바이러스가 인체 내 세포로 침입하는 것을 막음  </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="103" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 BC0XD7BFCB B">④제품의 특성</P>
</TD>

<TD WIDTH="561" HEIGHT="103">
<P USERMARK="F-BT12">코로나19 치료 효능이 에볼라치료제 렘데시비르보다 40배, 말라리아 치료제 클로로퀸보다 26배 높은 코로나19 항바이러스 활성도를 보이지만, 낮은 용해도로 인해서 인체 내에서 해당 효능을 기대하기 어렵기에, 나노화를 통해 용해도/생체이용률을 향상시킨 신약재창출(Drug repositioning) 약물임 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 BC0XD7BFCB B">⑤진행경과</P>
</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">비임상 실험을 통해 향상된 생체이용률 확인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 BC0XD7BFCB B">⑥향후계획</P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="31">
<P USERMARK="F-BT12">제제연구 완료 후, 비임상 시험을 통해 코로나19의 치료 효능 확인할 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 BC0XD7BFCB B">⑦경쟁제품</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">현재 개발 중인 코로나19 치료제 및 백신  </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 BC0XD7BFCB B">⑧관련논문 등</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 BC0XD7BFCB B">⑨시장규모</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 BC0XD7BFCB B">⑩기타사항</P>
</TD>

<TD WIDTH="561" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">마. 지적재산권 등</SPAN>
</P>

<TABLE BORDER="1" WIDTH="808" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="44"></COL>
<COL WIDTH="49"></COL>
<COL WIDTH="188"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">번호</P>
</TD>

<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">내용</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">권리자</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">출원일</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">등록일</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">주무관청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="7" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="241">
<P USERMARK="F-BT12">1</P>
</TD>

<TD ROWSPAN="7" WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="241">
<P USERMARK="F-BT12">특허권</P>
</TD>

<TD ROWSPAN="7" WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="241">
<P USERMARK="F-BT12">고체상 지질을 용매로 &cr;이용한 나노수준의 </P>
<P USERMARK="F-BT12">또는 비결정질 입자의 &cr;제조방법</P>
</TD>

<TD ROWSPAN="7" WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="241">
<P USERMARK="F-BT12">㈜바이오시네틱스,</P>
<P USERMARK="F-BT12">김갑식</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2004.11.09</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2006.07.14</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">대한민국</P>
<P USERMARK="F-BT12">특허청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2006.05.25</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2009.09.24</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">호주</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2006.05.29</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.05.26</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">캐나다</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2006.06.05</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2010.05.05</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">중국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2006.05.24</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2017.01.04</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">유럽</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2006.06.02</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2011.11.18</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">일본</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2006.06.02</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.07.03</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">미국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2</P>
</TD>

<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">특허권</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">디올 화합물을 이용한&cr;나노수준의 </P>
<P USERMARK="F-BT12">활성물질 입자 제조 방법</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">㈜바이오시네틱스,</P>
<P USERMARK="F-BT12">김갑식</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2006.05.04</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2013.12.10</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">대한민국</P>
<P USERMARK="F-BT12">특허청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">3</P>
</TD>

<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">특허권</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">저온 및 저압 하에서 &cr;초임계유체를 이용한 &cr;나노수준의 활성물질 &cr;입자 제조방법</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">㈜바이오시네틱스,</P>
<P USERMARK="F-BT12">김갑식</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">2006.05.04</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">2013.12.10</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">대한민국</P>
<P USERMARK="F-BT12">특허청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="5" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="155">
<P USERMARK="F-BT12">4</P>
</TD>

<TD ROWSPAN="5" WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="155">
<P USERMARK="F-BT12">특허권</P>
</TD>

<TD ROWSPAN="5" WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="155">
<P USERMARK="F-BT12">나노수준의 활성물질 &cr;입자 제조방법</P>
</TD>

<TD ROWSPAN="5" WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="155">
<P USERMARK="F-BT12">㈜바이오시네틱스,</P>
<P USERMARK="F-BT12">김갑식</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2013.07.05</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.07.09</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">호주</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2008.11.03</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.02.17</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">캐나다</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2008.11.03</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.04.09</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">유럽</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2008.11.03</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.11.04</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">인도</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2008.10.31</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2011.09.22</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">일본</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="8" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="274">
<P USERMARK="F-BT12">5</P>
</TD>

<TD ROWSPAN="8" WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="274">
<P USERMARK="F-BT12">특허권</P>
</TD>

<TD ROWSPAN="8" WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="274">
<P USERMARK="F-BT12">나노입자 제조방법 &cr;PCT/KR2011/001956</P>
</TD>

<TD ROWSPAN="8" WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="274">
<P USERMARK="F-BT12">㈜바이오시네틱스</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2011.03.22</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2018.02.27</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">대한민국</P>
<P USERMARK="F-BT12">특허청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.09.21</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.05.07</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">호주</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33" USERMARK="F-BT12">2012.09.13</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33" USERMARK="F-BT12">2020.07.14</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P USERMARK="F-BT12">캐나다</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.09.24</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.07.16</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">중국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.09.13</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">유럽</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.09.18</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2020.02.03</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">인도</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.09.21</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.08.14</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">일본</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2012.09.18</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.09.09</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">미국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="7" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="241">
<P USERMARK="F-BT12">6</P>
</TD>

<TD ROWSPAN="7" WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="241">
<P USERMARK="F-BT12">특허권</P>
</TD>

<TD ROWSPAN="7" WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="241">
<P USERMARK="F-BT12">나노입자 제조방법 &cr;PCT/KR2012/007581</P>
</TD>

<TD ROWSPAN="7" WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="241">
<P USERMARK="F-BT12">㈜바이오시네틱스</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2011.09.21</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2017.10.31</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">대한민국</P>
<P USERMARK="F-BT12">특허청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.03.14</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2015.06.11</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">호주</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.03.12</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2020.01.21</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">캐나다</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.03.20</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2016.10.19</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">중국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.03.17</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">유럽</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.03.20</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2017.06.02</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">일본</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2014.03.11</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2016.09.13</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">미국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">7</P>
</TD>

<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">특허권</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">신규약학 조성물</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">㈜대웅제약, &cr;㈜바이오시네틱스</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2015.01.14</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2015.02.05</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">대한민국</P>
<P USERMARK="F-BT12">특허청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">8</P>
</TD>

<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">특허권</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">초음파를 이용한 &cr;도세탁셀 &cr;수화물 제조방법</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">숭실대산학협력단</P>
<P USERMARK="F-BT12">㈜바이오시네틱스</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2013.06.10</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2015.03.27</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">대한민국</P>
<P USERMARK="F-BT12">특허청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">9</P>
</TD>

<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">특허권</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">탄화수소를 이용한 &cr;나노수준의 활성물질 &cr;입자 제조방법</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">㈜바이오시네틱스</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2013.08.21</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">2020.03.30</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79">
<P USERMARK="F-BT12">대한민국</P>
<P USERMARK="F-BT12">특허청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">10</P>
</TD>

<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">특허권</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">엘로티닙나노입자 및&cr;제조방법, 및 엘로티닙 &cr;나노입자를 함유하는 &cr;약학조성물 </P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">㈜바이오시네틱스</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">2016.03.23</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="103">
<P USERMARK="F-BT12">대한민국</P>
<P USERMARK="F-BT12">특허청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="14" WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="458">
<P USERMARK="F-BT12">11</P>
</TD>

<TD ROWSPAN="14" WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="458">
<P USERMARK="F-BT12">특허권</P>
</TD>

<TD ROWSPAN="14" WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="458">
<P USERMARK="F-BT12">지질을 밀링공정의 &cr;윤활제로 이용하는 &cr;활성물질 &cr;나노입자의 제조방법 </P>
</TD>

<TD ROWSPAN="14" WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="458">
<P USERMARK="F-BT12">㈜바이오시네틱스</P>
</TD>

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">2018.03.26</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<P USERMARK="F-BT12">대한민국</P>
<P USERMARK="F-BT12">특허청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.10.30</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">호주</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.10.30</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">브라질</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.10.30</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">캐나다</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.10.31</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">중국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.10.30</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">유럽</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.05.18</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">인도네시아</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.05.16</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">인도</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.10.24</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">일본</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.10.26</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">말레이지아</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.10.30</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">러시아</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.06.08</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">태국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.10.29</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">미국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">2018.04.27</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P USERMARK="F-BT12">베트남</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>주1. #7 특허는 특허권자인 대웅제약이 독점 실시권을 소유하고 있으며, 각 회사와의 동의 하에 당사가 실시권 사용 가능. #8 특허는 당사가 기술의 독점 실시권을 보유하고 있음.&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『수주상황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_수주상황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0">III. 재무에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0">1. 요약재무정보</TITLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">(1)요약재무상태표</SPAN>
<SPAN>                                                                                                                                                                                                    (단위 : 원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="646">

<COLGROUP>
<COL WIDTH="186"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="195" HEIGHT="31" VALIGN="MIDDLE" ALIGN="CENTER">
<P USERMARK="F-BT12 B">사업연도 </P>
</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="150" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">제17기</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12 BC0XD7D7D7 B">제16기</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="151" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">제15기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="195" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="150" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">(2020년 12월말)</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12 BC0XD7D7D7 B">(2019년 12월말)</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="151" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">(2018년 12월말)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">[유동자산]</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,306,173,448</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">2,546,898,692</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">3,415,536,977</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">·당좌자산</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,209,641,501</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">2,458,395,642</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">3,358,543,293</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">·재고자산</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">96,531,947</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">88,503,050</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">56,993,684</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">[비유동자산]</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">400,176,289</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,009,789,996</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,027,914,004</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">·유형자산</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">325,697,889</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">585,071,957</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">609,173,837</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">·무형자산</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">350,239,639</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">361,261,767</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">·기타비유동자산</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">74,478,400</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">74,478,400</TD>

<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">
<SPAN>57,478,400</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자산총계</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12 B">1,706,349,737</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12 B">3,556,688,688</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12 B">4,443,450,981</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">[유동부채]</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">185,374,351</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">230,721,316</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">103,621,258</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">[비유동부채]</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">395,126,921</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">372,147,600</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">365,448,697</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">부채총계</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12 B">580,501,272</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12 B">602,868,916</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12 B">469,069,955</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">[자본금]</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,787,337,500</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,787,337,500</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,775,487,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">[자본잉여금]</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">7,306,327,979</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">7,306,327,979</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">7,238,304,089</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">[자본조정]</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">36,506,504</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">26,243,921</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">11,586,715</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">[이익잉여금]</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(8,004,323,518)</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(6,166,089,628)</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(5,050,997,278)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="195" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자본총계</P>
</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12 B">1,125,848,465</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12 B">2,953,819,772</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12 B">3,974,381,026</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="195" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="150" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">(2020.01.01~&cr;2020.12.31)</TD>
<TD WIDTH="150" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12 BC0XD7D7D7 B">(2019.01.01~&cr;2019.12.31)</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="151" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">(2018.01.01~&cr;2018.12.31)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">매출액</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">229,187,298</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">378,596,015</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">225,216,858</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">영업이익(영업손실)</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(1,277,477,930)</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(1,144,815,834)</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(1,089,361,995)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">당기순이익(당기순손실)</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(1,838,233,890)</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(1,115,092,350)</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(1,045,592,049)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">주당순이익(주당순손실)</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(698)</TD>
<TD WIDTH="150" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(426)</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(402)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X1814FF"></P>
<WARNING>※ 아래 『재무제표』단위서식을 클릭하여 해당사항을 선택하면,&cr;    2.연결재무제표 ~ 5.재무제표주석 항목을 삽입할 수 있습니다.</WARNING>
</SECTION-2>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『재무제표』 삽입</COMMENT>
<LIBRARYLIST>11011#*재무제표_*.*</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">재무제표_직접작성</FILENAME>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0">2. 연결재무제표</TITLE>
<P>해당사항 없습니다.</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0">3. 연결재무제표 주석</TITLE>
<P>해당사항 없습니다.</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0">4. 재무제표</TITLE>

<P>
<SPAN USERMARK=" B">가. 재무상태표&cr;</SPAN>
<SPAN>                                                                              </SPAN>
<SPAN>   </SPAN>
<SPAN>                     (단위: 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="684">

<COLGROUP>
<COL WIDTH="220"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="229" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">과목</P>
</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="152" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2020년&cr;(제17기)</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="152" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2019년&cr;(제16기)</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="151" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">2018년</P>
<P USERMARK="F-BT12 B">(제15기)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅰ.유동자산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,306,173</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">2,546,899</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,415,537</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">(1) 당좌자산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,209,641</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">2,458,396</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,358,543</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">현금및현금성자산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,098,559</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,104,038</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,187,386</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">단기금융상품</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">2,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">매출채권</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">44,149</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">590</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">22,615</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">미수금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">21,256</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">230,640</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">64,683</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">선급금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">43,181</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">115,762</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">77,781</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">당기법인세자산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">2,496</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">7,366</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">6,078</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">(2) 재고자산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">96,532</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">88,503</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">56,994</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">제품</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">86,236</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">76,768</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">49,024</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">원재료</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">10,296</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">11,735</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">7,970</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅱ.비유동자산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">400,176</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,009,790</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,027,914</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">(1) 유형자산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">325,698</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">585,072</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">609,174</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">기계장치</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,134,121</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,125,121</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,070,816</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">기계장치감가상각누계액</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(784,028)</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(645,513)</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(487,153)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">기계장치정부보조금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(24,395)</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(37,706)</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(68,331)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">비품</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">46,329</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">46,329</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">42,426</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">비품감가상각누계액</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(41,870)</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(37,642)</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(32,485)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">비품정부보조금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(932)</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(2,100)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">유형자산손상차손누계액</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(4,459)</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">구축물</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">199,000</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">199,000</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">132,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">구축물감가상각누계액</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(121,132)</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(81,332)</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(45,999)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">유형자산손상차손누계액</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(77,868)</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">건설중인자산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">건설중인자산정부보조금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">임차개량자산</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">24,044</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">24,044</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">임차개량자산감가상각누계액</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(12,941)</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(6,297)</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">유형자산손상차손 누계액</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(11,103)</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">(2) 무형자산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">350,240</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">361,262</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">산업재산권</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">125,131</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">125,710</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">139,205</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">무형자산손상차손 누계액</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(125,131)</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">건설중인무형자산</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">241,263</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">238,625</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">236,152</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">건설중인무형자산 정부보조금</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(14,095)</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(14,095)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">무형자산손상차손 누계액</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(241,263)</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">(3) 기타비유동자산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">74,478</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">74,478</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">57,478</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">임차보증금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">73,065</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">73,065</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">56,065</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">기타보증금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,413</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,413</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,413</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자산총계</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,706,349</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,556,689</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">4,443,451</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">부채</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅰ. 유동부채</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">185,374</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">230,721</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">103,621</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">매입채무</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">27,500</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">미지급금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">121,211</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">126,246</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">10,568</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">예수금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">8,257</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">7,905</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">6,530</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">미지급비용</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">44,180</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">69,070</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">36,538</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">선수금</P>
</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">251</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,190</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">선수수익</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">48,795</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">복구충당부채</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">11,475</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅱ. 비유동부채</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">395,127</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">372,148</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">365,449</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">퇴직급여충당부채</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">381,797</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">347,794</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">278,826</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">장기미지급금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">86,623</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">복구충당부채</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">13,330</TD>

<TD WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">
<SPAN>24,354</SPAN>
</TD>
<TD WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">부채총계</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">580,501</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">602,869</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">469,070</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자본</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅰ. 자본금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,787,337</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">1,787,337</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">1,775,487</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">보통주 자본금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,317,445</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">1,317,445</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">1,305,595</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">우선주 자본금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">469,892</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">469,892</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">469,892</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅱ. 자본잉여금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">7,306,328</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">7,306,328</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">7,238,304</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">주식발행초과금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">7,306,328</TD>

<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">
<SPAN>7,306,328</SPAN>
</TD>

<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">
<SPAN>7,238,304</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK="F-BT" WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<SPAN USERMARK="F-12 B">Ⅲ. </SPAN>
<SPAN USERMARK="F-12 B">자본조정</SPAN>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">36,507</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">26,244</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">11,587</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">주식매입선택권</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">36,507</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">26,244</TD>

<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">
<SPAN>11,587</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅳ. 결손금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">8,004,324</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">6,166,089</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">5,050,997</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">미처리결손금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(8,004,324)</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">(6,166,089)</TD>

<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">(
<SPAN></SPAN>
<SPAN>5,050,997</SPAN>)
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자본총계</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,125,848</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">2,953,820</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">3,974,381</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="229" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">부채 및 자본총계</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,706,349</TD>
<TD USERMARK="F-BT12" WIDTH="152" HEIGHT="31" ALIGN="RIGHT">3,556,689</TD>
<TD USERMARK="F-BT12" WIDTH="151" HEIGHT="31" ALIGN="RIGHT">4,443,451</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">나. (포괄)손익계산서&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>                                                                              </SPAN>
<SPAN>   </SPAN>
<SPAN>                     (단위: 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="694">

<COLGROUP>
<COL WIDTH="216"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="225" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">과목</P>
</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="158" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2020년&cr;(제17기)</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="156" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2019년&cr;(제16기)</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="155" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">2018년</P>
<P USERMARK="F-BT12 B">(제15기)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅰ. 매출액</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">229,187</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">378,596</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">225,217</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">제품매출</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">212,987</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">275,101</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">195,679</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">용역매출</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">16,200</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">14,700</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">로열티매출</TD>
<TD WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">88,795</TD>

<TD WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">
<SPAN>29,538</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅱ. 매출원가</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">171,579</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">279,341</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">153,046</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">제품매출원가</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">154,643</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">261,109</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">137,281</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">기타매출원가</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">16,936</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">18,232</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">15,765</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅲ. 매출총이익</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">54,608</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">99,255</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">72,171</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅳ. 판매비와관리비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,332,086</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,244,071</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,161,533</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">급여</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">359,006</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">169,147</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">207,567</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">퇴직급여</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">10,704</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">16,348</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">24,911</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">복리후생비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">11,500</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">4,686</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">7,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">여비교통비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,318</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,162</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,803</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">접대비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,145</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,225</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">4,713</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">통신비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">2,348</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">2,679</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,077</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">수도광열비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,832</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">667</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">635</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">세금과공과</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">388</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">743</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">762</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">감가상각비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">2,773</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,550</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">25,760</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">무형자산상각비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">370</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">411</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">10,556</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">지급임차료</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">31,629</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">24,090</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">27,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">수선비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">5,150</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,902</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">467</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">보험료</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,200</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,200</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,200</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">경상연구개발비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">723,041</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">843,254</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">650,372</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">운반비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,876</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">4,040</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,154</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">교육훈련비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">28</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,163</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">147</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">도서인쇄비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">299</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">488</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">소모품비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">2,982</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">3,740</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">5,211</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">지급수수료</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">138,357</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">134,345</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">171,083</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">건물관리비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">7,002</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">2,225</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">2,650</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">판매촉진비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">25,138</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">23,006</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">10,450</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅴ. 영업이익</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,277,478)</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,144,816)</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,089,362)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅵ. 영업외수익</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">16,364</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">58,466</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">43,893</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">이자수익</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">16,277</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">58,395</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">39,523</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">잡이익</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">87</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">71</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">4,370</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅶ. 영업외비용</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">577,120</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">28,742</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">123</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">이자비용</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">452</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">309</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">외환차손</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">221</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">61</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">조업도손실</TD>
<TD WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">131,142</TD>
<TD WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">28,337</TD>
<TD WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">유형자산손상차손</TD>
<TD WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">93,006</TD>
<TD WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">무형자산손상차손</TD>
<TD WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">352,299</TD>
<TD WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">잡손실</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">35</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">78</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅷ. 법인세비용차감전순이익</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,838,234)</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,115,092)</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,045,592)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅸ. 법인세비용</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅹ. 당기순이익</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="158" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,838,234)</TD>

<TD USERMARK="F-BT12" WIDTH="156" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN>(1,115,092)</SPAN>
</TD>

<TD USERMARK="F-BT12" WIDTH="155" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN>(1,045,592)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">다. 자본변동표</P>

<P>
<SPAN>                                                                                                      </SPAN>
<SPAN>(단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="763">

<COLGROUP>
<COL WIDTH="76"></COL>
<COL WIDTH="169"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="85" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">구분</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="178" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">과목</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="95" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자본금</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="101" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자본&cr;잉여금</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="96" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자본조정</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="108" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">이익&cr;잉여금</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="100" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">총계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK="F-BT12" WIDTH="85" HEIGHT="313" ROWSPAN="7" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN>2018년&cr;(제15기)</SPAN>
</TD>
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2018.01.01 (보고금액)</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">1,759,893</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">7,202,116</TD>
<TD WIDTH="96" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">(3,777,117)</TD>
<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">5,184,892</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">전기오류수정</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="96" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">10,467</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(228,288)</TD>
<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(217,822)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">수정 후 자본</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">1,759,893</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">7,202,116</TD>
<TD WIDTH="96" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">10,467</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">(4,005,405)</TD>
<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">4,967,070</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">유상증자&cr;(주식매입선택권)</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">15,595</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">36,188</TD>
<TD WIDTH="96" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(4,998)</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">46,785</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">주식매입선택권 발행</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="96" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">6,118</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">6,118</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">당기순이익</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,045,592)</TD>

<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN>(1,045,592)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2018.12.31 (당기말)</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">1,775,488</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">7,238,304</TD>
<TD WIDTH="96" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">11,587</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">(5,050,997)</TD>
<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">3,974,381</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" HEIGHT="227" ROWSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">2019년&cr;(제16기)</TD>
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2019.1.1 (보고금액)</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">1,775,488</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">7,238,304</TD>
<TD USERMARK="F-BT12" WIDTH="96" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">11,587</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">(5,050,997)</TD>
<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">3,974,381</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">유상증자&cr;(주식매입선택권)</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">11,850</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">68,024</TD>
<TD USERMARK="F-BT12" WIDTH="96" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">(4,864)</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">75,010</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">주식매입선택권 인식</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="96" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">19,521</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">19,521</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">당기순손실</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="96" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,115,092)</TD>

<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN>(1,115,092)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="178" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2019.12.31 (당기말)</TD>
<TD USERMARK="F-BT12" WIDTH="95" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">1,787,338</TD>
<TD USERMARK="F-BT12" WIDTH="101" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">7,306,328</TD>
<TD USERMARK="F-BT12" WIDTH="96" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">26,244</TD>
<TD USERMARK="F-BT12" WIDTH="108" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">(6,166,089)</TD>
<TD USERMARK="F-BT12" WIDTH="100" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">2,953,820</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" HEIGHT="148" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">2020년&cr;(제17기)</TD>
<TD WIDTH="178" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">2020.1.1 (보고금액)</TD>
<TD WIDTH="95" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,787,338</TD>
<TD WIDTH="101" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">7,306,328</TD>
<TD WIDTH="96" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">26,244</TD>
<TD WIDTH="108" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(6,166,089)</TD>
<TD WIDTH="100" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">2,953,820</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">주식매입선택권 인식</TD>
<TD WIDTH="95" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="101" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="96" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">10,262</TD>
<TD WIDTH="108" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="100" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">10,262</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">당기순손실</TD>
<TD WIDTH="95" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="101" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="96" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="108" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(1,838,234)</TD>
<TD WIDTH="100" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(1,838,234)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">2020.12.31 (당기말)</TD>
<TD WIDTH="95" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,787,338</TD>
<TD WIDTH="101" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">7,306,328</TD>
<TD WIDTH="96" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">36,506</TD>
<TD WIDTH="108" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(8,004,323)</TD>
<TD WIDTH="100" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,125,849</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>
<P USERMARK=" B">라. 현금흐름표</P>

<P>
<SPAN>                                                                                                     </SPAN>
<SPAN> (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="757">

<COLGROUP>
<COL WIDTH="289"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="144"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="298" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">&cr;과 목</P>
</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="153" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2020년&cr;(제17기)</TD>
<TD USERMARK=" BC0XD7D7D7 B" WIDTH="153" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2019년&cr;(제16기)</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="153" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">2018년</P>
<P USERMARK="F-BT12 B">(제15기)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅰ. 영업활동으로 인한 현금흐름</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(967,595)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,033,432)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(888,044)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12"> 1. 당기순손실</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,838,234)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,115,092)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,045,592)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12"> 2. 현금의 유출이 없는 비용 등의 가산</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">717,719</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">301,718</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">183,182</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">감가상각비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">175,368</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">173,354</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">82,562</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">무형자산상각비</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">26,824</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">25,452</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">26,320</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">퇴직급여</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">59,507</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">83,081</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">68,182</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">주식보상비용</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">10,263</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">19,521</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">6,118</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">복구충당부채 전입액</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">451</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">310</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">무형자산손상차손</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">352,299</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">유형자산손상차손</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">93,006</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="55" VALIGN="MIDDLE">
<P USERMARK="F-BT12"> 3. 영업활동으로 인한  &cr;    자산부채의 변동</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">152,920</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">(220,058)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">(25,634)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">매출채권의 감소(증가)</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(43,559)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">22,025</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(2,648)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">미수금의 감소(증가)</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">209,384</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(165,957)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(16,481)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">선급금의 감소(증가)</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">72,580</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(37,981)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">37,546</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">당기법인세자산의 감소(증가)</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">4,870</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,288)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,978)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">재고자산의 증가</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(8,029)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(31,509)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(81,035)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">미지급금의 감소</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(5,035)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(7,841)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(593)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">예수금의 증가</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">352</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,375</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">912</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">선수금의 증가(감소)</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">251</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(1,190)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,190</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">선수수익의 감소(증가)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(48,795)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">48,795</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">미지급비용의 증가(감소)</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(24,890)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">32,532</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,783</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">퇴직금의 지급</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(25,504)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(8,929)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(13,125)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">매입채무의 증가(감소)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(27,500)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">27,500</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅱ. 투자활동으로 인한 현금흐름</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">962,116</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">843,362</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(2,453,807)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">1. 투자활동으로 인한 현금유입액</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">34,183</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">정부보조금의 수령</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">34,183</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">단기금융상품의 감소</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,000,000</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,000,000</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">2. 투자활동으로 인한 현금유출액</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(156,638)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(2,487,990)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">단기금융상품의 증가</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(2,000,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">기계장치의 취득</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(9,000)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(54,305)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(80,370)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">비품의 취득</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(3,903)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">건설중인자산의 취득</P>
</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(331,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">구축물의 취득</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(67,000)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">건설중인무형자산의 취득</TD>

<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN>(28,884)</SPAN>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(14,430)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(76,620)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">임차보증금의 증가</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(17,000)</TD>
<TD WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅲ. 재무활동으로 인한 현금흐름</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">106,722</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">84,671</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">1. 재무활동으로 인한 현금유입액</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">106,722</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">84,671</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">정부보조금의 수령</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">31,712</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">37,886</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">유상증자(주식매입선택권)</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">75,010</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">46,785</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">2. 재무활동으로 인한 현금유출액</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">단기차입금의 상환</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅳ. 현금의 증가(감소)</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(5,478)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(83,348)</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">(3,257,180)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅴ. 기초의 현금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,104,038</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,187,386</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">4,444,566</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="298" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">Ⅵ. 기말의 현금</P>
</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,098,559</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,104,038</TD>
<TD USERMARK="F-BT12" WIDTH="153" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,187,386</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0">5. 재무제표 주석</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="31" USERMARK="F-BT12">제17(당)기 2020년 1월 1일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="31" USERMARK="F-BT12">제16(전)기 2019년 1월 1일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="31" USERMARK="F-BT12">(주)바이오시네틱스</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN>1. 회사의 개요&cr;&cr;주식회사 바이오시네틱스(이하 "회사")는 나노기술을 이용한 약물전달 시스템 개발 및 건강기능식품, 화장품 원료개발업 등을 영위할 목적으로 2004년 1월 29일에 설립되었으며, 서울특별시 금천구 가산동에 본사를 두고 있습니다.</SPAN>
</P>
<P>&cr;회사의 설립시 자본금은 100,000천원이었으며 상환전환우선주 등 수차례 유상증자 등을 거쳐 보고기간말 현재의 자본금은 1,787,338천원이며, 2017년 중 주당 액면금액 5,000원에서 주당 액면금액 500원으로 주식분할을 하였습니다.&cr;</P>
<P>또한, 회사는 2017년 12월 15일 회사의 주식을 한국거래소 코넥스시장에 상장하였습니다.</P>
<P></P>

<P>
<SPAN>보고기간말 현재 회사의 주요 주주현황은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="637">

<COLGROUP>
<COL WIDTH="216"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주  주  명</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">소유주식수(주)</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">지분율(%)</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">김 갑 식</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">762,710</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21.34</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대표이사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(주)대웅제약</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">645,000</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18.04</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="53">한국투자글로벌제약산업육성&cr;사모투자전문회사</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">517,250</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">14.47</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">이 주 환</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,630</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11.91</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">부사장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="53">프리미어글로벌&cr;이노베이션1호 투자조합</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">422,535</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">11.82</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">기  타</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">801,550</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22.42</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">합  계</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,574,675</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN>2. 중요한 회계정책</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;재무제표의 작성에 적용된 중요한 회계정책은 아래에 제시되어 있습니다. 이러한 정책은 별도의 언급이 없다면, 표시된 회계기간에 계속적으로 적용되었습니다.&cr;</SPAN>
</P>
<P>2.1 재무제표 작성기준</P>
<P> </P>

<P>
<SPAN>회사는 2011년 1월 1일 이후에 개시하는 연차보고기간부터 일반기업회계기준을 적용하고 있습니다. 일반기업회계기준은 '주식회사의 외부감사에 관한 법률'의 적용대상기업 중 한국채택국제회계기준에 따라 회계처리하지 아니하는 기업에 적용되는 기준입니다. &cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>2.2 회계정책과 공시의 변경&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(1) 회사가 채택한</SPAN>
<SPAN> </SPAN>
<SPAN>제ㆍ</SPAN>
<SPAN>개</SPAN>
<SPAN>정 기준서&cr;&cr;① 회사는 </SPAN>
<SPAN></SPAN>
<SPAN>2020</SPAN>
<SPAN>년</SPAN>
<SPAN> 1월 1일로 개시하는 회계기간부터 다음의 </SPAN>
<SPAN></SPAN>
<SPAN>제ㆍ</SPAN>
<SPAN>개정 기준서를 신규로 적용하였습니다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P>- 일반기업회계기준 제8장 '지분법' (개정)&cr; &cr;개정된 기준은 실질적으로 기업의 관계기업에 대한 순투자액의 일부를 구성하는 우선주, 장기대여금, 장기수취채권 등과 같은 장기투자항목이 제6장 '금융자산ㆍ금융부채'의 적용 대상임을 명확히 하였으며, 관계기업에 대한 순투자의 일부를 구성하는장기투자지분의 손상 회계처리에 대해서는 제6장 '금융자산ㆍ금융부채'를 우선하여적용하고 제8장 '지분법'에 따른 관계기업의 손실을 추가로 반영하는 것으로 개정하였습니다. 동 개정이 재무제표에 미치는 중요한 영향은 없습니다.&cr;  &cr; - 일반기업회계기준 제16장 '수익' (개정)&cr; &cr;개정된 기준은 기업이 구매자에게 지급할 대가가 구매자에게서 받은 구별되는 재화나 용역에 대한 지급이라면 수익에서 차감하지 않는다는 점을 명확히 하였습니다. 동개정이 재무제표에 미치는 중요한 영향은 없습니다.&cr; &cr; - 일반기업회계기준 제18장 '차입원가' (개정)&cr; &cr;개정된 기준은 특정차입금을 관련 적격자산 차입원가 자본화가 종료되기 전까지의 자금으로 한정하며, 자본화가 종료되면 일반차입금에 포함됨을 명확히 하여 자본화이자율 산정 시 고려할 수 있는 것으로 개정하였습니다. 동 개정이 재무제표에 미치는 중요한 영향은 없습니다. </P>

<P>
<SPAN>&cr;2.3  외화환산&cr;</SPAN>
</P>
<P>(1) 기능통화와 표시통화&cr;</P>
<P>회사는 재무제표에 포함되는 항목들을 영업활동이 이루어지는 주된 경제환경에서의 통화("기능통화")를 적용하여 측정하고 있습니다. 회사의 기능통화는 대한민국 원화이며, 재무제표는 대한민국 원화로 표시하고 있습니다. &cr;</P>
<P>(2) 외화거래와 보고기간말의 외화환산&cr;</P>
<P>회사는 기능통화 이외의 다른 통화("외화")로 이루어진 거래를 기능통화로 인식하는 경우에 거래일의 외화와 기능통화 사이의 현물환율을 외화금액에 적용하여 기록하고있으며, 화폐성 외화자산과 부채는 보고기간말 현재의 환율로 환산하여 이로 인한 외화환산손익을 당기손익으로 처리하고 있습니다. 다만, 요건을 충족하는 현금흐름위험회피에 대한 위험회피금액과 외화표시 매도가능채무증권의 경우 동 금액을 기타포괄손익으로 인식하고 있습니다.&cr;</P>
<P>외화로 대가를 선지급하거나 선수취하여 인식한 비화폐성자산이나 비화폐성부채를 제거하면서 관련 자산, 비용, 수익 또는 이들 항목의 일부를 인식할 때에는, 그 비화폐성자산이나 비화폐성부채를 인식한 날을 거래일로 보고 그 날의 환율을 적용합니다.</P>
<P>   </P>
<P>비화폐성 금융자산ㆍ부채로부터 발생하는 외환차이는 공정가치 변동손익의 일부로 보고하고 있습니다. 당기손익인식지분상품으로부터 발생하는 외환차이는 공정가치 변동손익의 일부로 보아 당기손익으로, 매도가능지분상품의 외환차이는 공정가치 변동에 대한 기타포괄손익에 포함하여 인식하고 있습니다.</P>
<P>&cr;2.4 현금및현금성자산&cr;</P>
<P>회사는 통화 및 타인발행수표 등 통화대용증권과 당좌예금, 보통예금 및 큰 거래비용없이 현금으로 전환이 용이하고 이자율 변동에 따른 가치변동의 위험이 경미한 금융상품으로서 취득 당시 만기일(또는 상환일)이 3개월 이내인 것을 현금및현금성자산으로 처리하고 있습니다.&cr;&cr;2.5 대손충당금&cr;&cr;회사는 회수가 불확실한 매출채권 등은 합리적이고 객관적인 기준에 따라 산출한 대손추산액을 대손충당금으로 설정하고 있습니다. 대손추산액에서 대손충당금 잔액을 차감한 금액을 대손상각비로 인식하며, 상거래에서 발생한 매출채권에 대한 대손상각비는 판매비와 관리비로 계상하고, 기타 채권에 대한 대손상각비는 영업외비용으로 계상하고 있습니다. 회수가 불가능한 채권은 대손충당금과 상계하고, 대손충당금이 부족한 경우에는 그 부족액을 대손상각비로 인식하고 있습니다. &cr;</P>
<P>2.6 재고자산&cr;</P>

<P>
<SPAN>회사는 재고자산을 총평균법에 의해 산정된 취득원가로 평가하고 있으며, 연중 계속기록법에 의하여 수량 및 금액을 계산하고 매회계연도의 결산기에 실지재고조사를 실시하여 그 기록을 조정하고 있습니다. 또한, 재고자산의 시가가 취득원가 보다 하락한 경우에는 시가(제품, 상품 및 재공품의 시가는 순실현가능</SPAN>
<SPAN>가</SPAN>
<SPAN>치,</SPAN>
<SPAN> 원재</SPAN>
<SPAN>료의 시가는 현행대체원가)를 재무상태표가액으로 하고 있습니다. 다만, 재고자산의 평가손실을 초래했던 상황이 해소되어 새로운 시가가 장부금액보다 상승한 경우에는 최초의 장부금액을 초과하지 않는 범위 내에서 평가손실을 환입하고 있으며, 재고자산평가손실의 환입은 매출원가에서 차감하여 표시하고 있습니다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>
<P>2.7 유형자산&cr;</P>

<P>
<SPAN>회사는 유형자산의 취득원가를 구입원가 또는 제작원가 및 경영진이 의도하는 방식으로 자산을 가동하는 데 필요한 장소와 상태에 이르게 하는 데 직접 관련되는 지출 등으로 </SPAN>
<SPAN>구성되어 있습니다. </SPAN>
<SPAN></SPAN>
<SPAN>유형자산의 경제적 사용이 종료된 후에 원상회복을 위하여 그 자산을 제거, 해체하거나 또는 부지를 복원하는데 소요될 것으로 추정되는 원가가 충당부채의 인식요건을 충족하는 경우 그 지출의 현재가치도 취득원가에 포함하고 있습니다.</SPAN>
<SPAN USERMARK=" I">&cr;</SPAN>
</P>

<P>
<SPAN>회사는 유형자산을 취득원가</SPAN>
<SPAN></SPAN>
<SPAN>에서 아래의 추정내용연수와 감가상각방법에 따</SPAN>
<SPAN>라 산정된 감가상각누계액</SPAN>
<SPAN>과 손상차손누계액</SPAN>
<SPAN>을 차감한 금액으로 표시하고 있습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="633" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구    분</TH>
<TH WIDTH="211" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">추정내용연수 </TH>
<TH WIDTH="211" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">감가상각방법 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">기계장치 </TD>
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">5년</TD>
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">정액법 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">비품</TD>
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">5년</TD>
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">정액법 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">구축물</TD>
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">5년</TD>
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">정액법 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30">임차개량자산</TD>
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">3~7년</TD>
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">정액법 </TD>
</TR>
</TBODY>
</TABLE>
<P> </P>

<P>
<SPAN>유형자산의 취득 또는 완성 후의 지출이 생산능력 증대, 내용연수 연장, 상당한 원가절감 또는 품질향상을 가져오는 등 미래경제적효익의 유입 가능성이 매우 높고, 원가를 신뢰성 있게 측정할 수 있는 경우에는 자본적 지출로 인식하고, 그렇지 않은 경우에는 발생한 기간의 비용으로 인식하고 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN>2.8 무형자산&cr;</SPAN>
</P>

<P>
<SPAN>회사는 무형자산의 취득원가를 구입원가와 자산</SPAN>
<SPAN>을 사용할 수 있도록 준비하는데 직접 관련된 지출로 구성되어 있습니다. 회사는 무형자산을 취득원가에서 아래의 추정내용연수와 상각방법에 따라 산정된 상각누계액</SPAN>
<SPAN>과 손상차손누계액</SPAN>
<SPAN>을 차감한 금액으로 표시하고 있습니다.</SPAN>
</P>
<P> </P>

<TABLE BORDER="1" WIDTH="634" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="212" HEIGHT="33" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구    분</TH>
<TH WIDTH="211" HEIGHT="33" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">추정내용연수 </TH>
<TH WIDTH="211" HEIGHT="33" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각방법 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30">산업재산권 </TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="CENTER">5-10년 </TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="CENTER">정액법 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;2.9 정부보조금&cr;&cr;회사는 정부보조금에 부수되는 조건을 준수할 것이며, 보조금을 수취할 것으로 합리적인 확신이 있을 때 정부보조금을 인식합니다.&cr;&cr;자산관련보조금(공정가치로 측정되는 비화폐성 보조금 포함)을 받는 경우에는 관련 자산을 취득하기 전까지 받은 자산 또는 받은 자산을 일시적으로 운용하기 위하여 취득하는 다른 자산의 차감계정으로 회계처리하고, 관련 자산을 취득하는 시점에서 관련 자산의 차감계정으로 회계처리합니다. 자산관련보조금은 그 자산의 내용연수에 걸쳐 상각금액과 상계하며, 해당 자산을 처분하는 경우에는 그 잔액을 처분손익에 반영합니다.&cr;&cr;수익관련보조금은 특정의 비용을 보전할 목적으로 지급되는 경우에는 특정의 비용과&cr;상계처리합니다. 반면, 대응되는 비용이 없는 경우 회사의 주된 영업활동과 직접적인관련성이 있다면 영업수익으로, 그렇지 않다면 영업외수익으로 회계처리합니다. 다만, 수익관련보조금을 사용하기 위하여 특정의 조건을 충족해야 하는 경우에는 그 조건을 충족하기 전에 받은 수익관련보조금은 선수수익으로 회계처리합니다. &cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>2.10 비금융자산의 손상&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>회사는 아직 사용가능하지 않은 무형자산은 매 보고기간말에 손상검사를 실시하고 있습니다. 이 이외에 감가상각 또는 상각하는 자산의 경우는 장부금액이 회수가능하지 않을 수도 있음을 나타내는 환경의 변화나 사건과 같이 자산손상을 시사하는 징후가 있다면 손상검사를 수행하고 있습니다. 단, 유형자산의 경우에는 이러한 손상징후가 있다고 판단되고, 당해 유형자산(개별 자산 또는 유형자산만으로 구성된 현금창출단위 포함)의 사용 및 처분으로부터 기대되는 미래의 현금흐름총액의 추정액이 장부금액에 미달하는 경우에 손상검사를 수행하고 있습니다. 손상차손은 회수가능액을 초과하는장부금액으로 인식하고 있습니다. 회수가능액은 순공정가치와 사용가치 중 큰 금액으로 결정하고 있습니다. &cr;</SPAN>
<SPAN>&cr;손상차손이 인식된 비금융자산은 매 보고일에 손상차손의 환입가능성을 검토하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>2.11 충당부채와 우발부채&cr;&cr;회사는 과거사건이나 거래의 결과로 존재하는 현재 의무의 이행을 위하여 자원이 유출될 가능성이 매우 높고 동 손실의 금액을 신뢰성 있게 추정할 수 있는 경우에 그 손실금액을 충당부채로 계상하고 있습니다. 또한, 회사는 과거사건은 발생하였으나 불확실한 미래사건의 발생여부에 의해서 존재여부가 확인되는 잠재적인 의무가 있는 경우 또는 과거사건이나 거래의 결과 현재의무가 존재하나 자원이 유출될 가능성이 매우 높지 않거나 당해 의무를 이행하여야 할 금액을 신뢰성 있게 추정할 수 없는 경우 우발부채로 주석기재하고 있습니다.</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>&cr;충당부채는 의무를 이행하기 위하여 예상되는 지출액의 현재가치로 측정하며, 현재가치 평가에 사용하는 할인율은 그 부채의 고유한 위험과 화폐의 시간가치에 대한 현행 시장의 평가를 반영한 세전 이자율입니다. 또한, 충당부채는 보고기간말마다 그 잔액을 검토하고, 보고기간말 현재 최선의 추정치를 반영하여 증감조정하며, </SPAN>
<SPAN>이때 현재가치 평가에 사용한 할인율은 변동되지 않는 것으로 보고 당초에 사용한 할인율로 평가하고 있습니다. &cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>2.12 당기법인세와 이연법인세&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>회사는 </SPAN>
<SPAN>법인세비용을 법인세법 등의 법령에 의한 법인세부담액에 이연법인세 변동액을 가감하여 계상하고 있습니다. 자산ㆍ부채의 장부금액과 세무기준액의 차이인 일시적차이중 미래기간의 과세소득을 증가시키는 가산할 일시적차이에 대한 법인세효과는 예외항목에 해당되지 않는 경우 전액 이연법인세부채로 인식하고 있습니다. 미래기간의 과세소득을 감소시키는 차감할 일시적차이 및 결손금 등에 대한 법인세효과는 향후 과세소득의 발생가능성이 매우 높아 미래의 법인세 절감효과가 실현될 수 있을 것으로 기대되는 경우에 이연법인세자산으로 인식하고 있습니다. 또한, 자본계정에 직접 가감되는 항목과 관련된 법인세부담액과 이연법인세는 자본계정에 직접 가감하고있습니다.&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
</P>

<P>
<SPAN>2.13 </SPAN>
<SPAN>종업원급여&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(1) 퇴직급여충당부채</SPAN>
</P>
<P>&cr;회사는 임직원 퇴직금 지급규정에 따라 당기말 현재 1년이상 근속한 전임직원이 일시에 퇴직할 경우에 지급하여야 할 퇴직금 총 추계액을 퇴직급여충당부채로 설정하고 있습니다.</P>
<P> </P>

<P>
<SPAN></SPAN>
<SPAN>(2) 연차수당부채&cr;&cr;회사는 종업원이 미래의 연차유급휴가에 대한 권리를 발생시키는 근무용역을 제공하는 회계기간에 연차유급휴가와 관련된 비용과 부채를 인식하고 있습니다. 회사는 종업원의 미사용 연차에 대하여 보상을 하므로 근무용역의 제공으로 발생하는 연차유급휴가 전체에 대하여 비용과 부채를 인식합니다.&cr;</SPAN>
<SPAN></SPAN>
</P>
<P>2.14 수익인식&cr;</P>
<P>회사는 재화의 판매, 용역의 제공이나 자산의 사용에 대하여 받았거나 또는 받을 대가의 공정가치로 수익을 측정하고 있으며, 부가가치세, 매출에누리와 할인 및 환입은수익에서 차감하고 있습니다. 회사는 수익을 신뢰성 있게 측정할 수 있으며 관련된 경제적 효익의 유입 가능성이 매우 높은 경우에 수익을 인식합니다. </P>
<P></P>
<P>(1) 재화의 판매&cr;</P>
<P>회사는 재화의 판매에 따른 수익은 재화가 구매자에게 인도되는 시점에서 인식하고 있습니다. 재화의 인도는 재화가 특정 장소로 이전되고, 재화의 진부화와 손실에 대한 위험이 구매자에게 이전되며, 구매자가 판매 계약에 따라 재화의 수령을 승인하거나 그 승인기간이 만료되거나 또는 회사가 재화의 수령 승인요건이 충족되었다는 객관적인 증거를 가지는 시점이 되어야 발생합니다.</P>
<P></P>
<P>(2) 용역의 제공&cr;</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>회사는 </SPAN>
<SPAN>용역의 제공으로 인한 수익은 용역제공거래의 성과를 신뢰성있게 추정할 수 있는 경우에는 진행기준에 따라 수익을 인식하고, 용역제공거래의 성과를 신뢰성 있게 추정할 수 없는 경우에는 발생원가의 범위 내에서 회수가능한 금액만을 수익으로 인식하고 있습니다.&cr;&cr;</SPAN>
<SPAN>(3) 로열티 수익 &cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>회사는 </SPAN>
<SPAN>로열티 수익을 계약의 실질에 따라 발생기준에 의하여 인식하고 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN>(</SPAN>
<SPAN>4</SPAN>
<SPAN>)</SPAN>
<SPAN> </SPAN>
<SPAN>이자수익&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>회사는 </SPAN>
<SPAN>이자수익을 시간의 경과에 따라 유효이자율법에 의하여 인식하고 있습니다. 채권 손상이 발생하는 경우 채권금액의 장부금액을 회수가능액까지 손상차손을 인식하며, 시간의 경과에 따라 증가하는 부분은 이자수익으로 인식하고 있습니다. 손상채권에 대한 이자수익은 최초 유효이자율에 의하여 인식하고 있습니다.</SPAN>
<SPAN></SPAN>
<SPAN>&cr;&cr;2.15 주식선택권&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>회사는 </SPAN>주식결제형 주식기준보상거래의 경우 제공받는 재화나 용역의 공정가치로 측정하며, 종업원의 용역제공과 같이 제공받는 재화나 용역의 공정가치를 신뢰성 있게 측정할 수 없는 경우에는 부여한 지분상품의 공정가치에 기초하여 재화나 용역의 공정가치로 간접 측정하고 그 금액을 보상원가와 자본조정으로 회계처리하고 있습니 다.&cr;
</P>
<P>현금결제형 주식기준보상거래의 경우 제공받는 재화나 용역과 그 대가로 부담하는 부채를 부채의 공정가치로 측정하며, 부채가 결제될 때까지 매 보고기간말과 최종결제일에 부채의 공정가치를 재측정하고, 공정가치의 변동액은 보상원가로 회계처리하고 있습니다. </P>
<P> </P>
<P>회사나 거래상대방이 현금결제방식이나 주식결제방식을 선택할 수 있는 선택형주식기준보상거래에 대하여는 거래의 실질에 따라 회계처리하고 있습니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>2.16 금융자산과 금융부채의 측정&cr;</SPAN>
</P>

<P>
<SPAN>회사는 금융자산과 금융부채의 최초인식시 공정가치로 측정하고 있으며, 이 때의 공정가치는 일반적으로 거래가격(금융자산의 경우에는 제공한 대가의 공정가치, 금융부채의 경우에는 수취한 대가의 공정가치)입니다. 그러나 장기연불조건의 매매거래, 장기금전대차거래 또는 이와 유사한 거래에서 발생하는 채권ㆍ채무로서 명목금액과 공정가치의 차이가 유의적인 경우에는 공정가치로 평가합니다. &cr;&cr;제공(수취)한 대가에 금융상품이 아닌 다른 것에 대한 대가가 포함되었다면 그 금융상품의 공정가치는 시장가격으로 평가하되, 시장가격이 없는 경우에는 평가기법(현재가치평가기법을 포함)을 사용하여 공정가치를 추정합니다. 다만, 제공하거나 수취한 대가에 금융상품이 아닌 다른 것에 대한 대가가 포함되었더라도, 자금의 사용에 따른 반대 급부(예를 들어 생산물 공급가액의 제약 등)를 부과하거나 제공하는 자금의 조달과 사용의 연계성이 확실한 경우 및 임대차보증금에 대하여는 거래가격 전체를 금융상품의 최초인식액으로 하고 있습니다. 회사는 단기매매증권, 파생상품(</SPAN>
<SPAN></SPAN>
<SPAN>현금흐름위험회피회계에서 위험회피수단으로 지정되는 경우는 제외</SPAN>
<SPAN>) 같이 최초 인식 이후 공정가치로 측정하고 공정가치의 변동을 당기손익으로 인식하는 금융자산이나 금융부채가 아닌 경우에는 당해 금융자산의 취득 또는 금융부채의 발행과 직접적으로 관련된 거래원가를 최초인식하는 공정가치에 가산 또는 차감하고 있습니다. &cr;&cr;회사는 금융상품의 현재가치 측정시에 당해 거래의 내재이자율을 적용하고 있으나, 이러한 이자율을 구할 수 없거나 동종시장이자율과의 차이가 유의적인 경우에는 동종시장이자율을 적용하고, 동종시장이자율을 실무적으로 산정할 수 없는 경우에는 객관적이고 합리적인 기준에 의하여 산출한 가중평균이자율을 적용하고 있으며, 가중평균이자율을 산출하기 위한 객관적이고 합리적인 기준이 없는 경우에는 회사채 유통수익률을 기초로 회사의 신용도 등을 반영하여 회사에 적용될 자금조달비용을 합리적으로 추정하여 적용합니다. </SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>2.</SPAN>
<SPAN>17 </SPAN>
<SPAN>전기오류수정손익&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>회사는 </SPAN>
<SPAN>전기 또는 그 이전기간의 재무제표를 작성할 때 발생하였던 오류가 당기에 발견되는 경우 당기 손익계산서에 영업외손익 중 전기오류수정손익으로 계상하고 있습니다. 다만, 중대한 오류의 수정은 전기이월미처분이익잉여금에 반영하고 관련 계정잔액을 수정하며 중대한 오류의 영향을 받은 회계기간의 재무제표를 재작성하고 있습니다</SPAN>
<SPAN>.&cr;</SPAN>
<SPAN>&cr;3. 중요한 회계추정 및 가정&cr;&cr;회사는 미래에 대하여 추정 및 가정을 하고 있습니다. 추정 및 가정은 지속적으로 평가되며, 과거 경험과 현재의 상황에서 합리적으로 예측가능한 미래의 사건을 고려하여 이루어집니다. 이러한 회계추정은 실제 결과와 다를 수도 있습니다. 다음 회계연도에 자산 및 부채 장부금액의 조정에 영향을 미칠 수 있는 유의적 위험에 대한 추정 및 가정은 다음과 같습니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(1) 법인세&cr;&cr;</SPAN>
<SPAN>회사는 보고기간말 현재까지의 영업활동의 결과로 미래에 부담할 것으로 예상되는 법인세효과를 최선의 추정과정을 거쳐 당기법인세 및 이연법인세로 인식하였습니다.하지만 실제 미래 최종 법인세부담은 인식한 관련 자산ㆍ부채와 일치하지 않을 수 있으며, 이러한 차이는 최종 법인세 효과가 확정된 시점의 당기법인세 및 이연법인세 자산ㆍ부채에 영향을 줄 수 있습니다(주석</SPAN>
<SPAN> 13</SPAN>
<SPAN>참조).</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>4. 현금및현금성</SPAN>
<SPAN>자산</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN>보고기간말 현재 회사의 현금및현금성자산의 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="606">

<COLGROUP>
<COL WIDTH="597"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="606" HEIGHT="31" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="607">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내 역</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내역</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">예입처</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">현금및현금성자산</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">현금</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">88</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">102</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">보통예금</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">59,137</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">170,402</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">MMT</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,039,334</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">933,534</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="349" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,098,559</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,104,038</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;5. 단기금융상품&cr;&cr;보고기간말 현재 회사의 단기금융상품의 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="771" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="762"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="771" HEIGHT="31">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE AFIXTABLE="N" WIDTH="771" BORDER="1" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="107"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내 역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">예입처</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연이자율(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">만기일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="116" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER">단기금융상품</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">특정금전신탁</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="130" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">            500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">할인맞춤채권</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="130" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">            500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="512" HEIGHT="30" COLSPAN="5">합계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="130" HEIGHT="30">          -</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">1,000,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>6. 재고자산&cr;</SPAN>
</P>

<P>
<SPAN>(1) 재고자산 상세내역</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="33">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="602" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구     분</TH>
<TH WIDTH="201" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">당기말</TH>
<TH WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER">제     품</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT">86,236</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">76,768</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER">원 재 료</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT">10,296</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">11,735</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT">96,532</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">88,503</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN> &cr;</SPAN>
<SPAN>(2) 회사는 상기 재고자산 및 유형자산과 관련하여 부보금액 </SPAN>
<SPAN>2,3</SPAN>
<SPAN>10,000</SPAN>
<SPAN>천원(전기:</SPAN>
<SPAN> </SPAN>
<SPAN>2,3</SPAN>
<SPAN>1</SPAN>
<SPAN>0,000</SPAN>
<SPAN>천원)의 화재보험에 가입하고 있습니다(주석7 참조).</SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>7. 유형자산&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(1) 당기와 전기 중 회사의 유형자산 장부가액 증감내역은 다음과 같습니다.&cr;&cr;- 당기</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="733" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="724"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="733" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="734" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="172"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="181" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">
<SPAN>구 분</SPAN>
</TH>
<TH WIDTH="111" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">기계장치</TH>
<TH WIDTH="111" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">비품</TH>
<TH WIDTH="111" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">구축물</TH>
<TH WIDTH="110" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">임차개량자산</TH>
<TH WIDTH="110" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">계 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">기초</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">1,125,121</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">46,329</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">199,000</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">24,044</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">1,394,494</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">취득 </TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">9,000</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">9,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">기말취득원가 </TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">1,134,121</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">46,329</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">199,000</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">24,044</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">1,403,494</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">기말상각누계액</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(784,028)</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(41,870)</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(121,132)</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(12,942)</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(959,972)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">정부보조금</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(24,395)</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(24,395)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">유형자산손상차손누계액</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(4,459)</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(77,868)</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(11,102)</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(93,429)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">기말장부가액</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">325,698</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">325,698</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">감가상각비 </TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(125,204)</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(3,720)</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(39,799)</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(6,645)</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(175,368)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">유형자산손상차손</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(4,035)</TD>
<TD WIDTH="111" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(77,868)</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(11,102)</TD>
<TD WIDTH="110" HEIGHT="30" VALIGN="BOTTOM" ALIGN="RIGHT">(93,005)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;- 전기 </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="617">

<COLGROUP>
<COL WIDTH="608"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="733">

<COLGROUP>
<COL WIDTH="172"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="181" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>구 분</SPAN>
</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기계장치</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비품</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구축물</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임차개량자산</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">기초</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,070,816</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">42,426</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">132,000</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,245,242</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">취득</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">54,305</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">3,903</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">67,000</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">24,044</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">149,252</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">기말취득원가 </TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,125,121</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">46,329</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">199,000</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">24,044</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,394,494</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">기말상각누계액</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(645,513)</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(37,642)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(81,332)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(6,297)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(770,784)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">정부보조금</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(37,706)</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(932)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(38,638)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">기말장부가액</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">441,902</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">7,755</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">117,668</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">17,747</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">585,072</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30">감가상각비 </TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(127,735)</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(3,989)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(35,333)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(6,297)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(173,354)</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P>
<SPAN>(2) 당기 및 전기 중 유형자산 상각액은 다음과 같습니다.</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="617">

<COLGROUP>
<COL WIDTH="608"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="224"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="184"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="233" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당 기</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="233" VALIGN="MIDDLE" HEIGHT="30">제조원가</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,310</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,478</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="233" VALIGN="MIDDLE" HEIGHT="30">판매비와관리비</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,773</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,550</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="233" VALIGN="MIDDLE" HEIGHT="30">경상연구개발비</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">103,583</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">110,984</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="233" VALIGN="MIDDLE" HEIGHT="30">
<SPAN>영업외비용</SPAN>
<SPAN>(조업도손실)</SPAN>
</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,701</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,342</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="233" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">175,367</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">173,354</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(3) </SPAN>
<SPAN>회사는 상기 유형자산</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN> 및 재고자산과 관련하여 부보금액 </SPAN>
<SPAN>2</SPAN>
<SPAN>,310,000</SPAN>
<SPAN>천원(전기:</SPAN>
<SPAN> </SPAN>
<SPAN>2</SPAN>
<SPAN>,310,000</SPAN>
<SPAN>천원)의 화재보험에 가입하고 있습니다(주석6 참조).</SPAN>
<SPAN></SPAN>
<SPAN>&cr;&cr;(4) 회사는 회사가 체결한 임대차계약에 의하여 임차기간 종료 시 소요될 것으로 추정되는 복구원가 24,044천원을 임차개량자산의 취득원가로 계상하였습니다.</SPAN>
</P>
<P> </P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">상기 추정복구비용을 산정하는데 사용한 방법은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31" USERMARK=" BC0XD7D7D7">공장 1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31" USERMARK=" BC0XD7D7D7">공장 2</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31" USERMARK=" BC0XD7D7D7">공장 3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31">예상현금흐름</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31">11,436</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31">11,549</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31">2,564</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31">할인율 (%)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31">1.32</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31">0.97</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="31">1.46</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>(</SPAN>
<SPAN>5) 당기손익으로 인식한 리스료&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>&cr;회사는 본사 사무실 및 공장 등을 취소불가능한 운용리스로 이용하고 있으며, 이러한리스계약에 따라 지급하는 리스료는 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="33">
<SPAN>(단위: 천원</SPAN>
<SPAN>)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구  분</TH>
<TH WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">당기</TH>
<TH WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30">최소리스료 </TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">101,496</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">114,480</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="32" ALIGN="CENTER">합  계</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="RIGHT">101,496</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="RIGHT">114,480</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(6) 미래 최소리스료</P>

<P>
<SPAN>&cr;회사가 운용리스계약에 따라 향후 지급할 리스료는 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="33">
<SPAN>(단위: 천원</SPAN>
<SPAN>)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="603" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구  분</TH>
<TH WIDTH="201" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">당기말</TH>
<TH WIDTH="201" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30">1년이내 </TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT">79,296</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT">146,496</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30">1년초과  5년이내 </TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT">55,016</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT">374,312</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30">5년초과   </TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT">60,696</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT">134,312</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="RIGHT">580,808</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;8. 무형자산&cr;&cr;(1) 당기와 전기 중 회사의 무형자산 장부가액 변동내역은 다음과 같습니다.&cr;&cr;- 당기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="612">

<COLGROUP>
<COL WIDTH="603"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="612" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="612">

<COLGROUP>
<COL WIDTH="181"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="131"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">산업재산권</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">건설중인 무형자산</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">합계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">기초취득원가</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">264,473</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">238,624</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">503,097</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">취득</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,884</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,884</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">대체</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,245</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(26,245)</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">기말취득원가</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">290,718</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">241,263</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">531,981</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">기말상각누계액</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(165,587)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(165,587)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">정부보조금</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">무형자산손상차손누계액</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(125,131)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(241,263)</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(366,394)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">기말장부가액</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(26,824)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(26,824)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">무형자산손상차손</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(125,131)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(227,168)</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(352,299)</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>- 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="610">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="610" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="610">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="161" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">구 분</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">산업재산권</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">건설중인 무형자산</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30">기초취득원가</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">252,516</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">236,151</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">488,667</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30">취득</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">14,430</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">14,430</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30">대체</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">11,957</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(11,957)</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30">기말취득원가</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">264,473</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">238,624</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">503,097</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30">기말상각누계액</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(138,764)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(138,764)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30">정부보조금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(14,095)</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(14,095)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30">기말장부가액</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">125,709</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">224,529</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">350,238</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30">무형자산상각비</TD>

<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">
<SPAN>(</SPAN>
<SPAN>25,452</SPAN>
<SPAN></SPAN>
<SPAN>)</SPAN>
</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">- </TD>

<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">
<SPAN>(</SPAN>
<SPAN>25,452</SPAN>
<SPAN></SPAN>
<SPAN>)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN>2</SPAN>
<SPAN>) 무형자산 상각액 </SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="33">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구     분</TH>
<TH WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">당기</TH>
<TH WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE">제조원가</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">19,057</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">23,709</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE">판매비와 관리비</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">370</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">411</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE">영업외비용(조업도손실)</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">7,397</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">1,332</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" ALIGN="CENTER">합    계</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">26,824</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">25,452</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN>(</SPAN>
<SPAN>3</SPAN>
<SPAN>) 중요한 개별 무형자산의 내용</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="638" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="629"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="638" HEIGHT="33">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="641" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구     분</TH>
<TH WIDTH="120" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">내    용 </TH>
<TH WIDTH="120" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">당기말</TH>
<TH WIDTH="120" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">전기말</TH>
<TH WIDTH="161" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">잔여상각기간 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" HEIGHT="30" ALIGN="CENTER" USERMARK=" 0X0000FF" VALIGN="MIDDLE">
<SPAN USERMARK=" 0X000000">NUFS™</SPAN>
<SPAN USERMARK=" 0X000000">(*1)</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
</TD>

<TD WIDTH="120" HEIGHT="30" ALIGN="CENTER" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">의약품 제조</SPAN>
</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,511</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">58,995</TD>

<TD WIDTH="161" HEIGHT="30" ALIGN="CENTER" USERMARK=" 0X0000FF" VALIGN="MIDDLE">
<SPAN USERMARK=" 0X000000">4개월~5년 10개월</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN>SENS™</SPAN>
<SPAN>(*2)</SPAN>
</TD>
<TD WIDTH="120" HEIGHT="53" ALIGN="CENTER">화장품 및 &cr;식품 소재</TD>
<TD WIDTH="120" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">77,231</TD>
<TD WIDTH="120" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">65,955</TD>

<TD WIDTH="161" HEIGHT="53" ALIGN="CENTER" USERMARK=" 0X0000FF" VALIGN="MIDDLE">
<SPAN USERMARK=" 0X000000">4년 5개월~9년 8개월</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*1)  고형지질과 초임계유체를 이용한 나노입자화 기술 &cr;        </SPAN>
<SPAN>(Nanoparticulation Using Fat and Supercritical fluid)&cr;</SPAN>
<SPAN>(*2)  당류를 이용한 나노입자화 기술&cr;        </SPAN>
<SPAN>(Saccharides Employing Nanoparticle System)&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN></SPAN>
<SPAN>4</SPAN>
<SPAN>)</SPAN>
<SPAN> </SPAN>
<SPAN>당기 중</SPAN>
<SPAN> 비용으로 인식한 경상개발비는 </SPAN>
<SPAN></SPAN>
<SPAN>721,305</SPAN>
<SPAN>천원(전기: </SPAN>
<SPAN>843,253천원)입니다.</SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN>9.</SPAN>
<SPAN> 정부보조금&cr;&cr;</SPAN>
<SPAN>회사는 한국산업기술평가관리원과 나노 분말화 기술을 이용하여 용법 및 용량이 개선된 표적 항암제 개발 과제와 관련된 기술료 지원사업 등 협약서에 의하여 정부보조금을 </SPAN>
<SPAN></SPAN>
<SPAN>전기에 </SPAN>
<SPAN>317,118천원</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> 수령하였으며, 관련 내역은 다음과 같습니다.&cr; &cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(1) 보</SPAN>
<SPAN>고기간말 현재까지 회사가 수령한 정부보조금 누적액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="601">

<COLGROUP>
<COL WIDTH="592"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="601" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="238"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="167"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="247" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구 분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="177" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당기말</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="176" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="247" HEIGHT="30">상환의무가 없는 정부보조금</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,065,012</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="247" HEIGHT="30">상환의무가 있는 정부보조금(*)</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">118,335</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">118,335</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*)</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> 전기 중 회사는 상기 정부보조금과 관련된 과제(한국산업기술평가관리원의 '나노분말화 기술을 이용하여 용법 및 용량이 개선된 표적 항암제 개발')에 대하여 사업화 (품목허가) 시기가 지연되는 등 사업화 가능성이 낮으므로 차년도 계속 수행의 필요성이 적어 2019년 12월 17일 조기종료(성실 수행)되었으며, 이에 따라 장기미지급금을 미지급금으로 대체하였습니다. </SPAN>
<SPAN>해당 미지급금 118,335천원은</SPAN>
<SPAN> </SPAN>
<SPAN>산업기술혁신촉진법 시행령15조에 따라 </SPAN>
<SPAN></SPAN>
<SPAN>상환될 예정입니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>(2) 당기와 전기 중 정부보조금의 사용내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="601">

<COLGROUP>
<COL WIDTH="592"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="601" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK=" BC0XD7D7D7">구   분</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK=" BC0XD7D7D7">당   기</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK=" BC0XD7D7D7">전    기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">수령액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">317,118</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">사용액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK=" 0XEEAE00">
<SPAN USERMARK=" 0X000000">317,118</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">  유형자산취득</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">  경상연구개발비대체 등</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">285,406</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">  장기미지급금 대체</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">  미지급금 대체</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">31,712</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(3) 당기와 전기 중 자산취득에 사용된 정부보조금의 변동내역은 다음과 같습니다.&cr;&cr;- 당기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="601">

<COLGROUP>
<COL WIDTH="592"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="601" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="605">

<COLGROUP>
<COL WIDTH="181"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">유형자산</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">무형자산</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">합계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">기초</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,639</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,095</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,734</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">상각 등</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,244)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,095)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(28,339)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" VALIGN="MIDDLE" HEIGHT="30">기말</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,395</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,395</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;- 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="601">

<COLGROUP>
<COL WIDTH="592"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="601" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="180"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">유형자산</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">무형자산</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">합계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="189" VALIGN="MIDDLE" HEIGHT="30">기초</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70,431</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,095</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,526</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="189" VALIGN="MIDDLE" HEIGHT="30">상각액</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN>(31,79</SPAN>
<SPAN>2</SPAN>
<SPAN>)</SPAN>
</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN>(31,79</SPAN>
<SPAN>2</SPAN>
<SPAN>)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="189" VALIGN="MIDDLE" HEIGHT="30">기말</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN>38,63</SPAN>
<SPAN>9</SPAN>
</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,095</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN>52,73</SPAN>
<SPAN>4</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>10. </SPAN>
<SPAN>금융부채의 유동성 위험관리 방법 및 종류별 만기 분석&cr;&cr;(1) 유동성 위험 관리방법&cr;&cr;유동성위험이란 당사가 금융부채에 관련된 의무를 충족하는 데 어려움을 겪게 될 위험을 의미합니다. 회사의 유동성 관리방법은 재무적으로 어려운 상황에서도 받아들일 수 없는 손실이 발생하거나, 당사의 평판에 손상을 입힐 위험 없이, 만기일에 부채를 상환할 수 있는 충분한 유동성을 유지하도록 하는 것입니다.&cr;&cr;회사는 부채 상환을 포함하여, 단기 예상 운영비용을 충당할 수 있는 충분한 요구불예적금을 보유하고 있다고 확신하고 있습니다. 여기에는 합리적으로 예상할 수 없는극단적인 상황으로 인한 잠재적인 효과는 포함되지 않았습니다.</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(2) 금융부채의 계약상 만기 분석&cr;&cr;- 당기말</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="625" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="616"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="625" HEIGHT="33">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="626" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="178"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="78"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="187" VALIGN="MIDDLE" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구 분</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년에서&cr;2년이하</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2년에서&cr;5년이하</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">5년 초과</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">미지급금</TD>
<TD WIDTH="88" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">121,211</TD>
<TD WIDTH="88" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="87" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">121,211</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">미지급비용</TD>
<TD WIDTH="88" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">44,179</TD>
<TD WIDTH="88" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="87" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">44,179</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;- 전기말</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="626">

<COLGROUP>
<COL WIDTH="617"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="626" HEIGHT="33" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="178"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="78"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="187" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="88" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="88" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년에서&cr;2년이하</TH>
<TH WIDTH="88" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2년에서&cr;5년이하</TH>
<TH WIDTH="88" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">5년 초과</TH>
<TH WIDTH="87" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">매입채무</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">27,500</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">27,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">미지급금</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">126,246</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">126,246</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">미지급비용</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">69,070</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>

<TD USERMARK=" 0X0000FF" WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">
<SPAN USERMARK=" 0X000000">69,070</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>11</SPAN>
<SPAN>. 퇴직급여충당부채&cr;&cr;</SPAN>
<SPAN>(1) 당기와 전기 중 회사의 퇴직급여충당부채 증감 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="33" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="603">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당 기</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30">기초</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">347,793</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">278,826</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30">퇴직급여지급액</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(25,504)</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,114)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30">퇴직급여설정액</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">59,508</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">83,081</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30">기말</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">381,797</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">347,793</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(2) 보고기간말 현재 전 임직원의 퇴직금 소요액은 </SPAN>
<SPAN></SPAN>
<SPAN>381,797천원(전기말:</SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>347,793</SPAN>
<SPAN>첨원)</SPAN>
<SPAN></SPAN>
<SPAN>이며, 동일한 금액에 대하여 퇴직급여충당부채를 설정하고 있습니다. 한편, 회사는 별도의 퇴직보험에 가입하고 있지 않습니다.&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN>12</SPAN>
<SPAN>. 충당부채</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="707">

<COLGROUP>
<COL WIDTH="698"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="707" HEIGHT="33" ALIGN="RIGHT">
<SPAN>(단위: 천원</SPAN>
<SPAN>)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="708">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="160" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기초</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">설정액</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전입액</TH>
<TH WIDTH="109" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용액</TH>
<TH WIDTH="109" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">복구충당부채(*)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">24,354</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">452</TD>

<TD USERMARK=" 0X0000FF" WIDTH="109" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" 0X000000">-</SPAN>
</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">24,806</TD>
</TR>
</TBODY>
</TABLE>

<P>(*) 
<SPAN>회사는 당기말 현재 사무실 및 연구소, 공장 등의 임차계약 상 원상복구의무와 관련하여 장래에 지출될 것이 예상되는 금액을 임차기간(</SPAN>
<SPAN>2~6</SPAN>
<SPAN>년) 및 관련 복구견적금액등을 기초로 추정하여 복구충당부채로 계상하고 있습니다. 보고기간말 현재 임차계약에 의하여 당기말 현재 재무제표에 계상된 유형자산은 0</SPAN>
<SPAN>원입니다.&cr;</SPAN>
</P>

<P>
<SPAN>13</SPAN>
<SPAN>.  이연법인세&cr;</SPAN>
</P>
<P>(1) 당기 법인세 부담액 및 일시적 차이로 인한 이연법인세 변동액은 없습니다.</P>

<P USERMARK="F-GL 0X0000FF">
<SPAN USERMARK="F-BT 0X000000">&cr;</SPAN>
<SPAN USERMARK="F-BT 0X000000">(2) 법인세비용차감전순이익과 법인세비용간의 관계&cr;</SPAN>
</P>
<P>회사의 법인세비용차감전순손익과 법인세비용간의 관계는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="33" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="601">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">내 역</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당 기</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">법인세비용차감전순손실</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,838,234)</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,115,092)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">적용세율에 따른 세부담액</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(404,411)</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(245,320)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">조정사항 :</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">  이연법인세 미인식액</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">404,411</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">245,320</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">법인세비용</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="53">유효세율(법인세비용/법인세비용차감전순이익)</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">(*)</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">(*)</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 법인세비용차감전순손실이 발생하여 유효세율을 산정하지 아니하였습니다.</P>
<PGBRK></PGBRK>
<P>(3) 회사의 일시적차이 및 이연법인세자산(부채) 증감내역은 다음과 같습니다.&cr;</P>

<P>
<SPAN>- 당기</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="758" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="324"></COL>
<COL WIDTH="416"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" WIDTH="425" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="756">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="343" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">누적일시적차이</TH>
<TH WIDTH="255" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이연법인세자산(부채)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="85" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
<TH WIDTH="85" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="85" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감</TH>
<TH WIDTH="85" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="756" HEIGHT="30" COLSPAN="8">일시적차이로 인한 이연법인세</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">퇴직급여충당부채</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">353,072</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">353,072</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">408,200</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">408,200</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">77,676</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">12,128</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">89,804</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">254</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">254</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">56</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">56</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">정부보조금</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">150,603</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">13,820</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">136,783</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">33,133</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">(3,041)</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">30,092</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미지급비용</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">19,965</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">19,965</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">26,557</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">26,557</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">4,392</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,451</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">5,843</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">유형자산손상차손</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">93,006</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">93,006</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">20,461</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">20,461</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">무형자산손상차손</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">352,299</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">352,299</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">77,506</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">77,506</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">기타</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">28,337</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">28,337</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">6,234</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">(6,234)</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30" ALIGN="CENTER">소계</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">552,231</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">415,194</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">880,062</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,017,099</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">121,491</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">102,271</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">223,762</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">이월결손금</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">5,415,426</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">85,418</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">1,363,102</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">6,693,110</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,191,394</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">281,090</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,472,484</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">이월세액공제</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">286,210</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">37,365</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">323,575</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">5,967,657</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">500,612</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">2,243,164</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">7,710,209</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,599,095</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">420,726</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">2,019,821</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="501" HEIGHT="30" COLSPAN="5">이연법인세인식대상 제외(*)</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,599,095</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">420,726</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">2,019,821</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="501" HEIGHT="30" COLSPAN="5">이연법인세자산</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>- 전기</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="758" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="324"></COL>
<COL WIDTH="416"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" WIDTH="425" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="756">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="343" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">누적일시적차이</TH>
<TH WIDTH="255" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이연법인세자산(부채)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="85" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
<TH WIDTH="85" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="85" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감</TH>
<TH WIDTH="85" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="756" HEIGHT="30" COLSPAN="8">일시적차이로 인한 이연법인세</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">퇴직급여충당부채</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">353,072</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">353,072</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">408,200</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">408,200</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">77,676</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">12,128</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">89,804</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">감가상각비</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">254</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">254</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">56</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">56</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">150,603</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">13,820</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">136,783</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">33,133</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">(3,041)</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">30,092</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">정부보조금</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">19,965</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">19,965</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">26,557</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">26,557</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">4,392</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,451</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">5,843</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미지급비용</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">28,337</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">28,337</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">6,234</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">(6,234)</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30" ALIGN="CENTER">소계</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">552,231</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">415,194</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">434,757</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">571,794</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">121,491</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">4,304</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">125,795</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">이월결손금</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">5,415,426</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">85,418</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">1,390,661</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">6,720,669</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,191,394</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">287,153</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,478,547</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">이월세액공제</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">286,210</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">37,365</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">323,575</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">5,967,657</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">500,612</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT">1,825,418</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">7,292,463</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,599,095</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">328,822</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,927,917</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="501" HEIGHT="30" COLSPAN="5">이연법인세인식대상 제외(*)</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,599,095</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">328,822</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">1,927,917</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="501" HEIGHT="30" COLSPAN="5">이연법인세자산</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 이연법인세자산에 대한 미래 실현가능성은 회사의 성과, 전반적인 경제환경과 산업에 대한 전망, 향후 예상수익, 세액공제와 이월결손금의 공제가능기간 등 다양한요소들을 고려하여 평가합니다. 회사는 주기적으로 이러한 사항들을 검토하고 있는 바,당기말과 전기말 현재 이연법인세자산의 경우 실현가능성에 대한 판단을 토대로 이연법인세부채를 한도로 하여 인식하고 있습니다. </P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(4) 당기말 현재 이연법인세자산으로 인식되지 아니한 미사용 세무상 결손금 및 이월세액 공제내역은</SPAN>
<SPAN> 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="628" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="324"></COL>
<COL WIDTH="286"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30" USERMARK="F-BT"></TD>
<TD ALIGN="RIGHT" WIDTH="295" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="628">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">만기</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이월결손금</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이월세액공제</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER">2021년</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">91,206</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">54,152</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER">2022년</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">32,887</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">55,922</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER">2023년</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">150,908</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">66,154</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER">2024년</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">257,817</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">72,982</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER">2025년</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">392,859</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER">2026년 이후</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">5,767,433</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">6,693,110</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">249,210</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>14</SPAN>
<SPAN>. 자본금&cr;&cr;(1) </SPAN>
<SPAN>회사가 발행할 주식의 총수는 당기말 현재 20,000,000주(1주의 금액: 500원)이며, 당기말 현재 발행한 주식수는 보통주식 2,634,890주, 전환우선주 517,250주 및 상환전환우선주 422,535주입니다. &cr;</SPAN>
<SPAN>&cr;(2) 당기와 전기 중 회사의 자본금의 변동내역은 다음과 같습니다.&cr;&cr;- 당기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="33" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="767">

<COLGROUP>
<COL WIDTH="115"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD COLSPAN="2" WIDTH="215" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">보통주</TD>
<TD COLSPAN="2" WIDTH="214" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전환우선주</TD>
<TD COLSPAN="2" WIDTH="214" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">상환전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주식수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">자본금</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주식수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">자본금</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주식수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">자본금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="30">기초</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,634,890</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,317,445</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">517,250</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">258,625</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">422,535</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">211,268</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="30">유상증자</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="30">기말</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,634,890</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,317,445</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">517,250</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">258,625</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">422,535</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">211,268</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;- 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="33" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="767">

<COLGROUP>
<COL WIDTH="115"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD COLSPAN="2" WIDTH="215" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">보통주</TD>
<TD COLSPAN="2" WIDTH="214" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전환우선주</TD>
<TD COLSPAN="2" WIDTH="214" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">상환전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주식수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">자본금</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주식수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">자본금</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주식수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">자본금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="30">기초</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,611,190</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,305,595</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">517,250</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">258,625</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">422,535</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">211,268</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="30">유상증자</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,700</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,850</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="30">기말</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,634,890</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,317,445</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">517,250</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">258,625</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">422,535</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">211,268</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;전기 중 주식매수선택권 행사로 인하여 발행주식수가 변동되었습니다.&cr;&cr;(3) 회사는 2015년 12월 16일 참가적ㆍ누적적 전환우선주를 발행하였으며, 주요 발행조건은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="770">

<COLGROUP>
<COL WIDTH="137"></COL>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD WIDTH="624" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">내용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">발행주식수(*)</TD>
<TD WIDTH="624" VALIGN="MIDDLE" HEIGHT="30">참가적ㆍ누적적 전환우선주 517,250주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">발행가액(*)</TD>
<TD WIDTH="624" VALIGN="MIDDLE" HEIGHT="30">5,796원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">의결권</TD>
<TD WIDTH="624" VALIGN="MIDDLE" HEIGHT="30">보통주와 동일한 1주 1의결권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">배당금</TD>
<TD WIDTH="624" VALIGN="MIDDLE" HEIGHT="30">보통주와 동일한 배당률로 참가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">전환청구기간</TD>
<TD WIDTH="624" VALIGN="MIDDLE" HEIGHT="30">최초발행일 이후 31일이 되는 날부터 10년이 되는 날의 직전영업일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">전환주식수</TD>
<TD WIDTH="624" VALIGN="MIDDLE" HEIGHT="30">우선주 1주당 보통주 1주로 전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="122">전환비율 조정</TD>
<TD WIDTH="624" VALIGN="MIDDLE" HEIGHT="122">- IPO 공모단가의 70%에 해당하는 금액이 본건 우선주식의 전환가격을 하회하는 경우 전환 비율은 다음과 같이 조정&cr;  조정전 전환비율 X (본건의 전환가격 / IPO 공모단가의 70%)&cr;- 주식분할 또는 병합, 전환전에 무상감자를 할경우 전환비율은 분할 또는 병합, 감자의 비율에 따라 조정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="99">전환가격 조정</TD>
<TD WIDTH="624" VALIGN="MIDDLE" HEIGHT="99">- 유상증자 또는 주식관련사채를 본건 우선주식의 전환가격을 하회하는 경우 전환가격은 그 하회하는 발행가격으로 조정&cr;- 합병시 교환비율 산정을 위한 평가가격의 70%에 해당하는 금액이 본건 우선주식의 전환가격을 하회하는 경우 전환가격은 그 하회하는 평가가격의 70%에 해당하는 금액으로 조정</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*) 전기 이전에 주식분할(분할비율 1:10)로 인하여 발행할 주식수 및 행사가격이 조정되었습니다.</SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>(4) 회사는 2017년 11월 18일 참가적ㆍ누적적 상환전환우선주를 발행하였으며, 주요 발행조건은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="769">

<COLGROUP>
<COL WIDTH="125"></COL>
<COL WIDTH="626"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD WIDTH="635" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">내용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">발행주식수</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="30">참가적ㆍ누적적 상환전환우선주 422,535주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">발행가액</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="30">7,100원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">존속기간(*)</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="30">발행일로부터 10년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">의결권</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="30">보통주와 동일한 1주 1의결권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">배당금</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="30">보통주와 동일한 배당률로 참가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">전환기간</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="30">발행일의 익일~발생일로부터 10년 경과하기 전일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">전환주식수</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="30">우선주 1주당 보통주 1주로 전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">우선적권리</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="30">잔여재산분배에 있어 우선권(연 복리 7%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="260">전환비율 조정</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="260">- IPO 공모단가의 70%에 해당하는 금액이 본건 우선주식의 전환가격을 하회하는 경우 전환비율은 다음과 같이 조정&cr;   조정전 우선주 1주당 전환되는 보통주의 수 X (본건의 전환가격 / IPO 공모단가의 70%)&cr;- 주식배당, 무상증자 등으로 인해 발행주식수가 증가하는 경우 주주가 보유한 신주와 같은 조건 및 종류의 주식으로 무상지급받도록 하되 아래 수식을 따른다.&cr;발행 전 본건 종류주식의 주주 보유종류 주식수 x 〔(발행 후 회사 발행주식 총 수 /&cr;발행 전 회사 발행주기 총 수)-1〕, (발행주식 총수는 종류주식과 보통 주의 합)&cr;- 주식분할 또는 병합, 전환전에 무상감자를 할 경우 전환비율은 분할 또는 병합, 감자의 비율에 따라 조정. 경영과실 등의 사유로 특정 주주에 대해서만 차등적으로 무상감자 시 제외&cr;- 후행 투자자의 전환비율이 본건보다 유리할 경우 후행 투자자의 전환비율에 따라 전환비율 조정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="168">전환가격 조정</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="168">- 유상증자 또는 주식관련사채를 본건 우선주식의 전환가격을 하회하는 경우 전환가격은 그 하회하는 발행가격으로 조정. 추후 신주의 인수가격을 하회하는 발행가격으로 부여되는 주식매수선택권은 제외&cr;- 합병시 교환비율 산정을 위한 평가가격의 70%에 해당하는 금액이 본건 우선주식의 전환가격을 하회하는 경우 전환가격은 그 하회하는 평가가격의 70%에 해당하는 금액으로 조정. 회사가 존속법인이 아닌 합병 후 소멸되는 법인인 경우에는 합병 직후 전환가격은 위 전환가격을 합병비율에 상응하게 재조정하여 산출한 가액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">상환기간</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="30">발행로부터 3년이 경과한 날로부터 전환 또는 존속기간까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">상환조건</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="30">배당가능이익 한도내 상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="76">상환금액</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="76">본건 종류주식의 인수단가와 동 금액에 대하여 발행일로부터 상환일까지 연 복리 7%를 적용하여 산출한 이자 금액을 합계액으로 하되 본건 종류주식 발행일로부터 상환일까지 지급된 배당금이 있을 경우 차감하여 계산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="99">기한이익&cr;상실조항</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="99">- 기한 전 상환: 중요자산을 사업목적 외의 용도에 사용하거나 유출시킨 행위를 하는 등 계약에서 정해진 행위를 하는 경우, 특별상환권을 행사할 수 있음. 특별상환청구가 있을 때 회사는투자자에게 투자원금 및 투자원금에 연복리 19%를 가산한 금액에 지급된 배당금을 차감하여 상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">신주인수권</TD>
<TD WIDTH="635" VALIGN="MIDDLE" HEIGHT="30">보통주와 동등한 신주인수권 존재</TD>
</TR>
</TBODY>
</TABLE>

<P>(*) 존속기간 내 보통주로 전환하지 않으면 존속기간만료 다음날 보통주로 자동전환됩니다.
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN>15</SPAN>
<SPAN>. 주식기준보상&cr;&cr;</SPAN>
<SPAN>(1) 주식선택권의 내역&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>회</SPAN>
<SPAN>사는 </SPAN>
<SPAN>임직원 등에게 회사의 주식을 미리 정해진 가격("행사가격")으로 취득할 수 있는 주식선택권</SPAN>
<SPAN>을 부여하였으며,</SPAN>
<SPAN> 보고기간말</SPAN>
<SPAN> 현재 주식기준보상약정과 관련된 주요사항은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="842">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1차</TH>
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2차</TH>
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3차</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">부여시점</TD>
<TD WIDTH="211" HEIGHT="30">2014년 3월 28일</TD>
<TD WIDTH="210" HEIGHT="30">2016년 3월 18일</TD>
<TD WIDTH="210" HEIGHT="30">2018년 11월 13일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="99" VALIGN="MIDDLE">행사가능기간</TD>
<TD WIDTH="211" HEIGHT="99" VALIGN="MIDDLE">부여일로부터 3년이 경과한 날로부터 5년 이내</TD>
<TD WIDTH="210" HEIGHT="99" VALIGN="MIDDLE">부여일로부터 3년이 경과한 날로부터 5년 이내</TD>
<TD WIDTH="210" HEIGHT="99">부여일로부터 3년이 경과한 날로부터 70%, 4년이 경과한날로 부터 30%를 행사권리 시점으로부터 5년 이내</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">발행할 주식수(*)</TD>
<TD WIDTH="211" HEIGHT="30">38,890주</TD>
<TD WIDTH="210" HEIGHT="30">32,000주</TD>
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE">70,939주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">행사가격(*)</TD>
<TD WIDTH="211" HEIGHT="30">1,500원</TD>
<TD WIDTH="210" HEIGHT="30">4,000원</TD>
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE">7,760원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">부여방법</TD>
<TD WIDTH="211" HEIGHT="30">신주발행 교부</TD>
<TD WIDTH="210" HEIGHT="30">신주발행 교부</TD>
<TD WIDTH="210" HEIGHT="30">신주발행 교부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">행사권리시점</TD>
<TD WIDTH="211" HEIGHT="30">2017년 3월 28일</TD>
<TD WIDTH="210" HEIGHT="30">2019년 3월 18일</TD>
<TD WIDTH="210" HEIGHT="30">2021년 11월 13일</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*) 2017년 중 주식분할(분할비율 1:10)로 인하여 발행할 주식수 및 행사가격이 조정되었습니다.&cr;&cr;(2) 주식선택권의 증감내역</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="763">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="127" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="318" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="318" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="159" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식선택권수량(주)</TH>
<TH WIDTH="159" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중평균행사가격(원)</TH>
<TH WIDTH="159" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식선택권수량(주)</TH>
<TH WIDTH="159" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중평균행사가격(원)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" HEIGHT="30" ALIGN="CENTER">기  초 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">74,179</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">7,267</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">106,293 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">6,279</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" HEIGHT="30" ALIGN="CENTER">상  실 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(12,635)</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">7,267</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(8,414)</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">6,279</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" HEIGHT="30" ALIGN="CENTER">행  사 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(23,700)</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">3,188</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" HEIGHT="30" ALIGN="CENTER">기  말 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">61,544</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">7,267</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">74,179 </TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">7,267</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" HEIGHT="55" ALIGN="CENTER">기말 현재&cr;행사가능주식 수</TD>
<TD WIDTH="159" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">16,000</TD>
<TD WIDTH="159" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">4,000</TD>
<TD WIDTH="159" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">16,000</TD>
<TD WIDTH="159" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE">4,000</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(3) 주식선택권(자본조정)의 변동</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="633">

<COLGROUP>
<COL WIDTH="296"></COL>
<COL WIDTH="319"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="31"></TD>
<TD WIDTH="328" HEIGHT="31" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="633">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,243</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,586</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">당기 비용 인식분</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,263</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,521</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">당기 행사분</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,864)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">기말</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,506</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,243</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(4) 공정가치 측정방법&cr;&cr;회사는 부여된 주식선택권에 대해서 공정가치접근법을 적용하여 보상비용을 산정하였으며, 보상원가 산정에 사용된 제반 가정은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="131"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="160" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1차</TH>
<TH WIDTH="159" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2차</TH>
<TH WIDTH="159" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3차</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" HEIGHT="30" VALIGN="MIDDLE">무위험이자율</TD>
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">3.43%</TD>
<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">1.80%</TD>
<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2.17%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" HEIGHT="30" VALIGN="MIDDLE">기대행사기간</TD>
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">취득일로부터 5년</TD>
<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">취득일로부터 5년</TD>
<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">취득일로부터 5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" HEIGHT="30" VALIGN="MIDDLE">기대주가변동성</TD>
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">4.80%</TD>
<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">11.90%</TD>
<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">13.10%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" HEIGHT="30" VALIGN="MIDDLE">공정가액(*)</TD>
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">160.24원</TD>
<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">226.88원</TD>
<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">1,084.54원</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 공정가치 평가결과는 주식선택권 1주 기준입니다.&cr;&cr;(5) 주식기준보상거래의 영향&cr;&cr;주식기준보상으로 인하여 인식된 보상원가는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="633">

<COLGROUP>
<COL WIDTH="296"></COL>
<COL WIDTH="319"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="305" HEIGHT="31"></TD>
<TD WIDTH="328" HEIGHT="31" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="633">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" HEIGHT="31" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="211" HEIGHT="31" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="211" HEIGHT="31" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="31" VALIGN="MIDDLE">총보상원가</TD>
<TD WIDTH="211" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">10,262</TD>
<TD WIDTH="211" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">19,521</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="31" VALIGN="MIDDLE">  제조원가</TD>
<TD WIDTH="211" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">1,655</TD>
<TD WIDTH="211" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">2,388</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="31" VALIGN="MIDDLE">  판매비와관리비(급여)</TD>
<TD WIDTH="211" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">8,607</TD>
<TD WIDTH="211" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">17,133</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="31" VALIGN="MIDDLE">잔여보상원가(주식선택권)</TD>
<TD WIDTH="211" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">16,336</TD>
<TD WIDTH="211" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">45,752</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>상기 보상원가는 모두 자본조정의 주식매입선택권으로 인식하고 있습니다.&cr;&cr;(6) 회사는 2017년 중 코넥스 시장에 상장함에 따라 2017년까지 적용하였던 '중소기업 회계처리 특례' 적용을 중단하고 일반기업회계기준 제19장 '주식기준보상'의 규정을 적용하였습니다.&cr;</P>

<P>
<SPAN>16.</SPAN>
<SPAN> 결</SPAN>
<SPAN>손금&cr;</SPAN>
<SPAN>&cr;(1</SPAN>
<SPAN>) 당</SPAN>
<SPAN>기와 </SPAN>
<SPAN>전기의</SPAN>
<SPAN> 결손금처리계산서의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="709">

<COLGROUP>
<COL WIDTH="296"></COL>
<COL WIDTH="395"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="31"></TD>
<TD WIDTH="404" HEIGHT="31" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="709">

<COLGROUP>
<COL WIDTH="210"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="219" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">과목</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="246" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 17(당)기</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="244" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">제 16(전)기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="246" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN>(처리예정일 2021년 3월 </SPAN>
<SPAN>29</SPAN>
<SPAN>일)</SPAN>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="244" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN>(처리</SPAN>
<SPAN>확</SPAN>
<SPAN>정</SPAN>
<SPAN>일 2020년 3월 30일)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">I.  미처리결손금</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,004,324</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,166,090</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">1. 전기이월미처리결손금</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,166,090</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,050,997</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">2. 당기순손실</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,838,234</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,115,092</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">II. 결손금처리액</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">III. 차기이월미처리결손금</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,004,324</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>

<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN>6,166,090</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>17. 매출액&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>회사는 (주)솔루스 첨단소재에서 원재료를 유상사급방식으로 매입하여 가공 후 공급하고 있으므로 유상사급에 의한 원재료 매입액을 매출액과 매출원가에서 각각 차감하여 표시하고 있습니다. 당기와 전기  </SPAN>
<SPAN>관련</SPAN>
<SPAN> 매출액 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="296"></COL>
<COL WIDTH="286"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="31"></TD>
<TD WIDTH="295" HEIGHT="31" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="159"></COL>
<COL WIDTH="207"></COL>
<COL WIDTH="207"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" USERMARK=" BC0XD7D7D7">구   분</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30" USERMARK=" BC0XD7D7D7">당   기</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30" USERMARK=" BC0XD7D7D7">전    기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">총 매출액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30">190,685</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30">532,725</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">유상사급 차감</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30">(102,506)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30">(292,378)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">순 매출액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30">88,179</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30">240,347</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN>18</SPAN>
<SPAN>. </SPAN>
<SPAN>부가</SPAN>
<SPAN>가치 관련자료&cr;</SPAN>
</P>
<P>당기 및 전기 중 매출원가 또는 판매비와 관리비에 포함된 부가가치계산에 필요한 자료는 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="296"></COL>
<COL WIDTH="286"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="31"></TD>
<TD WIDTH="295" HEIGHT="31" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="871">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">계 정 과 목</TD>
<TD COLSPAN="4" WIDTH="376" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당  기</TD>
<TD COLSPAN="4" WIDTH="372" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전  기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">판매&cr;관리비</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">경상연구&cr;개발비</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">매출원가 및&cr;조업도손실</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">합계</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">판매&cr;관리비</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">경상연구&cr;개발비</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">매출원가 및&cr;조업도손실</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">합계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">급여</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">359,006</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">374,837</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">81,421</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">815,264</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">169,147</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">541,493</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">98,628</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">809,268</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,704</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,240</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,563</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">59,507</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,348</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,495</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">238</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN>83,081</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">복리후생비</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,500</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,470</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,653</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,623</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,686</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,578</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,323</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,587</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">감가상각비</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,773</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">103,583</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,011</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">175,367</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,550</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">110,984</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,820</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">173,354</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">370</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,454</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,824</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">411</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,041</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,452</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">지급임차료</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31,628</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,131</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,500</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,259</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,090</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,190</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35,200</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">114,480</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">세금과공과</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">388</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">451</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">742</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">135</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">877</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">416,369</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">557,261</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">226,665</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,224,728</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">218,974</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN>790,740</SPAN>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">222,385</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,232,099</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>19</SPAN>
<SPAN>. 포괄손익계산서</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="640" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="631"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" WIDTH="640" HEIGHT="33">
<SPAN>(단위: 천원</SPAN>
<SPAN>)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="639">

<COLGROUP>
<COL WIDTH="307"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="316" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구  분</TH>
<TH WIDTH="162" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">당기</TH>
<TH WIDTH="161" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="316" HEIGHT="30">
<SPAN>당기순</SPAN>
<SPAN>손실</SPAN>
</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">1,838,234</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">1,115,092</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30">기타포괄손익: </TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="316" HEIGHT="30">
<SPAN>포괄</SPAN>
<SPAN>손실</SPAN>
</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">1,838,234</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">1,115,092</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>20</SPAN>
<SPAN>. 주당손실&cr;&cr;회사의 주당손익은 보통주 1주에 대한 이익을 계산한 것으로 그 내역은 다음과 같습니다.&cr;&cr;(1) 기본주당손실</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="699">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="229"></COL>
<COL WIDTH="229"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD WIDTH="238" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당 기</TD>
<TD WIDTH="238" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">보통주당기순손실</TD>
<TD WIDTH="238" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,838,233,890원</TD>

<TD WIDTH="238" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN>1,115,092,350</SPAN>
<SPAN>원</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">가중평균유통보통주식수(*)</TD>
<TD WIDTH="238" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,634,890주</TD>
<TD WIDTH="238" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,616,638주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">주당손실</TD>
<TD WIDTH="238" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">698원</TD>

<TD WIDTH="238" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN>426</SPAN>
<SPAN>원</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 가중평균유통보통주식수&cr;&cr;- 당기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="710">

<COLGROUP>
<COL WIDTH="189"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주식수</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">일 수</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">적 수</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">가중평균주식수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.01.01~2020.12.31</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,634,890주</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">365일</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">961,734,850</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,634,890주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">365일</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">961,734,850</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,634,890주</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;- 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="714">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주식수</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">일 수</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">적 수</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">가중평균주식수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.01.01~2019.05.20</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,611,190주</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">140일</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">365,566,600</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,001,552주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.05.21~2019.12.15</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,618,890주</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">209일</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">547,348,010</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,499,584주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.12.16~2019.12.31</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,634,890주</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16일</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,158,240</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">115,502주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">365일</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">955,072,850</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,616,638주</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(2) 희석주당손실&cr;&cr;회사가 발행한 상환전환우선주 및 전환우선주, 주식매수선택권의 희석효과는 없으며, 당기 및 전기 희석주당순손실은 반희석효과로 기본주당순손실과 일치합니다.</SPAN>
</P>
<P></P>

<P>
<SPAN>21</SPAN>
<SPAN>. </SPAN>
<SPAN>현금 유ㆍ출입이 없는 중요한 거래</SPAN>
<SPAN>&cr;</SPAN>
</P>

<P>
<SPAN>당기와 전기의 투자와 재무활동 중 현금의 유입과 유출이 없는 중요한 거래내역은 &cr;다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="632">

<COLGROUP>
<COL WIDTH="287"></COL>
<COL WIDTH="327"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="296" HEIGHT="30"></TD>
<TD WIDTH="336" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE AFIXTABLE="N" WIDTH="632" BORDER="1" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="185"></COL>
<COL WIDTH="185"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="244" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내   역</TH>
<TH ALIGN="CENTER" WIDTH="194" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당   기 </TH>
<TH ALIGN="CENTER" WIDTH="194" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전   기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">건설중인무형자산의 본계정 대체</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">26,245</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">11,957</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">장기미지급금의 유동성 대체</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">118,335</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">주식선택권 자본전환</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">4,864</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">퇴직급여충당부채의 미지급금 전환</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">5,185</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">임차개량자산과 복구충당부채 계상</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="194" HEIGHT="30" ALIGN="RIGHT">24,044</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>22</SPAN>
<SPAN>. 특수관계자간 거래&cr;&cr;(1) 보고기간말 현재 회사의 특수관계자 현황은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="660">

<COLGROUP>
<COL WIDTH="187"></COL>
<COL WIDTH="183"></COL>
<COL WIDTH="182"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="196" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="192" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="191" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
<TH WIDTH="81" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">최상위지배자</TD>
<TD WIDTH="192" HEIGHT="30" VALIGN="MIDDLE">김갑식</TD>
<TD WIDTH="191" HEIGHT="30" VALIGN="MIDDLE">김갑식</TD>
<TD WIDTH="81" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="106" ROWSPAN="2" VALIGN="MIDDLE">기타특수관계자</TD>
<TD WIDTH="192" HEIGHT="53" VALIGN="MIDDLE">한국투자글로벌제약산업육성사모투자전문회사</TD>

<TD WIDTH="191" HEIGHT="53" VALIGN="MIDDLE" USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">한국투자글로벌제약산업육성사모투자전문회사</SPAN>
</TD>
<TD WIDTH="81" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">(*)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" HEIGHT="53" VALIGN="MIDDLE">프리미어글로벌이노베이션1호 투자조합</TD>
<TD WIDTH="191" HEIGHT="53" VALIGN="MIDDLE">프리미어글로벌이노베이션1호 투자조합</TD>
<TD WIDTH="81" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">(*)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*) 전환우선주 및 상환전환우선주 투자계약상 임원선임권과 주요경영사항에 대한 사전 동의 등의 권리를 보유하고 있습니다.&cr;</SPAN>
<SPAN>&cr;(2) 당기와 전기 중 특수관계자와의 중요한 매출 및 매입 등의 거래 내역은 없으며, 보고기간말 현재 특수관계자에 대한 중요한 채권,채무 내역은 없습니다.&cr;&cr;(3) 당기와 전기 중 특수관계자와의 자금거래 내역은 없습니다.&cr;&cr;(4) 당기말 현재 당사가 특수관계자의 자금조달 등을 위하여 제공하고 있거나 특수관계자로부터 제공받은 보증 및 담보의 내역은 없습니다.&cr;&cr;(5) 회사는 기업 활동의 계획ㆍ운영ㆍ통제에 대하여 중요한 권한과 책임을 가진 등기임원, 비등기임원을 주요 경영진으로 판단하였으며, 당기와 전기 중 주요 경영진에 대한 보상을 위해 지급한 금액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="33">
<SPAN>(단위: 천원</SPAN>
<SPAN>)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="200" HEIGHT="33" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구  분</TH>
<TH WIDTH="200" HEIGHT="33" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="200" HEIGHT="33" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31">단기종업원급여</TD>
<TD WIDTH="200" HEIGHT="31" ALIGN="RIGHT">301,643</TD>
<TD WIDTH="200" HEIGHT="31" ALIGN="RIGHT">300,964</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31">퇴직급여 </TD>
<TD WIDTH="200" HEIGHT="31" ALIGN="RIGHT">28,809</TD>
<TD WIDTH="200" HEIGHT="31" ALIGN="RIGHT">30,802</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="31">주식기준보상</TD>
<TD WIDTH="200" HEIGHT="31" ALIGN="RIGHT">-</TD>
<TD WIDTH="200" HEIGHT="31" ALIGN="RIGHT">605</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">330,452</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">332,371</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>23</SPAN>
<SPAN>. 타인으로부터 제공받은 보증&cr;&cr;당기말 현재 회사는 타인으로부터 제공받은 지급보증은 없습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>24</SPAN>
<SPAN>. 우발부채와 주요 약정사항&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(1) 주식회사 대웅제약&cr;회사는 회사가 보유한 아프리피탄트(Aprepitant) 가용화 기술을 적용하여 주식회사 대웅제약과 공동연구를 진행하고 향후 기술이전 및 상업화에 대한 권리를 이전하는 계약을 2013년 11월 1일자로 체결하였습니다. 회사는 제공한 아프리피탄트 가용화 기술에 대한 보상으로 향후 개발단계에 따라 기술료 및 상업화에 따른 로열티를 수령하기로 하였습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(2) 주식회사 삼양바이오팜 &cr;</SPAN>
<SPAN></SPAN>
<SPAN>회사는 회사가 보유한 나노 분말화 기술을 이용하여 용법 및 용량이 개선된 표적항암제 개발 기술이전계약을 주식회사 삼양바이오팜과 2017년 12월 15일자로 체결하였습니다. 회사는 상기의 기술이전계약에 대하여 계약에 따른 지급기준에 따라 기술이전기간동안 기간 상각하여 용역매출로 인식하였습니다. &cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>한편, 회사는 주석 9에서 설명하고 있는 정부과제에 대하여 주식회사 삼양팜비오를 참여기관으로 하여 수행하고 있었으나, 2019년 12월 17일자로 사업화(품목허가) 시기가 지연되는 등 </SPAN>
<SPAN>사업화 가능성이 낮으므로 차년도 계속 수행의 필요성이 적어 2019년 12월 17일 조기종료(성실 수행)되었으며</SPAN>
<SPAN>, 동 과제와 관련하여 주식회사 삼양에서 제시한 조건을 미충족한 근거로 상기 기술이전계약이 해지되었습니다.</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(3) 솔루스 첨단소재 주식회사&cr;</SPAN>
<SPAN></SPAN>
<SPAN>회사는 (주)솔루스 첨단소재와 2011년 11월 28일자로 공동연구개발 및 사업화 계약서를 체결하였습니다. 동계약에 따라 회사는 (주)솔루스 첨단소재가 공급한 세라마이드를 주원료로 하여 생산한 하이드로세라마이드를 (주)솔루스 첨단소재에 독점공급하고 있습니다.</SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>25</SPAN>
<SPAN>. 영업의 집중&cr;&cr;당기 및 전기 중 외부 고객 (주)솔루스 첨단소재에 대한 매출액은 </SPAN>
<SPAN>당기 </SPAN>
<SPAN> 88,179천원(총매출의 41.4%), 전기</SPAN>
<SPAN> 240,347</SPAN>
<SPAN>천원(총매출의 63.5%)</SPAN>
<SPAN> 입니다.</SPAN>
<SPAN></SPAN>
<SPAN>이처럼 회사의 영업은동 회사와의 영업관계에 중요하게 의존하고 있으며, 회사의 재무제표는 이러한 영업관계가 당분간 계속될 것이라는 가정하에 작성된 것입니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>26.</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>보고기간 후 사건&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>회사의 재무제표는 2021년 2월 3일자 이사회에서 사실상 확정되었으며, </SPAN>
<SPAN>2021년 3월</SPAN>
<SPAN>29</SPAN>
<SPAN>일자</SPAN>
<SPAN> 주주총회에서 최종 승인</SPAN>
<SPAN>될 예정입니다.</SPAN>
</P>
<PGBRK></PGBRK>
<P></P>
<P></P>
</SECTION-2>
</LIBRARY>
</INSERTION>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0">6. 기타 재무에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 대손충당금 설정현황&cr;</SPAN>
<SPAN>해당사항 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">나. 재고자산 현황 등&cr;&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">(1) 재고자산의 보유현황&cr;</SPAN>
<SPAN USERMARK=" B">                                                                          </SPAN>
<SPAN>              (단위: 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="719">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="136" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">사업부문</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="152" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">계정과목</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="113" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">제17기</TD>
<TD WIDTH="113" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12 BC0XD7D7D7 B">제16기</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="113" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">제15기</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="92" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="93" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">의학 및 약학&cr;연구개발업</TD>
<TD WIDTH="152" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">제품</TD>
<TD WIDTH="113" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">80,236</TD>
<TD WIDTH="113" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">76,768</TD>
<TD WIDTH="113" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">49,024</TD>
<TD WIDTH="92" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">원재료</TD>
<TD WIDTH="113" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">10,296</TD>
<TD WIDTH="113" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">11,735</TD>
<TD WIDTH="113" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">7,970</TD>
<TD WIDTH="92" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">합계</TD>
<TD WIDTH="113" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">96,532</TD>
<TD WIDTH="113" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">88,503</TD>
<TD WIDTH="113" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">56,994</TD>
<TD WIDTH="92" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="55" COLSPAN="2" USERMARK="F-BT12">총자산대비 재고자산  구성비율(%)&cr;[재고자산합계÷기말자산총계×100]</TD>
<TD WIDTH="113" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">4.54%</TD>
<TD WIDTH="113" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">2.49%</TD>
<TD WIDTH="113" HEIGHT="55" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1.28%</TD>
<TD WIDTH="92" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="79" COLSPAN="2" USERMARK="F-BT12">재고자산회전율(회수)&cr;[연환산 매출원가÷&cr;{(기초재고+기말재고)÷2}]</TD>
<TD WIDTH="113" HEIGHT="79" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1.89</TD>
<TD WIDTH="113" HEIGHT="79" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">3.84</TD>
<TD WIDTH="113" HEIGHT="79" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">2.97</TD>
<TD WIDTH="92" HEIGHT="79" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">(2) 재고자산의 실사내용&cr;</SPAN>
<SPAN>1) 2020년 재고자산 실사 : 2021년 1월 4일&cr;2) 2019년 재고자산 실사 : 2019년 12월 31일&cr;3) 2018년 재고자산 실사 : 2019년 1월 4일</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN USERMARK=" B">다. 채무증권 발행실적 등 &cr;</SPAN>
<SPAN>해당사항 없습니다.</SPAN>
</P>

<INSERTION ABASISNUMBER="SE2" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『진행률적용 수주계약 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*진행률적용수주계약현황*.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N">채무증권 발행실적</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="747" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="445"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="454" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="1">(단위 : 원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="748" BORDER="1">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="67"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="80" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="73" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">평가등급&cr;(평가기관)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상환&cr;여부</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">-</TE>
<TU WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="-">-</TU>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="-">-</TU>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">-</TE>
<TU WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="-">-</TU>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="-">-</TU>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MONT">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『사채관리계약 주요내용 및 충족여부 등』 삽입</COMMENT>
<LIBRARYLIST>11011#*사채관리계약주요내용.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N">기업어음증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N">단기사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N">회사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="762" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="465" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="761" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N">신종자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="757" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="460" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="758" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;15년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과&cr;20년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N">조건부자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0">IV. 이사의 경영진단 및 분석의견</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">1. 예측정보에 대한 주의사항&cr;</SPAN>
<SPAN>&cr;- 당사가 동 사업보고서에서 미래에 발생할 것으로 예상ㆍ예측한 활동, 사건 또는 현상은, 당해 공시서류 작성시점의 사건 및 재무성과에 대하여 회사의 견해를 반영한 것입니다. 동 예측정보는 미래 사업환경과 관련된 다양한 가정에 기초하고 있으며, 동 가정들은 결과적으로 부정확한 것으로 판명될 수도 있습니다. 또한, 이러한 가정들에는 예측정보에서 기재한 예상치와 실제 결과 간에 중요한 차이를 초래할 수 있는 위험, 불확실성 및 기타 요인을 포함하고 있습니다. 이러한 중요한 차이를 초래할 수 있는 요인에는 회사 내부경영과 관련되 요인과 외부환경에 관한 요인이 포함되어 있으며, 이에 한하지 않습니다. 당사는 동 예측정보 작성시점 이후에 발생하는 위험 또는 불확실성을 반영하기 위하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할 의무는 없습니다. 결론적으로, 동 사업보고서상에, 회사가 예상한 결과 또는 사항이 실현되거나 회사가 당초에 예상한 영향이 발생한다는 확신을 제공할 수 없습니다. 동 보고서에 기재된 예측정보는 동 보고서 작성시점을 기준으로 작성한 것이며, 회사가 이러한 위험요인이나 예측정보를 업데이트할 예정이 없음을 유의하시기 바랍니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">2. 개요&cr;</SPAN>
<SPAN>&cr;주식회사 바이오시네틱스이사회는 2020년 01월 01일부터 2020년 12월 31일까지 제17기 사업연도의 회계 및 업무에 대한 경영진단을 실시하여 다음과 같이 진단한 의견을 제출합니다.회사의 경영에 대한 전반적인 사항을 파악하기 위하여 장부와 관계서류를 열람하고 재무제표 및 동 부속명세서에 대해서도 면밀히 검토하였습니다.경영진단을 위하여 필요하다고 인정되는 서류에 대한 보고를 받았으며 중요한 업무에 관한 서류를 열람하고 그내용을 면밀히 검토하는 등 적정한 방법을 사용하여 회사경영에 대한 내용을 파악하였습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">3. 재무상태 및 영업실적&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">가. 영업실적</SPAN>
<SPAN>                                                                                                                                                                                                       (단위 : 백만원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="667" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="211"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">구 분</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">제17기&cr;(2020년)</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">제16기&cr;(2019년)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">증감</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">증감율(%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">매출액 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">229</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">379</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(150)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(39.58%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">매출원가 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">175</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">279</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(104)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(37.28%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">매출총이익 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">54</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">99</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(45)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(45.45%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">판매비와관리비 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,332</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,244</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">88</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">7.07%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">영업이익(손실) </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(1,278)</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(1,145)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(133)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">11.62%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">기타수익</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">0.08</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">0.07</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">0.01</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">14.29%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">기타비용</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">131</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">28</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">103</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">367.86%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">금융수익 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">16</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">58</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(42)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(72.41%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">금융비용 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">0.45</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">0.3</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(0.15)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">50.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-BT12">법인세비용차감전&cr;계속영업이익(손실)</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-BT12">(1,838)</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-BT12">(1,115)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-BT12">(723)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="55" USERMARK="F-BT12">64.84%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">계속영업법인세비용(수익)</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">당기순이익(손실)</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(1,838)</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(1,115)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(723)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">64.84%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">나. 재무상태&cr;</SPAN>
<SPAN>                                                                                                   (단위 : 백만원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="611" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="168"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">구분</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">제17기&cr;(2020년)</TD>

<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">
<SPAN>제16기&cr;(2019년)</SPAN>
</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">증감</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12">자산</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12"></TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12"></TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12">유동자산</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,306</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">2,547</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(1,241)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12">비유동자산</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">400</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,010</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(610)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12 B">자산총계</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,706</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">3,557</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(1,851)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12">부채</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12"></TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12"></TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12">유동부채</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">185</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">231</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(46)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12">비유동부채</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">395</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">372</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12 B">부채총계</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">580</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">603</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(23)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12">자본</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12"></TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12"></TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12">자본금</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,787</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,787</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12">자본잉여금</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">7,306</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">7,306</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12">자본조정</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">37</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">26</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12">이익잉여금</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(8,004)</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(6,166)</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(1,838)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12 B">자본총계</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,126</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">2,954</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(1,828)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="31" USERMARK="F-BT12 B">부채 및 자본총계</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,706</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">3,557</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(1,851)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">4. 유동성 및 자금조달과 지출&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">가. 유동성&cr;</SPAN>
<SPAN>최근 2개 사업연도 동안 당사의 현금흐름은 아래와 같습니다. &cr;                                                                                         </SPAN>
<SPAN>         (단위 : 백만원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="630" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="210"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">구 분</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">제17기</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">제16기</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">증감액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="31" USERMARK="F-BT12">영업활동으로 인한 현금흐름</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(967)</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(1,033)</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">66</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="31" USERMARK="F-BT12">투자활동으로 인한 현금흐름</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">962</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">843</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">119</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="31" USERMARK="F-BT12">재무활동으로 인한 현금흐름</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">107</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="31" USERMARK="F-BT12">기초의 현금</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,104</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,187</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(83)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="31" USERMARK="F-BT12">기말의 현금</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,099</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">1,104</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(5)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;- 자금 지출과 관련하여 현재 1년 이내 지출이 확정된 중요한 사안은 없으며, 추후 일정 규모를 초과하는 자금 지출에 대한 결정이 있을 경우 공시 등을 통해 공표될 예정입니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">나. 자금조달&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">1) 단기차입금&cr;</SPAN>
<SPAN>해당사항 없습니다.</SPAN>
</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">2) 장기차입금의 내역&cr;</SPAN>
<SPAN> 해당사항 없습니다.</SPAN>
</P>
<P>  </P>

<P>
<SPAN USERMARK=" B">3) 사채의 내역   </SPAN>
<SPAN>&cr;해당사항 없습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">4) 신주인수권부사채의 내역&cr;</SPAN>
<SPAN>해당사항 없습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">5. 부외거래&cr;</SPAN>
<SPAN>해당사항 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">6. 그 밖에 투자의사결정에 필요한 사항&cr;</SPAN>
<SPAN>- 당사는 최근 당사가 영위하는 각 사업부분의 전방시장의 활발한 개발계획과 수주 규모의 확대 등에 적극적으로 참여 및 대응하기 위하여 수주 상황에 따른 R&D 투자 계획 수립과 우수한 인력의 채용 및 영입을 위한 전략을 수립하고 있습니다.</SPAN>
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0">V. 감사인의 감사의견 등</TITLE>
<P></P>
<WARNING>※ 회계감사인의 감사(검토)의견, 회계감사인과의 감사/비감사 용역 체결현황이 있을 경우&cr;    아래 『회계감사인의 감사의견』단위서식을 클릭하여 삽입하신 후 입력하세요.</WARNING>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『회계감사인의 감사의견』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인의감사의견.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">25_회계감사인의감사의견</FILENAME>

<P USERMARK=" 0X0000FF B">
<SPAN USERMARK=" 0X000000">1. </SPAN>
<SPAN USERMARK=" 0X000000">회계감사인의 명칭 및 감사의견</SPAN>
</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="743" BORDER="1">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="256"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="265" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="149" HEIGHT="31" ACODE="OPN_YEAR1" VALIGN="MIDDLE" USERMARK="F-BT12">제17기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="31" ACODE="OPN_AUR1" VALIGN="MIDDLE" USERMARK="F-BT12">성현회계법인</TE>
<TE ALIGN="CENTER" WIDTH="114" HEIGHT="31" ACODE="OPN_CMT1" VALIGN="MIDDLE" USERMARK="F-BT12">적정</TE>
<TE WIDTH="265" HEIGHT="31" ACODE="OPN_EMP1" VALIGN="MIDDLE" USERMARK="F-BT12" ALIGN="CENTER">-</TE>
<TE ALIGN="CENTER" WIDTH="102" HEIGHT="31" ACODE="OPN_POT1" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="149" HEIGHT="103" ACODE="OPN_YEAR2" VALIGN="MIDDLE" USERMARK="F-BT12">제16기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="103" ACODE="OPN_AUR2" VALIGN="MIDDLE" USERMARK="F-BT12">태성회계법인</TE>
<TE ALIGN="CENTER" WIDTH="114" HEIGHT="103" ACODE="OPN_CMT2" VALIGN="MIDDLE" USERMARK="F-BT12">적정</TE>
<TE WIDTH="265" HEIGHT="103" ACODE="OPN_EMP2" USERMARK="F-BT12">감사의견에 영향을 미치지 않는 사항으로서 이용자는 회사의 재무제표에 대한 주석27에 주의를 기울여야 할 필요가 있습니다.</TE>
<TE ALIGN="CENTER" WIDTH="102" HEIGHT="103" ACODE="OPN_POT2" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="149" HEIGHT="31" ACODE="OPN_YEAR3" VALIGN="MIDDLE" USERMARK="F-BT12">제15기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="31" ACODE="OPN_AUR3" VALIGN="MIDDLE" USERMARK="F-BT12">태성회계법인</TE>
<TE ALIGN="CENTER" WIDTH="114" HEIGHT="31" ACODE="OPN_CMT3" VALIGN="MIDDLE" USERMARK="F-BT12">적정</TE>
<TE ALIGN="CENTER" WIDTH="265" HEIGHT="31" ACODE="OPN_EMP3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="102" HEIGHT="31" ACODE="OPN_POT3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">주1. 주석 27) </SPAN>
<SPAN USERMARK=" 0X000000">오류수정&cr;회사는 전기 재무상태표 상 아래의 오류로 인한 재무제표의 영향이 중대하다고 판단하였으며, 비교표시된 전년도 재무제표는 이러한 수정사항을 반영하여 재작성된 것입니다. 이러한 수정사항은 전기에 보고된 순이이익이나 순자산가액에 영향을 미치지 아니합니다.&cr;&cr;회사의 제15기오류수정손익의 내역은 다음과 같습니다&cr;                                                                                                       (단위: 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1006">

<COLGROUP>
<COL WIDTH="172"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="181" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">구분</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="104" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자산(유동)</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="115" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자산(비유동)</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="76" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">부채 </P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="90" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">자본 </P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="104" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">  매출  </P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="114" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">  매출원가   </P>
</TD>
<TD WIDTH="97" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12 BC0XD7D7D7 B">판매관리비</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="125" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">  당기순이익  </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">수정 전</P>
</TD>
<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">3,637,594</TD>
<TD WIDTH="115" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">805,857</TD>
<TD WIDTH="76" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">469,070</TD>
<TD WIDTH="90" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">3,974,381</TD>
<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">428,196</TD>
<TD WIDTH="114" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">340,261</TD>
<TD WIDTH="97" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,177,297</TD>
<TD WIDTH="125" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(1,045,592)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">오류 수정 효과:</P>
</TD>
<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="115" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="76" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="90" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="114" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="97" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
<TD WIDTH="125" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">건설중인무형자산(*1)</P>
</TD>
<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(222,057)</TD>

<TD WIDTH="115" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">222,057</P>
</TD>

<TD WIDTH="76" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="90" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="114" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>
<TD WIDTH="97" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>

<TD WIDTH="125" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">매출액(*2) </P>
</TD>

<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="115" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="76" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="90" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">(202,979)</P>
</TD>

<TD WIDTH="114" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">(202,979)</P>
</TD>
<TD WIDTH="97" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>

<TD WIDTH="125" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="31" VALIGN="MIDDLE" USERMARK="F-BT12">기타매출원가(*3)</TD>
<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="115" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="76" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="90" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
<TD WIDTH="114" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">15,764</TD>
<TD WIDTH="97" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(15,764)</TD>
<TD WIDTH="125" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">수정액 합계 </P>
</TD>

<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">  (222,057)</P>
</TD>

<TD WIDTH="115" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">222,057</P>
</TD>

<TD WIDTH="76" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="90" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">-</P>
</TD>

<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">  (202,979)</P>
</TD>

<TD WIDTH="114" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-BT12">  (187,215)</P>
</TD>
<TD WIDTH="97" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(15,764)</TD>
<TD WIDTH="125" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" HEIGHT="31" VALIGN="MIDDLE">
<P USERMARK="F-BT12">수정 후</P>
</TD>
<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">3,415,537</TD>
<TD WIDTH="115" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,027,914</TD>
<TD WIDTH="76" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">469,070</TD>
<TD WIDTH="90" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">3,974,381</TD>
<TD WIDTH="104" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">225,217</TD>
<TD WIDTH="114" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">153,046</TD>
<TD WIDTH="97" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">1,161,533</TD>
<TD WIDTH="125" HEIGHT="31" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT12">(1,045,592)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*1) 출원중인 특허권의 선급금과 건설중인무형자산 계정재분류 오류&cr;(*2) 유상사급 회계처리 및 매출액의 총액회계처리 오류&cr;(*3) 판매비와관리비와 용역매출원가 계정재분류 오류&cr;</SPAN>
</P>
<P USERMARK=" B">2. 감사용역 체결현황</P>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="186"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="195" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="194" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="192" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="117" HEIGHT="55" ACODE="SIGK_YEAR1" VALIGN="MIDDLE" USERMARK="F-BT12">제17기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="122" HEIGHT="55" ACODE="SIGK_AUR1" VALIGN="MIDDLE" USERMARK="F-BT12">성현회계법인</TE>
<TE ALIGN="CENTER" WIDTH="195" HEIGHT="55" ACODE="SIGK_CNT1" VALIGN="MIDDLE" USERMARK="F-BT12">재무제표의 검토 및 감사&cr;(중간/기말감사)</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="55" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">37,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="55" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">321</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="55" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">37,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="55" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">321</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="117" HEIGHT="55" ACODE="SIGK_YEAR2" VALIGN="MIDDLE" USERMARK="F-BT12">제16기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="122" HEIGHT="55" ACODE="SIGK_AUR2" VALIGN="MIDDLE" USERMARK="F-BT12">태성회계법인</TE>
<TE ALIGN="CENTER" WIDTH="195" HEIGHT="55" ACODE="SIGK_CNT2" VALIGN="MIDDLE" USERMARK="F-BT12">재무제표의 검토 및 감사&cr;(중간/기말감사)</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="55" ACODE="SIGK_CPAY2" VALIGN="MIDDLE">19,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="55" ACODE="SIGK_CTIM2" VALIGN="MIDDLE">208</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="55" ACODE="SIGK_FPAY2" VALIGN="MIDDLE">19,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="55" ACODE="SIGK_FTIM2" VALIGN="MIDDLE">208</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="117" HEIGHT="55" ACODE="SIGK_YEAR3" VALIGN="MIDDLE" USERMARK="F-BT12">제15기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="122" HEIGHT="55" ACODE="SIGK_AUR3" VALIGN="MIDDLE" USERMARK="F-BT12">태성회계법인</TE>
<TE ALIGN="CENTER" WIDTH="195" HEIGHT="55" ACODE="SIGK_CNT3" VALIGN="MIDDLE" USERMARK="F-BT12">재무제표의 검토 및 감사&cr;(중간/기말감사)</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="55" ACODE="SIGK_CPAY3" VALIGN="MIDDLE">16,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="55" ACODE="SIGK_CTIM3" VALIGN="MIDDLE">172</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="55" ACODE="SIGK_FPAY3" VALIGN="MIDDLE">16,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="96" HEIGHT="55" ACODE="SIGK_FTIM3" VALIGN="MIDDLE">172</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">3. 회계감사인과의 비감사용역 계약체결 현황</P>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="741" BORDER="1">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="182" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="193" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="129" HEIGHT="33" ACODE="SIGL_YEAR1" VALIGN="MIDDLE" USERMARK="F-BT12">제17기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="99" HEIGHT="33" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="182" HEIGHT="33" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="193" HEIGHT="33" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="33" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="33" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="129" HEIGHT="31" ACODE="SIGL_YEAR2" VALIGN="MIDDLE" USERMARK="F-BT12">제16기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="99" HEIGHT="31" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="182" HEIGHT="31" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="193" HEIGHT="31" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="31" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="31" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="129" HEIGHT="31" ACODE="SIGL_YEAR3" VALIGN="MIDDLE" USERMARK="F-BT12">제15기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="99" HEIGHT="31" ACODE="SIGL_CRT3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="182" HEIGHT="31" ACODE="SIGL_CNT3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="193" HEIGHT="31" ACODE="SIGL_TIM3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="31" ACODE="SIGL_PAY3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="31" ACODE="SIGL_NOTE3" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<P>
<SPAN USERMARK=" B">4. 내부회계관리제도&cr;</SPAN>당사의 회계감사인은 2020년(제17기) 내부회계관리제도 운영실태보고서를 검토한 결과, 운영실태보고 내용이 중요성의 관점에서 내부회계관리제도 모범규준의 규정에 따라 작성되지 않았다고 판단하게 하는 점이 발견되지 아니하였다고 의견을 표명하였습니다. &cr;
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『내부감사기구가 회계감사인과 논의한 결과』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인과논의한결과.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">46_회계감사인과논의한결과</FILENAME>

<P>
<SPAN USERMARK=" B">4. </SPAN>
<SPAN USERMARK=" B">내부감사기구가 회계감사인과 논의한 결과</SPAN>
</P>

<TABLE-GROUP ACLASS="DIS_CUS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="775" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="324"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">참석자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">방식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="333" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요 논의 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="91" ACODE="DIS_DIV" VALIGN="MIDDLE" USERMARK="F-BT12">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="91" AUNIT="DIS_DATE" AUNITVALUE="20201127" VALIGN="MIDDLE">2020년 11월 27일</TU>

<TE ALIGN="CENTER" WIDTH="169" HEIGHT="91" ACODE="DIS_ATT" VALIGN="MIDDLE" USERMARK="F-BT12">
<P>회사측 : 감사</P>
<P>감사인 : 업무수행이사 외 1명</P>
</TE>
<TE ALIGN="CENTER" WIDTH="88" HEIGHT="91" ACODE="DIS_WAY" VALIGN="MIDDLE" USERMARK="F-BT12">서면보고</TE>
<TE WIDTH="333" HEIGHT="91" ACODE="DIS_CONT" VALIGN="MIDDLE" USERMARK="F-BT12">감사팀 구성,  경영진 및 감사인의 책임, 감사인의 독립성 등</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="91" ACODE="DIS_DIV" VALIGN="MIDDLE" USERMARK="F-BT12">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="91" AUNIT="DIS_DATE" AUNITVALUE="20210316" VALIGN="MIDDLE">2021년 03월 16일</TU>

<TE ALIGN="CENTER" WIDTH="169" HEIGHT="91" ACODE="DIS_ATT" VALIGN="MIDDLE" USERMARK="F-BT12">
<P>회사측 : 감사</P>
<P>감사인 : 업무수행이사 외 1명</P>
</TE>
<TE ALIGN="CENTER" WIDTH="88" HEIGHT="91" ACODE="DIS_WAY" VALIGN="MIDDLE" USERMARK="F-BT12">서면보고</TE>
<TE WIDTH="333" HEIGHT="91" ACODE="DIS_CONT" VALIGN="MIDDLE" USERMARK="F-BT12">감사에서의 유의적 발견사항, 유의적 내부통제의 미비점, 감사인의 독립성 등</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『조정협의회내용 및 재무제표 불일치정보』 삽입</COMMENT>
<LIBRARYLIST>11011#*조정협의회내용및재무제표불일치정보.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0">1. 이사회에 관한 사항</TITLE>
<P></P>
<P>사외이사 및 그 변동현황</P>

<TABLE-GROUP ACLASS="OUT_DIR" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">이사의 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="340" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">사외이사 변동현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">중도퇴임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="130" HEIGHT="30" ACODE="DIR_NUM" VALIGN="MIDDLE">5</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="ODIR_NUM" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_PRE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_DIS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="ODIR_RET" VALIGN="MIDDLE">1</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1. 2020년 5월 21일 사외이사 김코리후제이가 중도퇴임하였습니다.</P>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『사외이사 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_사외이사_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">40_02_사외이사_교육_미실시내역</FILENAME>
<P USERMARK=" B">마. 사외이사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ODRT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" HEIGHT="127" ACODE="ODRT_EDU_NOT_DTL" USERMARK="F-BT12">이사회 개최 전 안건 내용을 충분히 검토할 수 있도록 사전에 자료를 제공하며, 사내 주요 현안 및 요청사항 등에 대해서도 수시로 정보를 제공하고 있습니다. &cr;향후 사외이사의 전문성 강화를 위하여 교육이 필요할 경우 교육을 실시할 예정입니다..</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0">2. 감사제도에 관한 사항</TITLE>
<P USERMARK=" B">&cr;(1) 감사기구 관련 사항&cr;</P>
<P USERMARK=" B">(가) 감사 설치여부, 구성방법 등</P>
<P>당사는 보고서 제출일 현재 감사위원회를 별도로 설치하지 않고 있으며, 주주총회 결의에 의하여 선임된 비상근 감사 1인이 감사 업무를 수행하고 있습니다.</P>

<TABLE BORDER="1" WIDTH="668" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="95"></COL>
<COL WIDTH="555"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>

<TD WIDTH="564" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">내용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="247">
<P USERMARK="F-BT12">구성 및 &cr;선임 방법</P>
</TD>

<TD WIDTH="564" VALIGN="MIDDLE" HEIGHT="247">
<P USERMARK="F-BT12">1. 당 회사의 감사는 1명 이상 2인 이내로 하며 주주총회에서 선임한다.</P>
<P USERMARK="F-BT12">2. 감사의 선임을 위한 의안은 이사의 선임을 위한 의안과는 별도로 상정하여 의결한다.</P>
<P USERMARK="F-BT12">3. 감사의 선임은 출석한 주주의 의결권의 과반수로 하되 발행주식총수의 4분의 1이상의 수로 하여야 한다. 그러나 의결권있는 발행주식총수의 100분의 3을 초과하는 수의 주식을 가진 주주는 그 초과하는 주식에 관하여 제1항의 감사의 선임에 있어서는 의결권을 행사하지 못한다. &cr;다만, 소유주식수의 산정에 있어 최대주주와 그 특수관계인, 최대주주 또는 그특수관계인의 계산으로 주식을 보유하는 자, 최대주주 또는 그 특수관계인에게 의결권을 위임한 자가 소유하는 의결권 있는 주식의 수는 합산한다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">(나) 감사위원회(감사)의 감사업무에 필요한 경영정보접근을 위한 &cr;내부장치마련 여부</P>
<P>당사의 정관은 감사의 감사업무에 필요한 경영정보접근을 위하여 &cr;다음과 같이 규정하고 있습니다.</P>

<TABLE BORDER="1" WIDTH="744" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="95"></COL>
<COL WIDTH="631"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">구분</P>
</TD>

<TD WIDTH="640" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">내용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="415">
<P USERMARK="F-BT12">권한</P>
</TD>

<TD WIDTH="640" HEIGHT="415">
<P USERMARK="F-BT12">1. 감사는 당회사의 회계와 업무를 감사한다.</P>
<P USERMARK="F-BT12">2. 감사는 이사회에 출석하여 의견을 진술할 수 있다.</P>
<P USERMARK="F-BT12">3. 감사는 회의의 목적사항과 소집의 이유를 기재한 서면을 이사회에 제출하여 임시주주총회의 소집을 청구할 수 있다.</P>
<P USERMARK="F-BT12">4. 감사는 그 직무를 수행하기 위하여 필요한 때에는 자회사에 대하여 영업의 보고를 요구 할 수 있다. &cr;이 경우 자회사가 지체없이 보고를 하지 아니할 때 또는 그 보고의 내용을 확인할 필요가 있는 때에는 자회사의 업무와 재산상태를 조사할 수 있다.</P>
<P USERMARK="F-BT12">5. 감사는 이사가 주주총회에 제출할 의안 및 서류를 조사하여 법령 또는 정관에 위반하거나 현저하게 부당한 사항이 있는지의 여부에 관하여 주주총회에 그 의견을 진술하여야 한다.</P>
<P USERMARK="F-BT12">6. 감사에 대해서는 제38조 제3항의 규정을 준용한다.</P>
<P USERMARK="F-BT12">7. 감사는 회사의 비용으로 전문가의 도움을 구할 수 있다.</P>
<P USERMARK="F-BT12">8. 감사는 필요하면 회의의 목적사항과 소집이유를 적은 서면을 이사(소집권자가 있는 &cr;경우에는 소집권자)에게 제출하여 이사회 소집을 청구할 수 있다.</P>
<P USERMARK="F-BT12">9. 제8항의 청구를 하였는데도 이사가 지체없이 이사회를 소집하지 아니하면 그 청구한 감사가 이사회를 소집할 수 있다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P USERMARK=" B"> (다) 감사의 인적 사항</P>

<TABLE BORDER="1" WIDTH="734" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="74"></COL>
<COL WIDTH="405"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="94"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">성 명</P>
</TD>

<TD WIDTH="414" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">주요 경력</P>
</TD>

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">결격요건 여부</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">비 고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="176" USERMARK="F-BT12">서 미 영</TD>

<TD WIDTH="414" VALIGN="MIDDLE" HEIGHT="176">
<P USERMARK="F-BT12">-04.10 한국 공인회계사 등록</P>
<P USERMARK="F-BT12">-05.02 서울대학교 독어교육과 학사 졸업</P>
<P USERMARK="F-BT12">-05.03 세무사 등록</P>
<P USERMARK="F-BT12">-04.10~15.12 삼일회계법인 Senior manager</P>
<P USERMARK="F-BT12">-16.01~17.05 태성회계법인 이사</P>
<P USERMARK="F-BT12">-17.05~19.06 삼덕회계법인 이사</P>
<P USERMARK="F-BT12">-19.07~ 삼덕회계법인 상무</P>
</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="176" USERMARK="F-BT12">해당사항 없음</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="176">
<P USERMARK="F-BT12">-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">(2) 감사의 주요활동내역&cr;&cr;[2017년 이사회]</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="902">

<COLGROUP>
<COL WIDTH="62"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="393"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="55"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="86" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">회차</P>
</TD>

<TD ROWSPAN="2" WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="86" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">개최일자</P>
</TD>

<TD ROWSPAN="2" WIDTH="402" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="86" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">의 안 내 용</P>
</TD>

<TD ROWSPAN="2" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="86" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">가결 여부</P>
</TD>
<TD COLSPAN="2" WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">감사 윤원태</TD>

<TD ROWSPAN="2" WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="86" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">비고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">참석여부</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12 BC0XD7D7D7 B">찬반</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2017-1</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2017.02.16</TD>
<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-BT12">1. 영업보고 및 재무제표승인의 건&cr;2. 정기주주총회 개최의 건</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">가결</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">참석</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">찬성</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127" USERMARK="F-BT12">2017-2</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127" USERMARK="F-BT12">2017.11.03</TD>
<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="127" USERMARK="F-BT12">1. 증권 명의개서대리인 선임의 건&cr;2. 신주식 발행의 건&cr;3. 이사회 운영 규정 개정의 건&cr;4. 이해관계자와의 거래에 대한 통제 규정 제정의 건&cr;5. 임시주주총회 개최의 건</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127" USERMARK="F-BT12">가결</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127" USERMARK="F-BT12">참석</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127" USERMARK="F-BT12">찬성</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="127" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2017-3</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2017.11.20</TD>
<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-BT12">1. 코넥스상장 동의에 관한 건&cr;2. 내부회계관리제도 제정의 건</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">가결</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">참석</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">찬성</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">&cr;[2018년 이사회]</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1071">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="379"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="53"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">회차</P>
</TD>

<TD ROWSPAN="2" WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">개최일자</P>
</TD>

<TD ROWSPAN="2" WIDTH="388" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">의 안 내 용</P>
</TD>

<TD ROWSPAN="2" WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">가결 여부</P>
</TD>
<TD COLSPAN="2" WIDTH="166" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">감사 윤원태</TD>
<TD COLSPAN="2" WIDTH="166" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">감사 이종윤</TD>

<TD ROWSPAN="2" WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">비고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">참석여부</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">찬반</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">참석여부</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">찬반</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2018-1</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2018.02.07</TD>
<TD WIDTH="388" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-BT12">1. 내부회계관리제도 운영실태 평가보고의 건&cr;2. 제14기 재무제표 승인의 건</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">가결</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">참석</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">찬성</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">-</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">-</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018-2</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.03.08</TD>
<TD WIDTH="388" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">1. 정기주주총회 소집의 건</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">가결</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018-3</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2018.11.13</TD>
<TD WIDTH="388" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">1. 주식매수선택권 부여의 건</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">가결</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">참석</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">찬성</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">주1. </SPAN>
<SPAN USERMARK=" !B">2018년 2월 14일 </SPAN>
<SPAN USERMARK=" !B">윤원태 감사가 사임하고, 2018년 3</SPAN>
<SPAN USERMARK=" !B">월</SPAN>
<SPAN USERMARK=" !B"> 28일 이종윤 감사가 &cr;신규 선임되었습니다.&cr;&cr;</SPAN>
<SPAN>[2019년 이사회]</SPAN>
</P>

<TABLE BORDER="1" WIDTH="956" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="393"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="53"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7" ROWSPAN="2">
<P USERMARK="F-BT12 B">회차</P>
</TD>

<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7" ROWSPAN="2">
<P USERMARK="F-BT12 B">개최일자</P>
</TD>

<TD WIDTH="402" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7" ROWSPAN="2">
<P USERMARK="F-BT12 B">의 안 내 용</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7" ROWSPAN="2">
<P USERMARK="F-BT12 B">가결 여부</P>
</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B" COLSPAN="2">감사 이종윤</TD>

<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7" ROWSPAN="2">
<P USERMARK="F-BT12 B">비고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">참석여부</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">찬반</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">2019-1</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">2019.02.12</TD>
<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="79" USERMARK="F-BT12">1. 제15기 영업보고 및 재무제표 승인의 건&cr;2. 주식매수선택권 부여 취소의 건&cr;3. 내부회계관리제도 운영규정 변경의 건</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">가결</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">참석</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">찬성</TD>
<TD WIDTH="62" VALIGN="MIDDLE" HEIGHT="79" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2019-2</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2019.03.12</TD>
<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">1. 정기주주총회 소집의 건</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">가결</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">참석</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">찬성</TD>
<TD WIDTH="62" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">2019-3</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">2019.03.29</TD>
<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="79" USERMARK="F-BT12">1. 대표이사 선임의 건&cr;2. 평가보상위원회 설립의 건&cr;3. 평가보상위원회 규정 제정의 건 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">가결</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">불참</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="79" USERMARK="F-BT12">-</TD>
<TD WIDTH="62" VALIGN="MIDDLE" HEIGHT="79" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">[2020년 이사회]</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="956">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="393"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="53"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="79" HEIGHT="62" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">회차</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="107" HEIGHT="62" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">개최일자</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="402" HEIGHT="62" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">의 안 내 용</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="102" HEIGHT="62" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">가결 여부</P>
</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="204" HEIGHT="31" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">감사 이종윤</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="62" HEIGHT="62" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-BT12 B">비고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="102" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">참석여부</TD>
<TD USERMARK="F-BT12 BC0XD7D7D7 B" WIDTH="102" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">찬반</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="79" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2020-1</TD>
<TD USERMARK="F-BT12" WIDTH="107" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">2020.02.05</TD>
<TD USERMARK="F-BT12" WIDTH="402" HEIGHT="55" VALIGN="MIDDLE">1. 내부회계관리제도 운영실태보고의 건&cr;2. 제16기 영업보고의 건</TD>
<TD USERMARK="F-BT12" WIDTH="102" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD USERMARK="F-BT12" WIDTH="102" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD USERMARK="F-BT12" WIDTH="102" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="62" HEIGHT="55" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-BT12" WIDTH="79" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">2020-2</TD>
<TD USERMARK="F-BT12" WIDTH="107" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">2020.03.13</TD>
<TD USERMARK="F-BT12" WIDTH="402" HEIGHT="31" VALIGN="MIDDLE">1. 정기주주총회 소집의 건</TD>
<TD USERMARK="F-BT12" WIDTH="102" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD USERMARK="F-BT12" WIDTH="102" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD USERMARK="F-BT12" WIDTH="102" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="62" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-BT12">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>주1.</SPAN>
<SPAN USERMARK=" B"> </SPAN>
<SPAN></SPAN>
<SPAN>2020년 3월 30일 </SPAN>
<SPAN>이종윤 감사가 사임하고, 2020년 3</SPAN>
<SPAN>월</SPAN>
<SPAN> 30일 서미영 감사가 &cr;신규 선임되었습니다.&cr;</SPAN>
<SPAN USERMARK=" B">&cr;[2021년 이사회]</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="956">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="393"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="53"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">회차</P>
</TD>

<TD ROWSPAN="2" WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">개최일자</P>
</TD>

<TD ROWSPAN="2" WIDTH="402" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">의 안 내 용</P>
</TD>

<TD ROWSPAN="2" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">가결 여부</P>
</TD>
<TD COLSPAN="2" WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">감사 서미영</TD>

<TD ROWSPAN="2" WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">비고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">참석여부</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">찬반</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2021-1</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">2021.02.03</TD>
<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="55" USERMARK="F-BT12">1. 내부회계관리제도 운영실태보고의 건&cr;2. 제17기 영업보고의 건</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">가결</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">참석</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">찬성</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2021-2</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">2021.03.09</TD>
<TD WIDTH="402" VALIGN="MIDDLE" HEIGHT="31" USERMARK="F-BT12">1. 정기주주총회 소집의 건</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">가결</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">참석</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">찬성</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회 위원의 인적사항 및 사외이사 여부』 삽입</COMMENT>
<LIBRARYLIST>11011#*감사위원현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">41_04_감사_교육_미실시내역</FILENAME>

<P>
<SPAN USERMARK=" B">(3) 감사 교육 미실시 내역</SPAN>
</P>

<TABLE-GROUP ACLASS="ADT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="151" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" HEIGHT="151" ACODE="ADT_EDU_NOT_DTL" USERMARK="F-BT12">당사에 선임된 감사위원은 각각 회계, 세무, 법무 및 경영 전문가로서 전문성을 충분히 갖추고 있어 당기 중 감사위원을 대상으로 교육을 실시하거나 위탁 교육등 외부기관이 제공하는 교육을 이수한 바 없습니다. 추후에 경영상의 중요한 내용이 있을 경우 내부교육을 실시 할 예정입니다</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">42_02_감사_지원조직_현황</FILENAME>
<P USERMARK=" B">(4) 감사 지원조직 현황</P>

<TABLE-GROUP ACLASS="ADT_OGN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="853" BORDER="1">

<COLGROUP>
<COL WIDTH="88"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="195"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">부서(팀)명</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직원수(명)</TH>
<TH WIDTH="204" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위(근속연수)</TH>
<TH WIDTH="462" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACODE="ADT_OGN_NM" USERMARK="F-BT12">경영지원팀</TE>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" ACODE="ADT_OGN_CNT" USERMARK="F-BT12">2</TE>
<TE WIDTH="204" VALIGN="MIDDLE" HEIGHT="55" ACODE="ADT_OGN_PST" ALIGN="CENTER" USERMARK="F-BT12">부장 외&cr;(평균근속연수: 2년 6개월)</TE>
<TE WIDTH="462" VALIGN="MIDDLE" HEIGHT="55" ACODE="ADT_OGN_DTL" USERMARK="F-BT12">재무제표, 주주총회, 이사회 등 경영전반에 관한 감사업무 지원</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『준법지원인 등 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_준법지원인등_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">43_02_준법지원인등_지원조직_해당사항없음</FILENAME>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>지원조직이 없는 경우에는 그 사실을 기재한다.</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
</LIBRARY>
</INSERTION>

<P>
<SPAN USERMARK=" B">(5) 준법지원인에 관한 사항&cr;</SPAN>당사는 본 보고서 작성일 현재 선임된 준법지원인이 없습니다.&cr;
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0">3. 주주의 의결권 행사에 관한 사항</TITLE>
<P></P>
<P USERMARK=" B">(1) 집중투표제의 배제여부</P>
<P>당사는 보고서 제출일 현재 집중투표제를 채택하고 있지 않습니다.</P>

<TABLE BORDER="1" WIDTH="605" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="596"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="605" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">이사의 선임(정관 제33조)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="605" VALIGN="MIDDLE" HEIGHT="55">
<P USERMARK="F-BT12">3. 2인 이상의 이사를 선임하는 경우 상법 제382조의 2에서 규정하는 집중투표제는 적용하지 아니한다. </P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">(2) 서면투표제 또는 전자투표제의 채택여부</P>
<P>당사는 보고서 제출일 현재 서면투표제 및 전자투표제를 채택하고 있지 않습니다.</P>
<P> </P>
<P USERMARK=" B">(3) 소수주주권의 행사여부</P>
<P>당사는 설립 이후 보고서 제출일 현재까지 소수주주권이 행사된 사실이 없습니다.</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0">VII. 주주에 관한 사항</TITLE>
<P></P>
<P USERMARK=" B">1. 최대주주 및 특수관계인의 주식소유 현황</P>

<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="741" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="421"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="430" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="746" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="56"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="134" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="316" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="166" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="65" HEIGHT="31" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">김갑식</TE>
<TE ALIGN="CENTER" WIDTH="134" HEIGHT="31" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-BT12">최대주주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="31" ACODE="STK_KND" USERMARK="F-BT12">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-BT12">762,710</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-BT12">21.34</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="31" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-BT12">762,710</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-BT12">21.34</TE>
<TE ALIGN="CENTER" WIDTH="166" HEIGHT="31" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="65" HEIGHT="31" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">이주환</TE>
<TE ALIGN="CENTER" WIDTH="134" HEIGHT="31" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-BT12">임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="31" ACODE="STK_KND" USERMARK="F-BT12">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-BT12">425,630</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-BT12">11.91</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="31" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-BT12">425,630</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-BT12">11.91</TE>
<TE ALIGN="CENTER" WIDTH="166" HEIGHT="31" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="65" HEIGHT="31" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">진용석</TE>
<TE ALIGN="CENTER" WIDTH="134" HEIGHT="31" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-BT12">임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="31" ACODE="STK_KND" USERMARK="F-BT12">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-BT12">16,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-BT12">0.45</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="31" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-BT12">16,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-BT12">0.45</TE>
<TE ALIGN="CENTER" WIDTH="166" HEIGHT="31" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="65" HEIGHT="31" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">이순연</TE>
<TE ALIGN="CENTER" WIDTH="134" HEIGHT="31" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-BT12">배우자</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="31" ACODE="STK_KND" USERMARK="F-BT12">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-BT12">37,100</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-BT12">1.04</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="31" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-BT12">37,100</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-BT12">1.04</TE>
<TE ALIGN="CENTER" WIDTH="166" HEIGHT="31" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="65" HEIGHT="31" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">이보연</TE>
<TE ALIGN="CENTER" WIDTH="134" HEIGHT="31" ACODE="SH5_RET" VALIGN="MIDDLE" USERMARK="F-BT12">최대주주의 처형</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="31" ACODE="STK_KND" USERMARK="F-BT12">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE" USERMARK="F-BT12">85,370</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="SH5_BGN_RT" VALIGN="MIDDLE" USERMARK="F-BT12">2.39</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="31" ACODE="SH5_END_CNT" VALIGN="MIDDLE" USERMARK="F-BT12">85,370</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="SH5_END_RT" VALIGN="MIDDLE" USERMARK="F-BT12">2.39</TE>
<TE ALIGN="CENTER" WIDTH="166" HEIGHT="31" ACODE="NOTE5" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="199" HEIGHT="62" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="65" HEIGHT="31" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE" USERMARK="F-BT12">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="STK_CNT_BIML" VALIGN="MIDDLE" USERMARK="F-BT12">1,326,810</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="STK_RATE_BIML" VALIGN="MIDDLE" USERMARK="F-BT12">37.13</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="31" ACODE="STK_CNT_GIML" VALIGN="MIDDLE" USERMARK="F-BT12">1,326,810</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="STK_RATE_GIML" VALIGN="MIDDLE" USERMARK="F-BT12">37.13</TE>
<TE ALIGN="CENTER" WIDTH="166" HEIGHT="31" ACODE="NOTE4" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="65" HEIGHT="31" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE" USERMARK="F-BT12">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="STK_CNT_BIML" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="STK_RATE_BIML" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="31" ACODE="STK_CNT_GIML" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="31" ACODE="STK_RATE_GIML" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="166" HEIGHT="31" ACODE="NOTE4" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1. 진용석 이사는 2021년 1월 말일자로 사임하였습니다.&cr;</P>

<P>
<SPAN USERMARK=" B">[최대주주의 주요 경력]</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="797">

<COLGROUP>
<COL WIDTH="53"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="515"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">성명</P>
</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">직위</TD>

<TD WIDTH="524" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">
<P USERMARK="F-BT12 B">주요경력</P>
</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">겸임현황</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="151" USERMARK="F-BT12">김갑식</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="151" USERMARK="F-BT12">대표이사&cr;(상근/등기)</TD>

<TD WIDTH="524" VALIGN="MIDDLE" HEIGHT="151">
<P USERMARK="F-BT12">- 88.02 경북대학교 화학과 학사</P>
<P USERMARK="F-BT12">- 92.02 경북대학교 대학원 화학과 석사</P>
<P USERMARK="F-BT12">- 99.02 서울대학교 대학원 화학과 박사</P>
<P USERMARK="F-BT12">- 92.01~95.02 C&C 신약개발 연구소</P>
<P USERMARK="F-BT12">- 98.12~03.11 ㈜유진사이언스 바이오텍 연구소 팀장</P>
<P USERMARK="F-BT12">- 04.01~현재 ㈜바이오시네틱스 대표이사</P>
</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="151" USERMARK="F-BT12">해당사항 없음</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주가 법인 또는 투자조합 등 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주의 최대주주(최대출자자)가 법인 또는 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주의최대출자자가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『최대주주 변동내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주변동내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P USERMARK=" B">2. 주식 소유현황</P>

<TABLE-GROUP ACLASS="SH5_PRE_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="299" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="189" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주명</TH>
<TH WIDTH="117" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="161" ROWSPAN="3" AUPDATECONT="N">5% 이상 주주</TD>

<TE WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35" ACODE="SH5_NM">
<P>(주)대웅제약</P>
</TE>
<TE WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="35" ACODE="SH5_TOT_CNT" USERMARK="F-BT12">645,000</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="35" ACODE="SH5_TOT_RT" USERMARK="F-BT12">18.04</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="N">

<TE WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="63" ACODE="SH5_NM">
<P>한국투자글로벌제약산업육성사모투자전문회사</P>
</TE>
<TE WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="63" ACODE="SH5_TOT_CNT" USERMARK="F-BT12">517,250</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="63" ACODE="SH5_TOT_RT" USERMARK="F-BT12">14.47</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="63" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="63" ACODE="SH5_NM">
<P>프리미어글로벌&cr;이노베이션1호 투자조합</P>
</TE>
<TE WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="63" ACODE="SH5_TOT_CNT" USERMARK="F-BT12">422,535</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="63" ACODE="SH5_TOT_RT" USERMARK="F-BT12">11.82</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="63" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="309" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" COLSPAN="2" AUPDATECONT="N">우리사주조합</TD>
<TE WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="SH5_WOO_CNT" USERMARK="F-BT12">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="SH5_WOO_RT" USERMARK="F-BT12">-</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『소액주주현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*소액주주현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">10_소액주주현황</FILENAME>

<TABLE-GROUP ACLASS="SH4_PRE_STT" ADELETETABLE="N">
<TITLE ATOC="N">소액주주현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="682" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="193" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="260" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="65" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="64" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="64" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">소액주주</TD>
<TE WIDTH="65" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_CNT">136</TE>
<TE WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_CNTT">147</TE>
<TE WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_RT">92.52</TE>
<TE WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNT">488,752</TE>
<TE WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNTT">3,574,675</TE>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_RT">7.31</TE>
<TE WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VIII. 임원 및 직원 등에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0">1. 임원 및 직원 등의 현황</TITLE>
<P></P>
<P USERMARK=" B">가. 임원 현황</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1583" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="1234"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1243" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1588" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="491"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당&cr;업무</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="500" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="151" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의&cr;관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기&cr;만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;있는 주식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="175" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">김갑식</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="175" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="175" AUNIT="SH5_BIH" AUNITVALUE="196612" VALIGN="MIDDLE">1966년 12월</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="175" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-BT12">대표이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="175" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="175" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="175" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-BT12">업무총괄</TE>

<TE WIDTH="500" HEIGHT="175" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P>- 88.02 경북대학교 화학과 학사</P>
<P>- 92.02 경북대학교 대학원 화학과 석사</P>
<P>- 99.02 서울대학교 대학원 화학과 박사</P>
<P>- 92.01~95.02 C&C 신약개발 연구소</P>
<P>- 98.12~03.11 ㈜유진사이언스 바이오텍 연구소 팀장</P>
<P>- 04.01~현재 ㈜바이오시네틱스 대표이사</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="175" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-BT12">762,710</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="175" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="175" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-BT12">본인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="175" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-BT12">16년&cr;10개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="175" AUNIT="SH5_FIH" AUNITVALUE="20220331" VALIGN="MIDDLE">2022.03.31</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="175" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">이주환</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="175" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="175" AUNIT="SH5_BIH" AUNITVALUE="196409" VALIGN="MIDDLE">1964년 09월</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="175" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-BT12">사내이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="175" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="175" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="175" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-BT12">경영관리</TE>

<TE WIDTH="500" HEIGHT="175" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P>- 85.02 서울대학교 경영학과 학사</P>
<P>- 87.02 한국과학기술원 경영과학과 석사</P>
<P>- 90.09~98.10 현대전자㈜ 미국법인</P>
<P>- 98.11~05.08 ㈜유진사이언스 부사장</P>
<P>- 07.01~08.08 ㈜에일리언테크놀로지아시아 전무</P>
<P>- 08.10~현재 ㈜바이오시네틱스 부사장</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="175" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-BT12">425,630</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="175" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="175" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-BT12">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="175" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-BT12">12년&cr;2개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="175" AUNIT="SH5_FIH" AUNITVALUE="20220331" VALIGN="MIDDLE">2022.03.31</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="147" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">진용석</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="147" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="147" AUNIT="SH5_BIH" AUNITVALUE="197403" VALIGN="MIDDLE">1974년 03월</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="147" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-BT12">사내이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="147" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="147" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="147" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-BT12">연구소장</TE>

<TE WIDTH="500" HEIGHT="147" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P>- 97.03~99.02 중앙대학교 대학원 유기화학 석사</P>
<P>- 06.09~09.09 독일 마틴루터대 공정화학공학 박사</P>
<P>- 09.10~14.04 ㈜대웅제약 생명과학연구소 수석연구원</P>
<P>- 14.04~16.02 ㈜엔씨켐 연구그룹장</P>
<P>- 16.02~현재 ㈜바이오시네틱스 연구소장</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="147" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-BT12">16,000</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="147" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="147" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-BT12">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="147" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-BT12">4년&cr;10개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="147" AUNIT="SH5_FIH" AUNITVALUE="20220329" VALIGN="MIDDLE">2022.03.29</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="231" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">황만순</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="231" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="231" AUNIT="SH5_BIH" AUNITVALUE="197009" VALIGN="MIDDLE">1970년 09월</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="231" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-BT12">기타비상무이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="231" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="231" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="231" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-BT12">기타비상무이사</TE>

<TE WIDTH="500" HEIGHT="231" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P>- 94.02 서울대학교 제약학 학사</P>
<P>- 96.02 서울대학교 약학대학 약제학 석사</P>
<P>- 96.03~01.06 ㈜유한양행 선임연구원</P>
<P>- 01.08~04.09 한국바이오기술투자 팀장</P>
<P>- 04.10~06.06 ㈜켐온 부사장</P>
<P>- 06.07~07.02 한국바이오기술투자 팀장</P>
<P>- 07.03~08.12 ㈜켐온 부사장</P>
<P>- 09.01~현재 한국투자파트너스 상무</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="231" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="231" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="231" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-BT12">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="231" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-BT12">4년&cr;9개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="231" AUNIT="SH5_FIH" AUNITVALUE="20201120" VALIGN="MIDDLE">2020.11.20</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="287" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">문현식</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="287" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="287" AUNIT="SH5_BIH" AUNITVALUE="197401" VALIGN="MIDDLE">1974년 01월</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="287" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-BT12">기타비상무이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="287" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="287" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="287" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-BT12">기타비상무이사</TE>

<TE WIDTH="500" HEIGHT="287" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P>- 98.02 서울대학교 섬유고분자공학과 학사, 석사</P>
<P>- 05.04 University of Michigan, Ann Arbor USA</P>
<P>           전자공학과 석사, 고분자 공학 박사</P>
<P>- 99.04~99.07 한국과학기술연구원(KIST)&cr;                     광전자 재료 소자 연구센터 연구원</P>
<P>- 03.09~05.06 University of Michigan, Ann Arbor USA</P>
<P>                     박사 수료 후 강사 및 연구원 (화학과, 고분자공학과)</P>
<P>- 05.07~11.06 삼성전자 광 에너지 사업 팀, LCD사업부, 차장</P>
<P>                      디스플레이 랩, 종합연구원, 전문연구원</P>
<P>- 11.07~현재 현대기술 투자, 벤처투자본부, 부장</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="287" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="287" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="287" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-BT12">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="287" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-BT12">2년&cr;9개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="287" AUNIT="SH5_FIH" AUNITVALUE="20210328" VALIGN="MIDDLE">2021.03.28</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="315" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">유종상</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="315" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="315" AUNIT="SH5_BIH" AUNITVALUE="197105" VALIGN="MIDDLE">1971년 05월</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="315" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-BT12">기타비상무이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="315" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="315" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="315" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-BT12">기타비상무이사</TE>

<TE WIDTH="500" HEIGHT="315" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P>- 94.02 고려대학교 농생물학 학사</P>
<P>- 96.02 포항공과대학교 생명과학 분자유전학 석사</P>
<P>- 05.02 포항공과대학교 생명과학 분자유전학 박사</P>
<P>- 96.05~96.09 삼성전자㈜ 종합기술원 </P>
<P>- 00.02~00.09 롯데그룹 중앙연구소 연구원</P>
<P>- 05.03~07.05 포항공과대학교 시스템바이오다이나믹스센터</P>
<P>- 07.06~12.03 삼성전자㈜ 종합기술원 전문연구원</P>
<P>- 12.04~13.12 삼성바오에피스㈜ 수석</P>
<P>- 14.01~16.03 기초과학연구원(IBS) 연구위원</P>
<P>- 16.04~17.11 ㈜테라젠이텍스 상무이사</P>
<P>- 17.12~현재 ㈜대웅C&D 센터장</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="315" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="315" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="315" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-BT12">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="315" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-BT12">1년&cr;9개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="315" AUNIT="SH5_FIH" AUNITVALUE="20220329" VALIGN="MIDDLE">2022.03.29</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="203" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-BT12">서미영</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="203" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="203" AUNIT="SH5_BIH" AUNITVALUE="198103" VALIGN="MIDDLE">1981년 03월</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="203" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-BT12">감사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="203" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="203" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="203" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-BT12">감사</TE>

<TE WIDTH="500" HEIGHT="203" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P>-04.10 한국 공인회계사 등록</P>
<P>-05.02 서울대학교 독어교육과 학사 졸업</P>
<P>-05.03 세무사 등록</P>
<P>-04.10~15.12 삼일회계법인 Senior manager</P>
<P>-16.01~17.05 태성회계법인 이사</P>
<P>-17.05~19.06 삼덕회계법인 이사</P>
<P>-19.07~ 삼덕회계법인 상무</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="203" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="203" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="203" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-BT12">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="203" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-BT12">9개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="203" AUNIT="SH5_FIH" AUNITVALUE="20220329" VALIGN="MIDDLE">2022.03.29</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1. 진용석 이사는 2021년 1월 말일자로 사임하였습니다.&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『등기임원후보자 및 해임대상자』 삽입</COMMENT>
<LIBRARYLIST>11011#*등기임원후보자및해임대상자.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P USERMARK=" B">나. 직원 현황</P>

<TABLE-GROUP ACLASS="EMPLOYEE" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="838" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="471"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="480" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="836" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="689" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="10">직원</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">소속 외&cr;근로자</TH>
<TH ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="189" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">성별</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="287" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직 원 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">평 균&cr;근속연수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">연간급여&cr;총 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">1인평균&cr;급여액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">남</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">여</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간의 정함이&cr;없는 근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간제&cr;근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">합 계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="105" HEIGHT="31" ACODE="EMP_OPR" VALIGN="MIDDLE" USERMARK="F-BT12">전략기획팀</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="31" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_REO" VALIGN="MIDDLE" USERMARK="F-BT12">1</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_REOS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_COC" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_COCS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="31" ACODE="EMP_CN" VALIGN="MIDDLE" USERMARK="F-BT12">1</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="EMP_AVY" VALIGN="MIDDLE" USERMARK="F-BT12">11년 10개월</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="31" ACODE="EMP_AIC" VALIGN="MIDDLE" USERMARK="F-BT12">62,329</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="31" ACODE="EMP_VIC" VALIGN="MIDDLE" USERMARK="F-BT12">62,329</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="252" ACODE="EMP_MAN" VALIGN="MIDDLE" ROWSPAN="8" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="252" ACODE="EMP_WOM" VALIGN="MIDDLE" ROWSPAN="8" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="252" ACODE="EMP_MW_TOTAL" VALIGN="MIDDLE" ROWSPAN="8" USERMARK="F-BT12">-</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="31" ACODE="NOTE" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="105" HEIGHT="31" ACODE="EMP_OPR" VALIGN="MIDDLE" USERMARK="F-BT12">경영지원팀</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="31" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_REO" VALIGN="MIDDLE" USERMARK="F-BT12">1</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_REOS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_COC" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_COCS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="31" ACODE="EMP_CN" VALIGN="MIDDLE" USERMARK="F-BT12">1</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="EMP_AVY" VALIGN="MIDDLE" USERMARK="F-BT12">4년 6개월</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="31" ACODE="EMP_AIC" VALIGN="MIDDLE" USERMARK="F-BT12">53,000</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="31" ACODE="EMP_VIC" VALIGN="MIDDLE" USERMARK="F-BT12">53,000</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="31" ACODE="NOTE" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="105" HEIGHT="31" ACODE="EMP_OPR" VALIGN="MIDDLE" USERMARK="F-BT12">"</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="31" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_REO" VALIGN="MIDDLE" USERMARK="F-BT12">1</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_REOS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_COC" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_COCS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="31" ACODE="EMP_CN" VALIGN="MIDDLE" USERMARK="F-BT12">1</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="EMP_AVY" VALIGN="MIDDLE" USERMARK="F-BT12">0년 9개월</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="31" ACODE="EMP_AIC" VALIGN="MIDDLE" USERMARK="F-BT12">16,385</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="31" ACODE="EMP_VIC" VALIGN="MIDDLE" USERMARK="F-BT12">16,385</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="31" ACODE="NOTE" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" WIDTH="105" HEIGHT="35" ACODE="EMP_OPR" VALIGN="MIDDLE">
<P>연구개발팀</P>
</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="35" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="35" ACODE="EMP_REO" VALIGN="MIDDLE" USERMARK="F-BT12">3</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="35" ACODE="EMP_REOS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="35" ACODE="EMP_COC" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="35" ACODE="EMP_COCS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="35" ACODE="EMP_CN" VALIGN="MIDDLE" USERMARK="F-BT12">3</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="35" ACODE="EMP_AVY" VALIGN="MIDDLE" USERMARK="F-BT12">4년 7개월</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="35" ACODE="EMP_AIC" VALIGN="MIDDLE" USERMARK="F-BT12">102,557</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="35" ACODE="EMP_VIC" VALIGN="MIDDLE" USERMARK="F-BT12">34,185</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="35" ACODE="NOTE" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="105" HEIGHT="31" ACODE="EMP_OPR" VALIGN="MIDDLE" USERMARK="F-BT12">"</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="31" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_REO" VALIGN="MIDDLE" USERMARK="F-BT12">1</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_REOS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_COC" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_COCS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="31" ACODE="EMP_CN" VALIGN="MIDDLE" USERMARK="F-BT12">1</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="EMP_AVY" VALIGN="MIDDLE" USERMARK="F-BT12">1년 9개월</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="31" ACODE="EMP_AIC" VALIGN="MIDDLE" USERMARK="F-BT12">30,500</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="31" ACODE="EMP_VIC" VALIGN="MIDDLE" USERMARK="F-BT12">30,500</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="31" ACODE="NOTE" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="105" HEIGHT="31" ACODE="EMP_OPR" VALIGN="MIDDLE" USERMARK="F-BT12">소재사업팀</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="31" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_REO" VALIGN="MIDDLE" USERMARK="F-BT12">4</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_REOS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_COC" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_COCS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="31" ACODE="EMP_CN" VALIGN="MIDDLE" USERMARK="F-BT12">4</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="EMP_AVY" VALIGN="MIDDLE" USERMARK="F-BT12">2년 3개월</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="31" ACODE="EMP_AIC" VALIGN="MIDDLE" USERMARK="F-BT12">123,000</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="31" ACODE="EMP_VIC" VALIGN="MIDDLE" USERMARK="F-BT12">30,750</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="31" ACODE="NOTE" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="105" HEIGHT="31" ACODE="EMP_OPR" VALIGN="MIDDLE" USERMARK="F-BT12">"</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="31" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_REO" VALIGN="MIDDLE" USERMARK="F-BT12">1</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_REOS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_COC" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_COCS" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="31" ACODE="EMP_CN" VALIGN="MIDDLE" USERMARK="F-BT12">1</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="EMP_AVY" VALIGN="MIDDLE" USERMARK="F-BT12">1년 0개월</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="31" ACODE="EMP_AIC" VALIGN="MIDDLE" USERMARK="F-BT12">32,000</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="31" ACODE="EMP_VIC" VALIGN="MIDDLE" USERMARK="F-BT12">32,000</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="31" ACODE="NOTE" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="31" AUPDATECONT="N" COLSPAN="2" VALIGN="MIDDLE">합 계</TD>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_REOT" VALIGN="MIDDLE" USERMARK="F-BT12">12</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_REOST" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="31" ACODE="EMP_COCT" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="31" ACODE="EMP_COCST" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="31" ACODE="EMP_CNT" VALIGN="MIDDLE" USERMARK="F-BT12">12</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="31" ACODE="EMP_AVYT" VALIGN="MIDDLE" USERMARK="F-BT12">2년 1개월</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="31" ACODE="EMP_AICT" VALIGN="MIDDLE" USERMARK="F-BT12">419,771</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="31" ACODE="EMP_VICT" VALIGN="MIDDLE" USERMARK="F-BT12">34,981</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="31" ACODE="NOTET" VALIGN="MIDDLE" USERMARK="F-BT12">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>* 직원 현황 표는 미등기임원을 포함하여 작성한다</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
<P></P>
<P USERMARK=" B">다. 미등기임원 보수 현황</P>

<TABLE-GROUP ACLASS="UNRESISTER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="787" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="420"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="429" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="786" BORDER="1">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="210"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">연간급여 총액</TH>
<TH WIDTH="164" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인평균 급여액</TH>
<TH WIDTH="219" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미등기임원</TD>
<TE WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_CNT">-</TE>
<TE WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_TOT">-</TE>
<TE WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_AVR">-</TE>
<TE WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0">2. 임원의 보수 등</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><이사ㆍ감사 전체의 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"><이사ㆍ감사 전체의 보수현황></P>
<P USERMARK=" B">1. 주주총회 승인금액</P>

<TABLE-GROUP ACLASS="SUB_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주총회 승인금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="PRT_PAY_SUB" USERMARK="F-BT12">이사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="PRT_PAY_NUM" USERMARK="F-BT12">5</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="PRT_PAY_KMY" USERMARK="F-BT12">500,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="NOTE" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="PRT_PAY_SUB" USERMARK="F-BT12">감사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="PRT_PAY_NUM" USERMARK="F-BT12">1</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="PRT_PAY_KMY" USERMARK="F-BT12">100,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="NOTE" USERMARK="F-BT12">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">2. 보수지급금액</P>
<P>2-1. 이사ㆍ감사 전체</P>

<TABLE-GROUP ACLASS="SUB_CMPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인당 평균보수액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="TRT_PAY_NUM" USERMARK="F-BT12">6</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="TRT_PAY_SUM" USERMARK="F-BT12">286,477</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="TRT_PAY_VIC" USERMARK="F-BT12">47,746</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="NOTE5" USERMARK="F-BT12">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P>2-2. 유형별</P>

<TABLE-GROUP ACLASS="SUB_CMPP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">보수총액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인당&cr;평균보수액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사&cr;(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_NUM" USERMARK="F-BT12">5</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_SUM" USERMARK="F-BT12">281,477</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_VIC" USERMARK="F-BT12">56,295</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사&cr;(감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_NUM" USERMARK="F-BT12">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_SUM" USERMARK="F-BT12">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_VIC" USERMARK="F-BT12">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" AUPDATECONT="N">감사위원회 위원</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="GRT_PAY_NUM" USERMARK="F-BT12">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="GRT_PAY_SUM" USERMARK="F-BT12">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="GRT_PAY_VIC" USERMARK="F-BT12">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="NOTE3" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" AUPDATECONT="N">감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="AUD_PAY_NUM" USERMARK="F-BT12">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="AUD_PAY_SUM" USERMARK="F-BT12">5,000</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="AUD_PAY_VIC" USERMARK="F-BT12">5,000</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="NOTE4" USERMARK="F-BT12">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상인 이사ㆍ감사의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN>(*) 이사 및 감사에게 지급한 개인별 보수가 5억원 미</SPAN>
<SPAN>만으로 해당사항 없습니다&cr;</SPAN>&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">2. 산정기준 및 방법</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK_HIGH" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN>(*) 이사 및 감사에게 지급한 개인별 보수가 5억원 미</SPAN>
<SPAN>만으로 해당사항 없습니다&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『주식매수선택권의 부여 및 행사현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*주식매수선택권의부여및행사현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">14_주식매수선택권의부여및행사현황</FILENAME>
<P><주식매수선택권의 부여 및 행사현황></P>
<P><표1></P>

<TABLE-GROUP ACLASS="SUB_SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="232"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="136" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="241" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주식매수선택권의 공정가치 총액</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" AUPDATECONT="N">등기이사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="RRT_PAY_NUM" USERMARK="F-BT12">1</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="RRT_PAY_SUMT" USERMARK="F-BT12">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="NOTE1" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" AUPDATECONT="N">사외이사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="ORT_PAY_NUM" USERMARK="F-BT12">-</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="ORT_PAY_SUMT" USERMARK="F-BT12">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="NOTE2" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">감사위원회 위원 또는 감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="GRT_PAY_NUM" USERMARK="F-BT12">-</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="GRT_PAY_SUMT" USERMARK="F-BT12">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE3" USERMARK="F-BT12">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" AUPDATECONT="N">계</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="TRT_PAY_NUM" USERMARK="F-BT12">1</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" ACODE="TRT_PAY_SUMT" USERMARK="F-BT12">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" ACODE="NOTE4" USERMARK="F-BT12">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P><표2></P>

<TABLE-GROUP ACLASS="SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="882" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="488"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="153" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="497" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="883" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="50"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="47"></COL>
<COL WIDTH="47"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="51"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="59" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여&cr;받은자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여일</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여방법</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="56" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="56" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최초&cr;부여&cr;수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="131" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기변동수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="131" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총변동수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기말&cr;미행사수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사&cr;가격</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="59" HEIGHT="30" ACODE="SH5_NM">-</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="-">-</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACODE="SH5_MTH">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="56" HEIGHT="30" ACODE="SH5_STK_KNDD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="56" HEIGHT="30" ACODE="SH5_START_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="65" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="65" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="65" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACODE="SH5_PER">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_PRC">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1. 당사는 2017년 4월 12일에 액면분할 (5,000원 → 500원) 하였으며, 상기 주식수는 액면가 500원 기준으로 하였습니다.&cr;</P>
</LIBRARY>
</INSERTION>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0">IX. 계열회사 등에 관한 사항</TITLE>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『타법인출자 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*타법인출자현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<P>
<SPAN USERMARK=" B">1. 관계회사 현황&cr;</SPAN>
<SPAN>당사는 당사가 직접지분을 보유한 관계회사는 없습니다. 다만, 기준일 현재 주요주주로서 당사의 지분 18.04%를 보유한 (주)대웅제약이 존재합니다.&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="61"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">회사명</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">소재지</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="160" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">업종</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">상장여부</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">결산일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7 B">지분율</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="31" USERMARK="F-BT12">(주)대웅제약</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="31" USERMARK="F-BT12">한국</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="160" HEIGHT="31" USERMARK="F-BT12">의약품 제조 및 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="31" USERMARK="F-BT12">상장</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="31" USERMARK="F-BT12">12월 31일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">2. 관계회사간 임원 겸직현황&cr;</SPAN>
<SPAN>해당사항 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">3. 타법인출자 현황&cr;</SPAN>
<SPAN>해당사항 없습니다.&cr;</SPAN>
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0">X. 이해관계자와의 거래내용</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">1.가지급금·대여금(증권 대여 포함) 및 가수금 내역</SPAN>
<SPAN>&cr;해당사항 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">2. 담보제공 내역</SPAN>
<SPAN>&cr;해당사항 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">3. 채무보증 내역</SPAN>
<SPAN>&cr;해당사항 없습니다.</SPAN>
</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">4. 매출·매입거래&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>최</SPAN>
<SPAN>근 3개년도 내에 해당사항이 없습니다.&cr;</SPAN>
<SPAN USERMARK=" 0X1814FF">&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">5. 차입금 내역</SPAN>
<SPAN>&cr;해당사항 없습니다.</SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>

<P>
<SPAN USERMARK=" B">&cr;가. 중요한 소송 사건 등&cr;</SPAN>-해당사항 없습니다.&cr;
<SPAN USERMARK=" B">&cr;나. 주주총회 의사록 요약&cr;</SPAN>&cr;최근 3년간 개최된 총회의사록에 기재된 안건 및 결의 내용은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" WIDTH="822" BORDER="1">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="364"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="74"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7">개최일자</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="132" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7">주주총회 종류</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="373" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7">의안내용</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7">가결여부</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="31" USERMARK="F-BT12 BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="175" USERMARK="F-BT12">2018.03.28</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="132" HEIGHT="175" USERMARK="F-BT12">제14기 &cr;정기주주총회</TD>
<TD WIDTH="373" HEIGHT="175" USERMARK="F-BT12">제1호 의안 : 제14기 재무제표 승인의 건&cr;제2호 의안 : 이사선임의 건&cr;제2-1호 의안 : 사외이사 김코리후제이 선임의 건&cr;제2-2호 의안 : 기타비상무이사 문현식 선임의 건&cr;제3호 의안 : 비상근감사 이종윤 선임의 건&cr;제4호 의안 : 이사 보수 한도 승인의 건&cr;제5호 의안 : 감사 보수 한도 승인의 건</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="175" USERMARK="F-BT12">원안대로 가결</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="175" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="247" USERMARK="F-BT12">2019.03.29</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="132" HEIGHT="247" USERMARK="F-BT12">제15기&cr;정기주주총회</TD>
<TD WIDTH="373" HEIGHT="247" USERMARK="F-BT12">제1호 의안 : 제15기 재무제표 승인의 건&cr;제2호 의안 : 정관 일부 변경의 건&cr;제3호 의안 : 이사 선임의 건&cr;제3-1호 의안 : 사내이사 김갑식 선임의 건&cr;제3-2호 의안 : 사내이사 이주환 선임의 건&cr;제3-3호 의안 : 사내이사 진용석 선임의 건&cr;제4호 의안 : 기타비상무 이사 유종상 선임의 건&cr;제5호 의안 : 주식매수선택권 부여 승인의 건&cr;제6호 의안 : 이사 보수 한도 승인의 건&cr;제7호 의안 : 감사 보수 한도 승인의 건</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="247" USERMARK="F-BT12">원안대로 가결</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="247" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="127" USERMARK="F-BT12">2020.03.30</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="132" HEIGHT="127" USERMARK="F-BT12">제16기&cr;정기주주총회</TD>
<TD WIDTH="373" HEIGHT="127" USERMARK="F-BT12">제1호 의안 : 제16기 재무제표 승인의 건&cr;제2호 의안 : 기타비상무이사 황만순 선임의 건&cr;제3호 의안 : 감사 서미영 선임의 건&cr;제4호 의안 : 이사 보수 한도 승인의 건&cr;제5호 의안 : 감사 보수 한도 승인의 건</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="127" USERMARK="F-BT12">원안대로 가결</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="127" USERMARK="F-BT12">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-15 B">2. 우발채무 등&cr;</SPAN>&cr;
<SPAN USERMARK=" B">가. 중요한 소송 사건 등&cr;</SPAN>-해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">나. 견질 또는 담보용 어음ㆍ수표 현황&cr;</SPAN>-해당사항 없습니다.&cr;
</P>

<P>
<SPAN USERMARK=" B">다. 채무보증현황&cr;</SPAN>-해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">라. 채무인수약정 현황&cr;</SPAN>-해당사항 없습니다.&cr;
<SPAN USERMARK=" B">&cr;마. 기타의 우발채무 등&cr;</SPAN>-해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">바. 자본으로 인정되는 채무증권의 발행&cr;</SPAN>-해당사항 없습니다.&cr;&cr;
<SPAN USERMARK="F-15"></SPAN>
<SPAN USERMARK="F-15 B">3. 제재현황 등 그밖의 사항&cr;</SPAN>&cr;
<SPAN USERMARK=" B">가. 제재현황&cr;</SPAN>-해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">나. 작성기준일 이후 발생한 주요사항&cr;</SPAN>-해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">다. 직접금융 자금의 사용&cr;</SPAN>&cr;
<SPAN USERMARK=" B">(1) 공모자금의 사용내역&cr;</SPAN>-해당사항 없습니다.&cr;
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『신용보강 제공 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*신용보강제공현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『장래매출채권 유동화 현황 및 채무비중』 삽입</COMMENT>
<LIBRARYLIST>11011#*장래매출채권유동화현황및채무비중.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『단기매매차익 미환수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*단기매매차익미환수현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『공모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*공모자금의사용내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『사모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*사모자금의사용내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">19_사모자금의사용내역</FILENAME>
<P USERMARK=" B">(2) 사모자금의 사용내역&cr;</P>

<TABLE-GROUP ACLASS="FUND_SA" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="779" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="470"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="479" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="783" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="171" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">주요사항보고서의&cr; 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="165" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용&cr; 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="81" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="81" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="129" HEIGHT="31" ACODE="PO_TYPE" VALIGN="MIDDLE" USERMARK="F-BT12">전환우선주</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="31" ACODE="MO_SEQ" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="31" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20151216">2015년 12월 16일</TU>
<TE ALIGN="CENTER" WIDTH="81" HEIGHT="31" ACODE="PLA_USE" VALIGN="MIDDLE" USERMARK="F-BT12">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="31" ACODE="PLA_AMT" VALIGN="MIDDLE" USERMARK="F-BT12">3,000,050</TE>
<TE ALIGN="CENTER" WIDTH="81" HEIGHT="31" ACODE="BRK_CON" VALIGN="MIDDLE" USERMARK="F-BT12">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="31" ACODE="BRK_AMT" VALIGN="MIDDLE" USERMARK="F-BT12">3,000,050</TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="31" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="129" HEIGHT="31" ACODE="PO_TYPE" VALIGN="MIDDLE" USERMARK="F-BT12">상환전환우선주</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="31" ACODE="MO_SEQ" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="31" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20171118">2017년 11월 18일</TU>
<TE ALIGN="CENTER" WIDTH="81" HEIGHT="31" ACODE="PLA_USE" VALIGN="MIDDLE" USERMARK="F-BT12">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="90" HEIGHT="31" ACODE="PLA_AMT" VALIGN="MIDDLE" USERMARK="F-BT12">2,999,999</TE>
<TE ALIGN="CENTER" WIDTH="81" HEIGHT="31" ACODE="BRK_CON" VALIGN="MIDDLE" USERMARK="F-BT12">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="31" ACODE="BRK_AMT" VALIGN="MIDDLE" USERMARK="F-BT12">2,016,585</TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="31" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『미사용자금의 운용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*미사용자금의운용내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『합병등 전후의 재무사항 비교표』 삽입</COMMENT>
<LIBRARYLIST>11011#*합병등전후의재무사항비교표.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『보호예수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*보호예수현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『특례상장기업 관리종목 지정유예 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*특례상장기업관리종목지정유예현황.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK=" B">라. 외국지주회사의 자회사 현황&cr;</SPAN>-해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">마. 합병등의 사후정보&cr;</SPAN>-해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">바. 녹색경영&cr;</SPAN>-해당사항 없습니다.&cr;&cr;
<SPAN USERMARK=" B">사. 보호예수 현황&cr;</SPAN>-해당사항 없습니다.
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">【 전문가의 확인 】</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0">1. 전문가의 확인</TITLE>
<P>해당사항 없습니다.&cr;</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0">2. 전문가와의 이해관계</TITLE>
<P>해당사항 없습니다.</P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>